Search:
(CSV files for researchmap) [PDF manual]

Research Activity

Field of Study

Metabolic Pathology
Bone and Calcium Metabolism
Endocrinology

Subject of Study

代謝疾患に伴う血管障害の病因と治療に関する研究 (diabetes, atherosclerosis)
血液·骨髄増殖性疾患に伴う骨破壊の病態と治療に関する研究 (多発性骨髄腫, bone metastasis)
内分泌疾患の病因·診断および治療に関する分子医学的研究 (ホルモンの作用機序, 骨カルシウム代謝学)

Book / Paper

Book:

1.Toshio Matsumoto :
骨代謝疾患,
Medic Media, Apr. 2013.
2.Itsuro Endo, Masahiro Abe and Toshio Matsumoto :
骨転移の分子標的治療薬,
Dec. 2012.
3.Takeshi Kondo, Itsuro Endo and Toshio Matsumoto :
テリパラチド皮下注製剤の骨形成促進作用とその使用法,
Jun. 2012.
4.Kumiko Kagawa, Masahiro Abe and Toshio Matsumoto :
がん骨転移治療―ビスフォスフォネート治療によるBone Management,
SENTAN IGAKU-SHA, Mar. 2012.
5.Shingen Nakamura, Masahiro Abe and Toshio Matsumoto :
新規治療薬の開発と臨床応用の可能性を探る (抗RANKL抗体などを中心に),
Mar. 2012.
6.Toshio Matsumoto :
内分泌疾患最近の動向,
メディカル·ジャーナル社, 2011.
7.Itsuro Endo and Toshio Matsumoto :
不動性骨粗鬆症,
Oct. 2010.
8.Itsuro Endo and Toshio Matsumoto :
新規開発中の治療薬,
医薬ジャーナル, 東京, Oct. 2010.
9.Itsuro Endo and Toshio Matsumoto :
不動性骨粗鬆症,
Oct. 2010.
10.Masashi Akaike and Toshio Matsumoto :
V 実験的研究 6.血管内皮障害―nitric oxideの観点から―,
KINPODO, INC., Oct. 2010.
11.Itsuro Endo and Toshio Matsumoto :
ビタミンDの古典的作用-基礎と臨床からー,
Jul. 2010.
12.Itsuro Endo and Toshio Matsumoto :
[Hormones and osteoporosis update. Vitamin D and bone].,
Jul. 2009.
(PubMed: 19567986)
13.Sumiko Yoshida, Itsuro Endo and Toshio Matsumoto :
骨代謝 (ホルモンの病態異常と臨床検査) -- (各論 多臓器,組織におけるホルモン相互間作用),
IGAKU-SHOIN Ltd.Tokyo,Japan, 2008.
(CiNii: 40016341813)
14.Masahiro Abe and Toshio Matsumoto :
第2章 サイトカインによる生体調節機構 3)代謝,
YODOSHA CO., LTD., Tokyo, Nov. 2005.
15.Masahiro Abe and Toshio Matsumoto :
A mechanism of bone destruction in multiple myeloma,
Medical Review Co.,Ltd, Osaka, Nov. 2005.
16.Masahiro Abe and Toshio Matsumoto :
Bone Marrow in Cancer Metastasis,
Shujunsha Co.Ltd., Tokyo, Jul. 2005.
17.Masahiro Abe and Toshio Matsumoto :
癌と骨組織との相互作用,
Nakayama-Shoten Co., Ltd., Tokyo, Oct. 2004.
18.Toshihiro Hashimoto, Masahiro Abe and Toshio Matsumoto :
[Biochemical markers in bone metastasis].,
癌と化学療法社, Tokyo, Jul. 2004.
(PubMed: 15272580,   Elsevier: Scopus)
19.Toshihiro Hashimoto, Masahiro Abe and Toshio Matsumoto :
癌に伴う骨病変の病態と治療,
Nankodo, Tokyo, Apr. 2004.
20.Yuichi Fujinaka and Toshio Matsumoto :
糖尿病 最新の治療 2004-2006,
Nankodo, Tokyo, Feb. 2004.
21.Yuichi Fujinaka and Toshio Matsumoto :
糖尿病,
2000.
22.Yuichi Fujinaka and Toshio Matsumoto :
糖尿病性昏睡,
2000.

Academic Paper (Judged Full Paper):

1.Yuichi Takashi, Shu Wakino, Hitoshi Minakuchi, Masashi Ishizu, Akio Kuroda, Hisato Shima, Manabu Tashiro, Keiko Miya, Kazuyoshi Okada, Jun Minakuchi, Shu Kawashima, Munehide Matsuhisa, Toshio Matsumoto and Seiji Fukumoto :
Circulating FGF23 is not associated with cardiac dysfunction, atherosclerosis, infection or inflammation in hemodialysis patients.,
Journal of Bone and Mineral Metabolism, 2019.
(DOI: 10.1007/s00774-019-01027-7,   PubMed: 31420749)
2.Yuichi Takashi, Hidetaka Kosako, Shun Sawatsubashi, Yuka Kinoshita, Nobuaki Ito, Maria K. Tsoumpra, Masaomi Nangaku, Masahiro Abe, Munehide Matsuhisa, Shigeaki Kato, Toshio Matsumoto and Seiji Fukumoto :
Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation,
Proceedings of the National Academy of Sciences of the United States of America, Vol.116, No.23, 11418-11427, 2019.
(Tokushima University Institutional Repository: 113621,   DOI: 10.1073/pnas.1815166116,   PubMed: 31097591)
3.Dong Bingzi, Itsuro Endo, Ohnishi Yukoyo, Mitsui Yukari, Kiyoe Kurahashi, Mai Kanai, Masahiro Hiasa, Jumpei Teramachi, Hirofumi Tenshin, Seiji Fukumoto, Masahiro Abe and Toshio Matsumoto :
Persistent Activation of Calcium-Sensing Receptor Suppresses Bone Turnover, Increases Microcracks, and Decreases Bone Strength.,
JBMR Plus, Vol.3, No.7, e10182, 2019.
(DOI: 10.1002/jbm4.10182,   PubMed: 31372589)
4.Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Takeshi Harada, Shingen Nakamura, Ryota Amachi, Hirofumi Tenshin, Masami Iwasa, Shiroh Fujii, Kumiko Kagawa, Hirokazu Miki, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma.,
British Journal of Haematology, Vol.180, No.4, 581-585, 2018.
(Tokushima University Institutional Repository: 112935,   DOI: 10.1111/bjh.14388,   PubMed: 27748523)
5.Shun Sawatsubashi, Yudai Joko, Seiji Fukumoto, Toshio Matsumoto and Shigeo S. Sugano :
Development of versatile non-homologous end joining-based knock-in module for genome editing.,
Scientific Reports, Vol.8, No.1, 593, 2018.
(Tokushima University Institutional Repository: 112400,   DOI: 10.1038/s41598-017-18911-9,   PubMed: 29330493,   Elsevier: Scopus)
6.Hirofumi Tenshin, Jumpei Teramachi, Asuka Oda, Ryota Amachi, Masahiro Hiasa, Ariunzaya Bat-Erdene, Keiichiro Watanabe, Masami Iwasa, Takeshi Harada, Shiroh Fujii, Kumiko Kagawa, Kimiko Sogabe, Shingen Nakamura, Hirokazu Miki, Kiyoe Kurahashi, Sumiko Yoshida, Kenichi Aihara, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects.,
Blood Advances, Vol.1, No.24, 2124-2137, 2017.
(Tokushima University Institutional Repository: 113517,   DOI: 10.1182/bloodadvances.2017008813,   PubMed: 29296860)
7.Takeshi Mitsuhashi, Ryoko Uemoto, Kazue Ishikawa, Sumiko Yoshida, Yasumasa Ikeda, Shusuke Yagi, Toshio Matsumoto, Masashi Akaike and Ken-ichi Aihara :
Endothelial Nitric Oxide Synthase-Independent Pleiotropic Effects of Pitavastatin Against Atherogenesis and Limb Ischemia in Mice.,
Journal of Atherosclerosis and Thrombosis, 2017.
(DOI: 10.5551/jat.37747,   PubMed: 28592707)
8.Kiyoe Kurahashi, Seika Inoue, Sumiko Yoshida, Yasumasa Ikeda, Kana Morimoto, Ryoko Uemoto, Kazue Ishikawa, Takeshi Kondo, Tomoyuki Yuasa, Itsuro Endo, Masato Miyake, Seiichi Oyadomari, Toshio Matsumoto, Masahiro Abe, Hiroshi Sakaue and Ken-ichi Aihara :
The Role of Heparin Cofactor in the Regulation of Insulin Sensitivity and Maintenance of Glucose Homeostasis in Humans and Mice.,
Journal of Atherosclerosis and Thrombosis, 2017.
(DOI: 10.5551/jat.37739,   PubMed: 28502917)
9.Akio Kuroda, Tsuruo Miho, Aki Nanako, Takeshi Kondo, Oguro Yukari, Motoyuki Tamaki, Ken-ichi Aihara, Itsuro Endo, Toshio Matsumoto, Masahiro Abe and Munehide Matsuhisa :
A Pirot study comparing the CGM-assessed glycemic profiles of patients with type 1 diabetes on insulin degludec and insulin glargine,
Diabetology International, Vol.8, No.1, 112-115, 2017.
(DOI: 10.1007/s13340-016-0289-4,   Elsevier: Scopus)
10.Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, Takeshi Harada, Asuka Oda, Shingen Nakamura, Derek Hanson, Keiichiro Watanabe, Shiroh Fujii, Hirokazu Miki, Kumiko Kagawa, Masami Iwasa, Itsuro Endo, Takeshi Kondo, Sumiko Yoshida, Ken-ichi Aihara, Kiyoe Kurahashi, Yoshiaki Kuroda, Hideaki Horikawa, Eiji Tanaka, Masahiro Abe and Toshio Matsumoto :
A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration.,
Oncotarget, Vol.7, No.43, 70447-70461, 2016.
(Tokushima University Institutional Repository: 113048,   DOI: 10.18632/oncotarget.11927,   PubMed: 27626482)
11.Takeshi Harada, Hirokazu Miki, Q Cui, A Oda, Ryota Amachi, Jumpei Teramachi, A Bat-Erdene, K Sogabe, M Iwasa, Shiroh Fujii, Shingen Nakamura, Kumiko Kagawa, Sumiko Yoshida, I Endo, Ken-ichi Aihara, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Expansion of Th1-like V9V2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid.,
Leukemia, Vol.31, No.1, 258-262, 2016.
(DOI: 10.1038/leu.2016.273,   PubMed: 27698446)
12.Takeshi Kondo, Itsuro Endo, Ken-ichi Aihara, Ohnishi Yukiyo, Dong Bingzi, Oguro Yukari, Kiyoe Kurahashi, Sumiko Yoshida, Yuichi Fujinaka, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Toshio Matsumoto and Masahiro Abe :
Serum carboxy-terminal telopeptide of type I collagen levels are associated with carotid atherosclerosis in patients with cardiovascular risk factors.,
Endocrine Journal, Vol.63, No.4, 397-404, 2016.
(DOI: 10.1507/endocrj.EJ15-0589,   PubMed: 26877258,   Elsevier: Scopus)
13.James Derek Hanson, Shingen Nakamura, Ryota Amachi, Masahiro Hiasa, Asuka Oda, Daisuke Tsuji, Kohji Itoh, Takeshi Harada, Kazuki Horikawa, Jumpei Teramachi, Hirokazu Miki, Toshio Matsumoto and Masahiro Abe :
Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation.,
Oncotarget, Vol.6, No.32, 33568-33586, 2015.
(DOI: 10.18632/oncotarget.5598,   PubMed: 26384349,   Elsevier: Scopus)
14.Shusuke Yagi, Ken-ichi Aihara, Masashi Akaike, Daiju Fukuda, HM Salim, Masayoshi Ishida, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Michio Shimabukuro, Toshio Matsumoto and Masataka Sata :
Predictive factors for efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus.,
Diabetes & Metabolism Journal, Vol.39, No.4, 342-347, 2015.
(DOI: 10.4093/dmj.2015.39.4.342,   PubMed: 26301197,   Elsevier: Scopus)
15.Seiji Fukumoto, Keiichi Ozono, Toshimi Michigami, Masanori Minagawa, Ryo Okazaki, Toshitsugu Sugimoto, Yasuhiro Takeuchi and Toshio Matsumoto :
Pathogenesis and diagnostic criteria for rickets and osteomalacia-proposal by an expert panel supported by the Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research, and the Japan Endocrine Society.,
Journal of Bone and Mineral Metabolism, Vol.33, No.5, 467-473, 2015.
(DOI: 10.1007/s00774-015-0698-7,   PubMed: 26197863,   Elsevier: Scopus)
16.Bingzi Dong, Itsuro Endo, Yukiyo Ohnishi, Takeshi Kondo, Tomoka Hasegawa, Norio Amizuka, Hiroshi Kiyonari, Go Shioi, Masahiro Abe, Seiji Fukumoto and Toshio Matsumoto :
Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).,
Journal of Bone and Mineral Research, Vol.30, No.11, 1980-1993, 2015.
(DOI: 10.1002/jbmr.2551,   PubMed: 25967373,   Elsevier: Scopus)
17.Itsuro Endo, Seiji Fukumoto, Keiichi Ozono, Noriyuki Namba, Daisuke Inoue, Ryo Okazaki, Mika Yamauchi, Toshitsugu Sugimoto, Masanori Minagawa, Toshimi Michigami, Masaki Nagai and Toshio Matsumoto :
Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment.,
Endocrine Journal, Vol.62, No.9, 811-816, 2015.
(DOI: 10.1507/endocrj.EJ15-0275,   PubMed: 26135520,   Elsevier: Scopus)
18.Jin Temma, Munehide Matsuhisa, Toru Horie, Akio Kuroda, Hiroyasu Mori, Motoyuki Tamaki, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe and Toshio Matsumoto :
Non-invasive Measurement of Skin Autofluorescence as a Beneficial Surrogate Marker for Atherosclerosis in Patients with Type 2 Diabetes,
The Journal of Medical Investigation : JMI, Vol.62, No.3-4, 126-129, 2015.
(Tokushima University Institutional Repository: 111266,   DOI: 10.2152/jmi.62.126,   PubMed: 26399335,   Elsevier: Scopus)
19.鈴木 麗子, 大和 光, Kazuyoshi Kawazoe, Ken-ichi Aihara, Itsuro Endo, 安芸 菜奈子, 倉橋 清衛, Toshio Matsumoto, Akio Kuroda and Munehide Matsuhisa :
インスリン注射により生じた皮下硬結を有する患者の実体調査とその介入の有用性の検討,
Practice, Vol.31, No.6, 815-821, 2014.
20.Shusuke Yagi, M Fujimura, Masashi Akaike, Ken-ichi Aihara, Takashi Iwase, M Tada, Yuka Ueda, Takayuki Ise, Koji Yamaguchi, Tetsuzo Wakatsuki, Toshio Matsumoto and Masataka Sata :
Increase in serum triglyceride was associated with coronary plaque vulnerability in a patient with rheumatoid arthritis.,
Journal of Cardiology Cases, Vol.10, No.2, 54-57, 2014.
(DOI: 10.1016/j.jccase.2014.04.009,   Elsevier: Scopus)
21.Shusuke Yagi, Ken-ichi Aihara, Takeshi Kondo, Itsuro Endo, Junko Hotsuchi, Takayuki Ise, Takashi Iwase, Masashi Akaike, Toshio Matsumoto and Masataka Sata :
High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients.,
Endocrine Journal, Vol.61, No.7, 727-733, 2014.
(DOI: 10.1507/endocrj.EJ14-0004,   PubMed: 24849536,   CiNii: 130004443979,   Elsevier: Scopus)
22.Masashi Akaike, Ken-ichi Aihara, Hiroaki Yanagawa, Takashi Iwase, Sumiko Yoshida, Sato Chiho, Saijo Tomoka, Hiroaki Mikasa, Kashiwada Yoshizaki, Yoshihisa Takaishi, Koichiro Tsuchiya, Toshiaki Tamaki, Toshio Matsumoto and Masataka Sata :
Efficacy and safety of Citrus sudachi peel in obese adults:A randomized, double-blind, pilot study,
Functional Foods in Health and Disease, Vol.4, No.6, 276-284, 2014.
23.Koichiro Hayashi, Michihiro Nakamura, Hirokazu Miki, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto, Sakamoto Wataru, Yogo Toshinobu and Kazunori Ishimura :
Magnetically Responsive Smart Nanoparticles for Cancer Treatment with a Combination of Magnetic Hyperthermia and Remote-Control Drug Release,
Theranostics, Vol.4, No.8, 834-844, 2014.
(DOI: 10.7150/thno.9199,   PubMed: 24955144,   Elsevier: Scopus)
24.Masahiro Hiasa, Jumpei Teramachi, A Oda, Ryota Amachi, T Harada, Shingen Nakamura, Hirokazu Miki, Shiroh Fujii, Kumiko Kagawa, Keiichiro Watanabe, Itsuro Endo, Y Kuroda, T Yoneda, Daisuke Tsuji, Michiyasu Nakao, Eiji Tanaka, Kenichi Hamada, Shigeki Sano, Kouji Itou, Toshio Matsumoto and Masahiro Abe :
Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma.,
Leukemia, 2014.
(DOI: 10.1038/leu.2014.147,   PubMed: 24787487)
25.Masahiro Abe, Takeshi Harada and Toshio Matsumoto :
Concise review: Defining and targeting myeloma stem cell-like cells.,
Stem Cells, Vol.32, No.5, 1067-1073, 2014.
(DOI: 10.1002/stem.1643,   PubMed: 24449391)
26.Koichiro Hayashi, Michihiro Nakamura, Hirokazu Miki, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto, Toshinari Kori and Kazunori Ishimura :
Photostable Iodinated Silica/Porphyrin Hybrid Nanoparticles with Heavy-Atom Effect for Wide-Field Photodynamic/Photothermal Therapy Using Single Light Source,
Advanced Functional Materials, Vol.24, No.4, 503-513, 2014.
(DOI: 10.1002/adfm.201301771,   Elsevier: Scopus)
27.Mizuho Kinouchi, Ken-ichi Aihara, Yuichi Fujinaka, Sumiko Yoshida, Yukari Ooguro, Kiyoe Kurahashi, Takeshi Kondo, Nanako Aki, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto :
Diabetic conditions differentially affect the endothelial function, arterial stiffness and carotid atherosclerosis.,
Journal of Atherosclerosis and Thrombosis, Vol.21, No.5, 486-500, 2014.
(DOI: 10.5551/jat.20834,   PubMed: 24401746,   CiNii: 130004444734,   Elsevier: Scopus)
28.Takeshi Kondo, Akio Kuroda, 曽我部 公子, 大黒 由加里, 倉橋 清衛, Motoyuki Tamaki, Mizuho Kinouchi, Sumiko Yoshida, 安芸 菜奈子, Itsuro Endo, Ken-ichi Aihara, Yuichi Fujinaka, Munehide Matsuhisa and Toshio Matsumoto :
Comparison of Continuous Glucose Monitoring (CGM) Values before and after Adrenalectomy in a Case of Adrenaline-producing Pheochromocytoma,
Journal of the The Japan Diabetes Society, Vol.57, No.9, 729-735, 2014.
(DOI: 10.11213/tonyobyo.57.729,   CiNii: 130004696304,   Elsevier: Scopus)
29.Takeshi Harada, Shuji Ozaki, Asuka Oda, Daisuke Tsuji, Akishige Ikegame, Masami Iwasa, Kengo Udaka, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Yoshiaki Kuroda, Shigeto Kawai, Kouji Itou, Hisafumi Yamada-Okabe, Toshio Matsumoto and Masahiro Abe :
Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors,
PLoS ONE, Vol.8, No.12, e83905, 2013.
(DOI: 10.1371/journal.pone.0083905,   PubMed: 24386306,   Elsevier: Scopus)
30.弘世 貴久, 渡邉 隆宏, 綿田 裕孝, 安孫子 亜津子, 羽田 勝計, 武部 典子, 佐藤 譲, 山口 賢, 石原 寿光, 前田 朝美, 江藤 一弘, 太田 明雄, 田中 逸, 武田 貞二, 駒津 光久, 卯木 智, 前川 聡, 伊藤 裕進, 能宗 伸輔, 廣峰 義久, 川畑 由美子, 池上 博司, 寺前 純吾, 花房 俊昭, 富永 貴元, 井上 康, 谷澤 幸生, Toshio Matsumoto, Akio Kuroda, Munehide Matsuhisa, 野見山 崇, 柳瀬 敏彦, 小林 邦久, 近藤 龍也, 荒木 栄一, 石井 則夫, 井形 元雄, 久木留 大介, 本島 寛之 and 河盛 隆造 :
Effectiveness of miglitol combined with various types of insulin therapy for reducing the daily glycemic fluctuation on Japanese type 2 diabetic patients: Evaluation with self-monitoring blood glucose (SMBG),
Therapeutic Research, Vol.34, No.12, 1503-1511, 2013.
(Elsevier: Scopus)
31.Sumiko Yoshida, Ken-ichi Aihara, Yasumasa Ikeda, Yuka Sumitomo-Ueda, Ryoko Uemoto, Kazue Ishikawa, Takayuki Ise, Shusuke Yagi, Takashi Iwase, Yasuhiro Mouri, Matomo Sakari, Takahiro Matsumoto, Ken-ichi Takeyama, Masashi Akaike, Mitsuru Matsumoto, Masataka Sata, Kenneth Walsh, Shigeaki Kato and Toshio Matsumoto :
Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling.,
Circulation, Vol.128, No.1, 60-71, 2013.
(DOI: 10.1161/CIRCULATIONAHA.113.001533,   PubMed: 23723256)
32.Shingen Nakamura, Hirokazu Miki, Shinsuke Kido, Ayako Nakano, Masahiro Hiasa, Asuka Oda, Hiroe Amou, Keiichiro Watanabe, Takeshi Harada, Shiroh Fujii, Kyoko Takeuchi, Kumiko Kagawa, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Activating transcription factor 4, an ER stress mediator, is required for, but exce ssive ER stress suppresses osteoblastogenesis by bortezomib.,
International Journal of Hematology, Vol.98, No.1, 66-73, 2013.
(DOI: 10.1007/s12185-013-1367-z,   PubMed: 23708974,   Elsevier: Scopus)
33.Koichiro Hayashi, Michihiro Nakamura, Hirokazu Miki, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto and Kazunori Ishimura :
Gold Nanoparticle Cluster/Plasmon-Enhanced Fluorescent Silica Core-Shell Nanoparticles for X-Ray Computed Tomography/Fluorescence Dual-Mode Imaging of Tumors,
Chemical Communications, Vol.49, 5334-5336, 2013.
(DOI: 10.1039/c3cc41876f,   PubMed: 23648868)
34.Koichiro Hayashi, Michihiro Nakamura, Wataru Sakamoto, Toshinobu Yogo, Hirokazu Miki, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto and Kazunori Ishimura :
"Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment,
Theranostics, Vol.3, No.6, 366-376, 2013.
(DOI: 10.7150/thno.5860,   PubMed: 23781284,   Elsevier: Scopus)
35.Shuji Kato, Itsuro Endo, Mitsunori Fujimura, Rika Kuriwaka-Kido, Yuichi Fujinaka, Ken-ichi Aihara, Takashi Iwase, Daisuke Inoue, Masashi Akaike, Masahiro Abe and Toshio Matsumoto :
Serum carboxy-terminal telopeptide of type I collagen (ICTP) as a surrogate marker for vulnerable plaques in atherosclerotic patients: A pilot study.,
Atherosclerosis, Vol.229, No.1, 182-185, 2013.
(DOI: 10.1016/j.atherosclerosis.2013.03.030,   PubMed: 23639859)
36.Sumiko Yoshida, Akio Kuroda, 新居 沙央里, 松本 友里, 近藤 絵里, 安藝 菜奈子, Itsuro Endo, Ken-ichi Aihara, 鈴木 麗子, Toshio Matsumoto and Munehide Matsuhisa :
The New Paradigm 722 Insulin Pump Can Achieve Good Glycemic Control with Carbohydrate Counting Alone : A Case Report of Type 1 Diabetes Mellitus,
Journal of the The Japan Diabetes Society, Vol.56, No.4, 240-245, 2013.
(DOI: 10.11213/tonyobyo.56.240,   CiNii: 40019683974,   Elsevier: Scopus)
37.Hiroshi Hagino, Masataka Shiraki, Masao Fukunaga, Tetsuo Nakano, Kunio Takaoka, Yasuo Ohashi, Toshitaka Nakamura and Toshio Matsumoto :
Number and severity of prevalent vertebral fractures and the risk of subsequent vertebral fractures in Japanese women with osteoporosis: results from the minodronate trial.,
Journal of Bone and Mineral Metabolism, Vol.31, No.5, 544-550, 2013.
(DOI: 10.1007/s00774-013-0439-8,   PubMed: 23529800,   Elsevier: Scopus)
38.Rika Kuriwaka-Kido, Shinsuke Kido, Yuka Miyatani, Yuji Ito, Takeshi Kondo, Takashi Omatsu, Bingzi Dong, Itsuro Endo, Ken-ichi Miyamoto and Toshio Matsumoto :
Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess.,
Endocrinology, Vol.154, No.3, 1156-1167, 2013.
(DOI: 10.1210/en.2013-1915,   PubMed: 23397032)
39.Akio Kuroda, Tetsuyuki Yasuda, Mitsuyoshi Takahara, Fumie Sakamoto, Ryuichi Kasami, Kazuyuki Miyashita, Sumiko Yoshida, Eri Kondo, Ken-ichi Aihara, Itsuro Endo, Taka-Aki Matsuoka, Hideaki Kaneto, Toshio Matsumoto, Iichiro Shimomura and Munehide Matsuhisa :
Carbohydrate-to-Insulin Ratio Is Estimated from 300-400 Divided by Total Daily Insulin Dose in Type 1 Diabetes Patients Who Use the Insulin Pump.,
Diabetes Technology & Therapeutics, Vol.14, No.11, 1077-1080, 2012.
(DOI: 10.1089/dia.2012.0109,   PubMed: 23101953)
40.Hiroshi Hagino, Toshiyuki Takano, Masao Fukunaga, Masataka Shiraki, Toshitaka Nakamura and Toshio Matsumoto :
Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis.,
Journal of Bone and Mineral Metabolism, Vol.31, No.2, 183-189, 2012.
(DOI: 10.1007/s00774-012-0397-6,   Elsevier: Scopus)
41.Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, Takashi Iwase, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya, Masataka Sata, Masashi Akaike, Shigeaki Kato, Toshio Matsumoto and Toshiaki Tamaki :
Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway,
The Journal of Biological Chemistry, Vol.287, No.41, 34256-34263, 2012.
(DOI: 10.1074/jbc.M112.353532,   PubMed: 22904320)
42.Koichiro Hayashi, Michihiro Nakamura, Hirokazu Miki, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto and Kazunori Ishimura :
Near-Infrared Fluorescent Silica/Porphyrin Hybrid Nanorings for In Vivo Cancer Imaging,
Advanced Functional Materials, Vol.22, No.17, 3539-3546, 2012.
(DOI: 10.1002/adfm.201200219)
43.Tamotsu Kanbara, Hirotsugu Kurobe, Takashi Kitaichi, Mikio Sugano, Nakayama Taisuke, Hajime Kinoshita, Takashi Iwase, Akaike Masafumi, Masahiro Abe, Masataka Sata, Toshio Matsumoto and Tetsuya Kitagawa :
Autologous Peripheral Blood-Derived Mononuclear Cells Induced by Erythropoietin Improve Critical Ischemic Limbs.,
Annals of Vascular Diseases, Vol.5, No.1, 52-60, 2012.
(DOI: 10.3400/avd.oa.11.00070,   PubMed: 23555486)
44.Toshio Matsumoto and Itsuro Endo :
Eldecalcitol for the treatment of osteoporosis.,
Drugs of Today, Vol.48, No.3, 189-196, 2012.
(DOI: 10.1358/dot.2012.48.3.1745223,   PubMed: 22462038)
45.Kumiko Kagawa, Ayako Nakano, Hirokazu Miki, Asuka Oda, Hiroe Amou, Kyoko Takeuchi, Shingen Nakamura, Takeshi Harada, Shiro Fujii, Kenichiro Yata, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.,
PLoS ONE, Vol.7, No.2, 2012.
(DOI: 10.1371/journal.pone.0031594,   PubMed: 22389670)
46.Sumiko Yoshida, Ken-ichi Aihara, Yuka Ueda, Takayuki Ise, Yasumasa Ikeda, 倉橋 清衛, Mizuho Kinouchi, Itsuro Endo, Yuichi Fujinaka, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
ロスバスタチンによる脂質低下作用非依存的な形態的および機能的頸動脈硬化改善作用,
Progress in Medicine, Vol.32, No.2, 315-320, 2012.
47.Hirotsugu Kurobe, Ken-ichi Aihara, Higashida Mayuko, Hirata Yoichiro, Nishiya Masako, Matsuoka Yuki, Tamotsu Kanbara, Nakayama Taisuke, Hajime Kinoshita, Mikio Sugano, Eiki Fujimoto, Kurobe Ayako, Sugawara Noriko, Takashi Kitaichi, Masashi Akaike, Masataka Sata, Toshio Matsumoto and Tetsuya Kitagawa :
Ezetimibe monotherapy ameliorates vascular function in patients with hypercholesterolemia through decreasing oxidative stress.,
Journal of Atherosclerosis and Thrombosis, Vol.18, No.12, 1080-1089, 2011.
(DOI: 10.5551/jat.9548,   PubMed: 22027560)
48.Hirokazu Miki, Shingen Nakamura, Shuji Ozaki, A Oda, H Amou, Akishige Ikegame, Keiichiro Watanabe, Masahiro Hiasa, Q Cui, T Harada, Shiroh Fujii, A Nakano, Kumiko Kagawa, Kyoko Takeuchi, Ken-ichiro Yata, A Sakai, Masahiro Abe and Toshio Matsumoto :
KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclasts.,
British Journal of Haematology, Vol.155, No.3, 328-339, 2011.
(DOI: 10.1111/j.1365-2141.2011.08844.x,   PubMed: 21902681)
49.Toshio Matsumoto, Rika Kuriwaka-Kido, Takeshi Kondo, Itsuro Endo and Shinsuke Kido :
Regulation of osteoblast differentiation by interleukin-11 via AP-1 and Smad signaling.,
Endocrine Journal, Vol.59, No.2, 91-101, 2011.
(DOI: 10.1507/endocrj.EJ11-0219,   PubMed: 21931225)
50.Toshio Matsumoto, Masako Ito, Yasufumi Hayashi, Takako Hirota, Yusuke Tanigawara, Teruki Sone, Masao Fukunaga, Masataka Shiraki and Toshitaka Nakamura :
A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study.,
Bone, Vol.49, No.4, 605-612, 2011.
(DOI: 10.1016/j.bone.2011.07.011,   PubMed: 21784190,   Elsevier: Scopus)
51.Qu Cui, Hironobu Shibata, Asuka Oda, Hiroe Amou, Ayako Nakano, Kenichiro Yata, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Takeshi Harada, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Targeting myeloma-osteoclast interaction with V9V2 T cells.,
International Journal of Hematology, Vol.94, No.1, 63-70, 2011.
(DOI: 10.1007/s12185-011-0885-9,   PubMed: 21698356)
52.Ayako Nakano, Masahiro Abe, Asuka Oda, Hiroe Amou, Masahiro Hiasa, Shingen Nakamura, Hirokazu Miki, Takeshi Harada, Shirou Fujii, Kumiko Kagawa, Kyoko Takeuchi, Takashi Watanabe, Shuji Ozaki and Toshio Matsumoto :
Delayed treatment with vitamin C and N-acetyl-L: -cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib.,
International Journal of Hematology, Vol.93, No.6, 727-735, 2011.
(DOI: 10.1007/s12185-011-0850-7,   PubMed: 21526377)
53.J Asano, A Nakano, A Oda, H Amou, Masahiro Hiasa, Kyoko Takeuchi, H Miki, S Nakamura, T Harada, Shiroh Fujii, Kumiko Kagawa, Itsuro Endo, Ken-ichiro Yata, A Sakai, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.,
Leukemia, 2011.
(DOI: 10.1038/leu.2011.60,   PubMed: 21475253)
54.Shusuke Yagi, Masashi Akaike, Ken-ichi Aihara, Takashi Iwase, Kazue Ishikawa, Sumiko Yoshida, Yuka Sumitomo-Ueda, Kenya Kusunose, Toshiyuki Niki, Koji Yamaguchi, Kunihiko Koshiba, Yoshio Taketani, Noriko Tomita, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Toshio Matsumoto and Masataka Sata :
Effect of low-dose (1 mg/day) pitavastatin on left ventricular diastolic function and albuminuria in patients with hyperlipidemia.,
The American Journal of Cardiology, Vol.107, No.11, 1644-1649, 2011.
(DOI: 10.1016/j.amjcard.2011.01.054,   PubMed: 21458773)
55.Shusuke Yagi, Masashi Akaike, Ken-ichi Aihara, Takashi Iwase, Yuka Sumitomo-Ueda, Sumiko Yoshida, Toshio Matsumoto and Masataka Sata :
Bosentan improves systemic sclerosis-related peripheral circulation insufficiency.,
International Journal of Cardiology, Vol.147, No.3, 472-475, 2011.
(DOI: 10.1016/j.ijcard.2011.01.025,   PubMed: 21296436)
56.Michihiro Nakamura, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto and Kazunori Ishimura :
One-pot synthesis and characterization of dual fluorescent thiol-organosilica nanoparticles as non-photoblinking quantum dots and their applications for biological imaging,
Journal of Materials Chemistry, Vol.21, 4689-4695, 2011.
(DOI: 10.1039/C0JM04259E)
57.Shunji Hashizume, Masashi Akaike, Hiroyuki Azuma, Kazue Ishikawa, Sumiko Yoshida, Yuka Ueda, Shusuke Yagi, Yasumasa Ikeda, Takashi Iwase, Ken-ichi Aihara, Masahiro Abe, Masataka Sata and Toshio Matsumoto :
Activation of peroxisome proliferator-activated receptor α in megakaryocytes reduces platelet-derived growth factor-BB in platelets.,
Journal of Atherosclerosis and Thrombosis, Vol.18, No.2, 138-147, 2011.
(DOI: 10.5551/jat.5868,   PubMed: 21060209)
58.Takayuki Ise, Ken-ichi Aihara, Yuka Ueda, Sumiko Yoshida, Yasumasa Ikeda, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Plasma heparin cofactor II activity is inversely associated with left atrial volume and diastolic dysfunction in humans with cardiovascular risk factors.,
Hypertension Research, Vol.34, No.2, 225-231, 2010.
(DOI: 10.1038/hr.2010.211,   PubMed: 21107326)
59.Shusuke Yagi, Masashi Akaike, Takashi Iwase, Kenya Kusunose, Toshiyuki Niki, Koji Yamaguchi, Kunihiko Koshiba, Sumiko Yoshida, Yuka Sumitomo-Ueda, Ken-ichi Aihara, Yoichiro Hirata, Munkhbaatar Dagvasumberel, Yoshio Taketani, Noriko Tomita, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Toshio Matsumoto and Masataka Sata :
Bosentan ameliorated exercise-induced pulmonary arterial hypertension complicated with systemic sclerosis.,
Internal Medicine, Vol.49, No.21, 2309-2312, 2010.
(DOI: 10.2169/internalmedicine.49.3812,   PubMed: 21048365,   CiNii: 130000413347)
60.Shinsuke Kido, Rika Kuriwaka-Kido, Yuka Umino-Miyatani, Itsuro Endo, Daisuke Inoue, Hisaaki Taniguchi, Yasumichi Inoue, Takeshi Imamura and Toshio Matsumoto :
Mechanical stress activates Smad pathway through PKCδ to enhance interleukin-11 gene transcription in osteoblasts.,
PLoS ONE, Vol.5, No.9, 2010.
(DOI: 10.1371/journal.pone.0013090,   PubMed: 20927330)
61.Shusuke Yagi, Masashi Akaike, Ken-ichi Aihara, Takashi Iwase, Sumiko Yoshida, Yuka Ueda, Yasumasa Ikeda, Kazue Ishikawa, Toshio Matsumoto and Masataka Sata :
High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension.,
Hypertension Research, Vol.34, No.1, 74-78, 2010.
(DOI: 10.1038/hr.2010.179,   PubMed: 20861841)
62.Takako Taniguchi, Shinsuke Kido, Emiko Yamauchi, Masahiro Abe, Toshio Matsumoto and Hisaaki Taniguchi :
Induction of endosomal/lysosomal pathways in differentiating osteoblasts as revealed by combined proteomic and transcriptomic analyses.,
FEBS Letters, Vol.584, No.18, 3969-3974, 2010.
(DOI: 10.1016/j.febslet.2010.07.055,   PubMed: 20682313)
63.Yuka Sumitomo-Ueda, Ken-ichi Aihara, Takayuki Ise, Sumiko Yoshida, Yasumasa Ikeda, Ryoko Uemoto, Shusuke Yagi, Takashi Iwase, Kazue Ishikawa, Yoichiro Hirata, Masashi Akaike, Masataka Sata, Shigeaki Kato and Toshio Matsumoto :
Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice.,
Hypertension, Vol.56, No.3, 430-436, 2010.
(DOI: 10.1161/HYPERTENSIONAHA.110.152207,   PubMed: 20660821)
64.Ryo Okazaki, Toshitsugu Sugimoto, Hiroshi Kaji, Yoshio Fujii, Masataka Shiraki, Daisuke Inoue, Itsuro Endo, Toshio Okano, Takako Hirota, Issei Kurahashi and Toshio Matsumoto :
Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D3 load in Japanese subjects.,
Journal of Bone and Mineral Metabolism, Vol.29, No.1, 103-110, 2010.
(DOI: 10.1007/s00774-010-0200-5,   PubMed: 20567864)
65.Sumiko Yoshida, Ken-ichi Aihara, Hiroyuki Azuma, Ryoko Uemoto, Yuka Sumitomo-Ueda, Shusuke Yagi, Yasumasa Ikeda, Takashi Iwase, Susumu Nishio, Hiromi Kawano, Junko Miki, Hirotsugu Yamada, Yoichiro Hirata, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Dehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial function.,
Atherosclerosis, Vol.212, No.1, 310-315, 2010.
(DOI: 10.1016/j.atherosclerosis.2010.05.011,   PubMed: 20627295)
66.Yasumasa Ikeda, Ken-ichi Aihara, Masashi Akaike, Takashi Sato, Kazue Ishikawa, Takayuki Ise, Shusuke Yagi, Takashi Iwase, Yuka Ueda, Sumiko Yoshida, Hiroyuki Azuma, Kenneth Walsh, Toshiaki Tamaki, Shigeaki Kato and Toshio Matsumoto :
Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice.,
Molecular Endocrinology, Vol.24, No.7, 1338-1348, 2010.
(DOI: 10.1210/me.2009-0402,   PubMed: 20501642)
67.Shusuke Yagi, Masashi Akaike, Mitsunori Fujimura, Takehiko Kimura, Takeshi Nishiuchi, Takashi Iwase, Ken-ichi Aihara, Sumiko Yoshida, Yuka Sumitomo-Ueda, Kenya Kusunose, Toshiyuki Niki, Koji Yamaguchi, Kunihiko Koshiba, Yoichiro Hirata, Munkhbaatar Dagvasumberel, Yoshio Taketani, Noriko Tomita, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Toshio Matsumoto and Masataka Sata :
Congenital ventricular aneurysm as an unexpected complication of monomorphic premature ventricular contractions.,
Internal Medicine, Vol.49, No.10, 907-912, 2010.
(DOI: 10.2169/internalmedicine.49.3008,   PubMed: 20467175,   CiNii: 130000251561)
68.Michihiro Nakamura, Shuji Ozaki, Masahiro Abe, Hiroyuki Doi, Toshio Matsumoto and Kazunori Ishimura :
Size-controlled synthesis, surface functionalization, and biological applications of thiol-organosilica particles.,
Colloids and Surfaces B:Biointerfaces, Vol.79, No.1, 19-26, 2010.
(DOI: 10.1016/j.colsurfb.2010.03.008,   PubMed: 20417071)
69.Kyoko Takeuchi, Masahiro Abe, Masahiro Hiasa, Asuka Oda, Hiroe Amou, Shinsuke Kido, Takeshi Harada, Osamu Tanaka, Hirokazu Miki, Shingen Nakamura, Ayako Nakano, Kumiko Kagawa, Kenichiro Yata, Shuji Ozaki and Toshio Matsumoto :
Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth.,
PLoS ONE, Vol.5, No.3, e9870, 2010.
(DOI: 10.1371/journal.pone.0009870,   PubMed: 20360846)
70.Shusuke Yagi, Masashi Akaike, Ken-ichi Aihara, Kazue Ishikawa, Takashi Iwase, Yasumasa Ikeda, Takeshi Soeki, Sumiko Yoshida, Yuka Sumitomo-Ueda, Toshio Matsumoto and Masataka Sata :
Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.,
Hypertension, Vol.55, No.4, 918-923, 2010.
(DOI: 10.1161/HYPERTENSIONAHA.109.146076,   PubMed: 20194307)
71.Shusuke Yagi, Masashi Akaike, Ken-ichi Aihara, Takashi Iwase, Kazue Ishikawa, Sumiko Yoshida, Yuka Sumitomo-Ueda, Kenya Kusunose, Toshiyuki Niki, Koji Yamaguchi, Kunihiko Koshiba, Yoichiro Hirata, Munkhbaatar Dagvasumberel, Yoshio Taketani, Noriko Tomita, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Toshio Matsumoto and Masataka Sata :
Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemia.,
Journal of Atherosclerosis and Thrombosis, Vol.17, No.2, 173-180, 2010.
(DOI: 10.5551/jat.2378,   PubMed: 20150722)
72.Hajime Kinoshita, Tamotsu Kanbara, Hirotsugu Kurobe, Tatsuo Motoki, Mikio Sugano, Homare Yoshida, Takashi Kitaichi, Masataka Sata, Toshio Matsumoto and Tetsuya Kitagawa :
Successful Implantations of Autologous Peripheral Blood-Derived Mononuclear Cells Pretreated by Erythropoietin and Blood Donation in a Patient with Buerger Disease and Intractable Finger Ulcers,
Japanese Journal of Cardiovascular Surgery, Vol.39, No.1, 29-33, 2010.
(DOI: 10.4326/jjcvs.39.29)
73.Masatomo Mihara, Ken-ichi Aihara, Yasumasa Ikeda, Sumiko Yoshida, Mizuho Kinouchi, Kiyoe Kurahashi, Yuichi Fujinaka, Masashi Akaike and Toshio Matsumoto :
Inhibition of thrombin action ameliorates insulin resistance in type 2 diabetic db/db mice.,
Endocrinology, Vol.151, No.2, 513-519, 2009.
(DOI: 10.1210/en.2009-0661,   PubMed: 19966184)
74.Masahiro Hiasa, Masahiro Abe, Ayako Nakano, Asuka Oda, Hiroe Amou, Shinsuke Kido, Kyoko Takeuchi, Kumiko Kagawa, Kenichiro Yata, Toshihiro Hashimoto, Shuji Ozaki, Kenzo Asaoka, Eiji Tanaka, Keiji Moriyama and Toshio Matsumoto :
GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-{alpha} converting enzyme (TACE),
Blood, Vol.114, No.20, 4517-4526, 2009.
(DOI: 10.1182/blood-2009-04-215020,   PubMed: 19762488)
75.Mitsunori Fujimura, Masashi Akaike, Takashi Iwase, Sumiko Yoshida, Yuka Sumitomo, Shusuke Yagi, Yasumasa Ikeda, Shunji Hashizume, Ken-ichi Aihara, Takeshi Nishiuchi, Yoshio Yasumura and Toshio Matsumoto :
Decrease in plasma brain natriuretic peptide level in the early phase after the start of carvedilol therapy is a novel predictor of long-term outcome in patients with chronic heart failure.,
Acta Cardiologica, Vol.64, No.5, 589-595, 2009.
(DOI: 10.2143/AC.64.5.2042687,   PubMed: 20058503)
76.Ken-ichi Aihara, Hiroyuki Azuma, Masashi Akaike, Hirotsugu Kurobe, Nobuyuki Takamori, Yasumasa Ikeda, Yuka Sumitomo, Sumiko Yoshida, Shusuke Yagi, Takashi Iwase, Kazue Ishikawa, Masataka Sata, Tetsuya Kitagawa and Toshio Matsumoto :
Heparin cofactor II is an independent protective factor against peripheral arterial disease in elderly subjects with cardiovascular risk factors.,
Journal of Atherosclerosis and Thrombosis, Vol.16, No.2, 127-134, 2009.
(DOI: 10.5551/jat.E695,   PubMed: 19403987)
77.Ken-ichi Aihara, Masashi Akaike, Yasumasa Ikeda, Yuka Ueda, Sumiko Yoshida, Takayuki Ise, Shusuke Yagi, Takashi Iwase, 近藤 彰, 田村 克也 and Toshio Matsumoto :
アンジオテンシンII受容体拮抗薬バルサルタンのNO bioavailability改善効果に関する臨床的検討,
Progress in Medicine, Vol.29, No.7, 1777-1782, 2009.
78.Ken-ichi Kitazoe, Masahiro Abe, Masahiro Hiasa, Asuka Oda, Hiroe Amou, Takeshi Harada, Ayako Nakano, Kyoko Takeuchi, Toshihiro Hashimoto, Ken-ichiro Yata, Shuji Ozaki and Toshio Matsumoto :
Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma.,
International Journal of Hematology, Vol.89, No.1, 45-57, 2008.
(DOI: 10.1007/s12185-008-0226-9,   PubMed: 19093163)
79.Shusuke Yagi, Masahi Akaike, Mitsunori Fujimura, Takayuki Ise, Sumiko Yoshida, Yuka Sumitomo, Yasumasa Ikeda, Takashi Iwase, Ken-ichi Aihara, Hiroyuki Azuma, Atsushi Kurushima, Youichi Ichikawa, Tetsuya Kitagawa, Takehiko Kimura, Takeshi Nishiuchi and Toshio Matsumoto :
Infective endocarditis caused by lactobacillus.,
Internal Medicine, Vol.47, No.12, 1113-1116, 2008.
(DOI: 10.2169/internalmedicine.47.0744,   PubMed: 18552468)
80.Itsuro Endo, Seiji Fukumoto, Keiichi Ozono, Noriyuki Namba, Hiroyuki Tanaka, Daisuke Inoue, Masanori Minagawa, Toshitsugu Sugimoto, Mika Yamauchi, Toshimi Michigami and Toshio Matsumoto :
Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.,
Bone, Vol.42, No.6, 1235-1239, 2008.
(DOI: 10.1016/j.bone.2008.02.014,   PubMed: 18396126)
81.Toshiyuki Obata, Ichiro Yokota, Kazuhiro Yokoyama, Eiji Okamoto, Yoshiko Kanezaki, Yoshinori Tanaka, Hiroshi Maegawa, Kiyoshi Teshigawara, Fumiko Hirota, Tomoyuki Yuasa, Kazuhiro Kishi, Atsushi Hattori, Seiichi Hashida, Kazuhiko Masuda, Mitsuru Matsumoto, Toshio Matsumoto, Atsunori Kashiwagi and Yousuke Ebina :
Soluble insulin receptor ectodomain is elevated in the plasma of patients with diabetes mellitus.,
Diabetes, Vol.56, No.8, 2028-2035, 2007.
(DOI: 10.2337/db07-0394,   PubMed: 17563065)
82.Ken-ichi Aihara, Hiroyuki Azuma, Masashi Akaike, Yasumasa Ikeda, Masataka Sata, Nobuyuki Takamori, Shusuke Yagi, Takashi Iwase, Yuka Sumitomo, Hirotaka Kawano, Takashi Yamada, Toru Fukuda, Takahiro Matsumoto, Keisuke Sekine, Takashi Sato, Yuko Nakamichi, Yoko Yamamoto, Kimihiro Yoshimura, Tomoyuki Watanabe, Takashi Nakamura, Akimasa Oomizu, Minoru Tsukada, Hideki Hayashi, Toshiki Sudo, Shigeaki Kato and Toshio Matsumoto :
Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice,
The Journal of Clinical Investigation, Vol.117, No.6, 1514-1526, 2007.
(DOI: 10.1172/JCI27095,   PubMed: 17549254)
83.Youichi Tanaka, Masahiro Abe, Masahiro Hiasa, Asuka Oda, Hiroe Amou, Ayako Nakano, Kyoko Takeuchi, Kenichi Kitazoe, Shinsuke Kido, Daisuke Inoue, Keiji Moriyama, Toshihiro Hashimoto, Shuji Ozaki and Toshio Matsumoto :
Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and Osteopontin,
Clinical Cancer Research, Vol.13, No.3, 816-823, 2007.
(DOI: 10.1158/1078-0432.CCR-06-2258,   PubMed: 17289872)
84.近藤 剛史, Itsuro Endo, 木内 美瑞穂, Yuichi Fujinaka, Daisuke Inoue, 福本 誠二, 大歯 浩一, Kenji Endo, Natsuo Yasui, 長谷川 匡, Hisanori Uehara, Yoshimi Bando and Toshio Matsumoto :
腫瘍性骨軟化症の一例,
日本内分泌学会雑誌, Vol.83, 136-138, 2007.
85.Masahiro Abe, Shinsuke Kido, Masahiro Hiasa, Nakano Ayako, Oda Asuka, Amou Hiroe and Toshio Matsumoto :
BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACI-Fc tratment in patients with multiple myeloma.,
Leukemia, Vol.20, No.7, 1313-1315, 2006.
(DOI: 10.1038/sj.leu.2404228,   PubMed: 16617317)
86.Y. Kuroda, Takao Mitsui, M. Kunishige, Masayuki Shono, Masashi Akaike, H. Azuma and Toshio Matsumoto :
Parkin enhances mitochondrial biogenesis in proliferating cells.,
Human Molecular Genetics, Vol.15, No.6, 883-895, 2006.
(DOI: 10.1093/hmg/ddl006,   PubMed: 16449237)
87.Ali Jalili, Shuji Ozaki, Tomoko Hara, Hironobu Shibata, Toshihiro Hashimoto, Masahiro Abe, Yasuhiko Nishioka and Toshio Matsumoto :
Induction of HM1.24 peptide specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma,
Blood, Vol.106, No.10, 3538-3545, 2005.
(DOI: 10.1182/blood-2005-04-1438,   PubMed: 16037388)
88.Takashi Oshima, Masahiro Abe, Jin Asano, Tomoko Hara, Kenichi Kitazoe, Etsuko Sekimoto, Yoichi Tanaka, Hironobu Shibata, Toshihiro Hashimoto, Shuji Ozaki, Shinsuke Kido, Daisuke Inoue and Toshio Matsumoto :
Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2,
Blood, Vol.106, No.9, 3160-3165, 2005.
(DOI: 10.1182/blood-2004-12-4940,   PubMed: 16030194)
89.Hironobu Shibata, Masahiro Abe, Kenji Hiura, Javier Wilde, Keiji Moriyama, Toshiaki Sano, Ken-ichi Kitazoe, Toshihiro Hashimoto, Shuji Ozaki, Shingo Wakatsuki, Shinsuke Kido, Daisuke Inoue and Toshio Matsumoto :
Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis.,
Clinical Cancer Research, Vol.11, No.17, 6109-6115, 2005.
(DOI: 10.1158/1078-0432.CCR-05-0181,   PubMed: 16144909)
90.Toshio Matsumoto, Takami Miki, Hiroshi Hagino, Toshitsugu Sugimoto, Sumiaki Okamoto, Takako Hirota, Yusuke Tanigawara, Yasufumi Hayashi, Masao Fukunaga, Masataka Shiraki and Toshitaka Nakamura :
A New Active Vitamin D, ED-71, Increases Bone Mass in Osteoporotic Patients under Vitamin D Supplementation: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial,
The Journal of Clinical Endocrinology and Metabolism, Vol.90, No.9, 5031-5036, 2005.
(DOI: 10.1210/jc.2004-2552,   PubMed: 15972580,   Elsevier: Scopus)
91.Yasumasa Ikeda, Ken-ichi Aihara, Takashi Sato, Masashi Akaike, Masanori Yoshizumi, Yuki Suzaki, Yuki Izawa-Ishizawa, Mitsunori Fujimura, Shunji Hashizume, Midori Kato, Shusuke Yagi, Toshiaki Tamaki, Hirotaka Kawano, Takahiro Matsumoto, Hiroyuki Azuma, Shigeaki Kato and Toshio Matsumoto :
Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis.,
The Journal of Biological Chemistry, Vol.280, No.33, 29661-29666, 2005.
(DOI: 10.1074/jbc.M411694200,   PubMed: 15961403)
92.Takashi Iwase, Noritoshi Nagaya, Takafumi Fujii, Takefumi Itoh, Shinsuke Murakami, Toshio Matsumoto, Kenji Kangawa and Soichiro Kitamura :
Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia,
Cardiovascular Research, Vol.66, No.3, 543-551, 2005.
(DOI: 10.1016/j.cardiores.2005.02.006,   PubMed: 15914119,   Elsevier: Scopus)
93.Kana Shichijo, Takao Mitsui, Makoto Kunishige, Yukiko Kuroda, Kenjiro Masuda and Toshio Matsumoto :
Involvement of mitochondria in myasthenia gravis complicated with dermatomyositis and rheumatoid arthritis: a case report,
Acta Neuropathologica, Vol.109, No.5, 539-542, 2005.
(DOI: 10.1007/s00401-005-0990-z,   PubMed: 15843907,   Elsevier: Scopus)
94.Midori Kato, Hiroyuki Azuma, Masashi Akaike, Takahiko Iuchi, Ken-ichi Aihara, Yasumasa Ikeda, Mitsunori Fujimura, Tomonori Yoshida, Hiroshi Yamaguchi, Shunji Hashizume and Toshio Matsumoto :
Aspirin inhibits thrombin action on endothelial cells via up-regulation of aminopeptidase N/CD13 expression.,
Atherosclerosis, Vol.183, No.1, 49-55, 2005.
(DOI: 10.1016/j.atherosclerosis.2005.03.003,   PubMed: 16216591)
95.Hajime Nawata, Satoshi Soen, Ryoichi Takayanagi, Ikuo Tanaka, Kunio Takaoka, Masao Fukunaga, Toshio Matsumoto, Yasuo Suzuki, Hiroyuki Tanaka, Saeko Fujiwara, Takami Miki, Akira Sagawa, Yoshiki Nishizawa and Yoshiki Seino :
Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research(2004),
Journal of Bone and Mineral Metabolism, Vol.23, No.2, 105-109, 2005.
(DOI: 10.1007/s00774-004-0596-x,   PubMed: 15750687,   Elsevier: Scopus)
96.Toshio Matsumoto and Masahiro Abe :
The Importance of Notch Signaling in Myeloma Cell-Osteoclast Interactions,
BoneKEy Osteovision, Vol.2, No.2, 7-10, 2005.
(DOI: 10.1138/20050148)
97.Takashi Iwase, Noritoshi Nagaya, Takafumi Fujii, Takefumi Itoh, Hatsue Ishibashi-Ueda, Masakazu Yamagishi, Kunio Miyatake, Toshio Matsumoto, Soichiro Kitamura and Kenji Kangawa :
Adrenomedullin enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia,
Circulation, Vol.111, No.3, 356-362, 2005.
(DOI: 10.1161/01.CIR.0000153352.29335.B9,   PubMed: 15655128,   Elsevier: Scopus)
98.Tomonori Yoshida, Hiroyuki Azuma, Ken-ichi Aihara, Mitsunori Fujimura, Masashi Akaike, Takao Mitsui and Toshio Matsumoto :
Vascular smooth muscle cell proliferation is dependent upon upregulation of mitochondrial transcription factor A (mtTFA) expression in injured rat carotid artery,
Atherosclerosis, Vol.178, No.1, 39-47, 2005.
(DOI: 10.1016/j.atherosclerosis.2004.08.029,   PubMed: 15585199)
99.M Kunishige, Takao Mitsui, I Endo and Toshio Matsumoto :
Dermatomyositis associated with impairment in both muscle aerobic and anaerobic function,
Clinical Neuropathology, Vol.24, No.1, 32-35, 2005.
(PubMed: 15696782)
100.山口 普史, Yasumasa Ikeda, 藤村 光則, 森岡 将臣, 橋詰 俊二, 加藤 みどり, Ken-ichi Aihara, Masashi Akaike, Hiroyuki Azuma, Toshio Matsumoto, 稲山 真美 and Masaki Hanibuchi :
アミオダロン肺合併症との鑑別を要したマイコプラズマ肺炎合併拡張型心筋症の1例,
Progress in Medicine, Vol.25, No.Suppl.1, 1552-1556, 2005.
101.H. Omori, Takao Mitsui, M. Kunishige, I. Endo, K. Takahashi and Toshio Matsumoto :
Systemic muscular inflammation in a patient with recurrent orbital myositis,
Clinical Neuropathology, Vol.24, No.4, 191-193, 2005.
(PubMed: 16033136,   Elsevier: Scopus)
102.Naoki Kimura, Shigeto Kawai, Yasuko Kinoshita, Takahiro Ishiguro, Yumiko Azuma, Shuji Ozaki, Masahiro Abe, Masamichi Sugimoto, Yuichi Hirata, Tetsuro Orita, Hisafumi Okabe, Toshio Matsumoto and Masayuki Tsuchiya :
2D7 diabody bound to the α2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells,
Biochemical and Biophysical Research Communications, Vol.325, No.4, 1201-1209, 2004.
(DOI: 10.1016/j.bbrc.2004.10.163,   PubMed: 15555554)
103.Masayuki Iki, Takashi Akiba, Toshio Matsumoto, Harumi Nishino, Sadanobu Kagamimori, Yoshiko Kagawa and Hideo Yoneshima :
Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study,
Osteoporosis International, Vol.15, No.12, 981-991, 2004.
(DOI: 10.1007/s00198-004-1634-1,   PubMed: 15570414,   Elsevier: Scopus)
104.Daisuke Inoue, Shinsuke Kido and Toshio Matsumoto :
Transcriptional Induction of FosB/FosB Gene by Mechanical Stress in Osteoblasts,
The Journal of Biological Chemistry, Vol.279, No.48, 49795-49803, 2004.
(DOI: 10.1074/jbc.M404096200,   PubMed: 15383527,   Elsevier: Scopus)
105.M Kunishige, Takao Mitsui, B. H. Tan, H. N. Leong, T Takasaki, I Kurane, A Mihara and Toshio Matsumoto :
Preferential gray matter involvement in dengue myelitis,
Neurology, Vol.63, No.10, 1980-1981, 2004.
(DOI: 10.1212/01.WNL.0000144194.29643.D0,   PubMed: 15557535,   Elsevier: Scopus)
106.YUKIKO WATANABE, HIROSHI OHSHIMA, KOH MIZUNO, CHIHARU SEKIGUCHI, MASAO FUKUNAGA, KENJIRO KOHRI, JÖRN RITTWEGER, DIETER FELSENBERG, Toshio Matsumoto and TOSHITAKA NAKAMURA :
Intravenous Pamidronate Prevents Femoral Bone Loss and Renal Stone Formation During 90-Day Bed Rest,
Journal of Bone and Mineral Research, Vol.19, No.11, 1771-1778, 2004.
(DOI: 10.1359/JBMR.040811,   PubMed: 15476576,   Elsevier: Scopus)
107.Yukiho Tanimoto, Masahiko Yokozeki, Hiura Kenji, Kazuya Matsumoto, Hideki Nakanishi, Toshio Matsumoto, PJ Marie and Keiji Moriyama :
A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation In Apert syndrome.,
The Journal of Biological Chemistry, Vol.279, No.44, 45926-45934, 2004.
(DOI: 10.1074/jbc.M404824200,   PubMed: 15310757,   CiNii: 80017019211)
108.Makoto Kunishige, Takao Mitsui, Hiide Yoshino, Atsuko Asano, Miho Tsuruo, Itsuro Endo, Fumikazu Yagi and Toshio Matsumoto :
Isolated cranial neuropathy associated with anti-glycolipid antibodies,
Journal of the Neurological Sciences, Vol.225, No.1-2, 51-55, 2004.
(DOI: 10.1016/j.jns.2004.06.017,   PubMed: 15465085,   Elsevier: Scopus)
109.Masahiro Abe, Kenji Hiura, Javier Wilde, Atsushi Shioyasono, Keiji Moriyama, Toshihiro Hashimoto, Shinsuke Kido, Takashi Oshima, Hironobu Shibata, Shuji Ozaki, Daisuke Inoue and Toshio Matsumoto :
Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion.,
Blood, Vol.104, No.8, 2484-2491, 2004.
(DOI: 10.1182/blood-2003-11-3839,   PubMed: 15187021)
110.Yuichi Fujinaka, Sumiko Yoshida, 鈴木 康博, Daisuke Inoue, Toshio Matsumoto, 影治 照喜, Kazuhito Matsuzaki, 岡崎 敏之, 里見 淳一郎, 永廣 信治, 隈 晴二, 佐野 壽昭, 新谷 保実 and 福本 礼 :
片側性副腎腫瘤を合併した Cushing 病の1例,
ホルモンと臨床, Vol.52, 135-140, 2004.
(CiNii: 10013547538)
111.Ken-ichi Aihara, Hiroyuki Azuma, Masashi Akaike, Yasumasa Ikeda, Michiko Yamashita, Toshiki Sudo, Hideki Hayashi, Yoshihisa Yamada, Fuminari Endoh, Mitsunori Fujimura, Tomonori Yoshida, Hiroshi Yamaguchi, Shunji Hashizume, Midori Kato, Kimihiro Yoshimura, Yoko Yamamoto, Shigeaki Kato and Toshio Matsumoto :
Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice,
The Journal of Biological Chemistry, Vol.279, No.34, 35798-35802, 2004.
(DOI: 10.1074/jbc.M404865200,   PubMed: 15205460,   CiNii: 80016878495)
112.A. Ohno, Takao Mitsui, I. Endo, M. Kunishige, T. Sigekiyo and Toshio Matsumoto :
Dermatomyositis associated with Sjögren's syndrome: VEGF involvement in vasculitis,
Clinical Neuropathology, Vol.23, No.4, 178-182, 2004.
(PubMed: 15328883,   Elsevier: Scopus)
113.Yasushi Oshima, Yukiko Kuroda, Makoto Kunishige, Toshio Matsumoto and Takao Mitsui :
OXIDATIVE STRESS-ASSOCIATED MITOCHONDRIAL DYSFUNCTION IN CORTICOSTEROID-TREATED MUSCLE CELLS,
Muscle & Nerve, Vol.30, No.1, 49-54, 2004.
(DOI: 10.1002/mus.20036,   PubMed: 15221878,   Elsevier: Scopus)
114.Ken-ichi Aihara, Hiroyuki Azuma, Nobuyuki Takamori, Yasuhiko Kanagawa, Masashi Akaike, Mitsunori Fujimura, Tomonori Yoshida, Shunji Hashizume, Midori Kato, Hiroshi Yamaguchi, Shuji Kato, Yasumasa Ikeda, Tomoko Arase, Akira Kondo and Toshio Matsumoto :
Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals.,
Circulation, Vol.109, No.22, 2761-2765, 2004.
(DOI: 10.1161/01.CIR.0000129968.46095.F3,   PubMed: 15148272)
115.Makoto Kunishige, Takao Mitsui, Yukiko Kuroda, Sumiko Yoshida, Masaaki Kosaka and Toshio Matsumoto :
Expanding phenotype and clinical heterogeneity in patients with identical mutation of the parkin gene.,
European Neurology, Vol.51, No.3, 183-185, 2004.
(DOI: 10.1159/000077671,   PubMed: 15073448)
116.Toshihiro Hashimoto, Masahiro Abe, Takashi Oshima, Hironobu Shibata, Shuji Ozaki, Daisuke Inoue and Toshio Matsumoto :
Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1α and MIP-1β correlates with lytic bone lesions in patients with multiple myeloma,
British Journal of Haematology, Vol.125, No.1, 38-41, 2004.
(DOI: 10.1111/j.1365-2141.2004.04864.x,   PubMed: 15015966)
117.Yoshiko Kanezaki, Toshiyuki Obata, Rie Matsushima, Asako Minami, Tomoyuki Yuasa, Kazuhiro Kishi, Yoshimi Bando, Hisanori Uehara, Keisuke Izumi, Tasuku Mitani, Mitsuru Matsumoto, Yukari Takeshita, Yutaka Nakaya, Toshio Matsumoto and Yousuke Ebina :
KATP Channel Knockout Mice Crossbred with Transgenic Mice Expressing a Dominant-Negative Form of Human Insulin Receptor have Glucose Intolerance but not Diabetes,
Endocrine Journal, Vol.51, No.2, 133-144, 2004.
(DOI: 10.1507/endocrj.51.133,   PubMed: 15118262)
118.Masashi Akaike, Hiroyuki Azuma, 石川 雅康, 井上 利彦, 遠藤 武徳, 岡崎 誠司, 小島 章裕, 佐藤 幸一, 田村 克也, 田村 隆一, 長楽 雅仁, 中平 晴仁, 林 郁郎, 日浅 光春, 藤村 光則, 松本 直也, 宮 恵子, 山口 普史, 吉田 健三, 渡部 滋夫 and Toshio Matsumoto :
日本動脈硬化学会による診療ガイドラインからみた高コレステロール血症治療の動向とその問題点,
Progress in Medicine, Vol.24, No.3, 767-772, 2004.
119.Daisuke Inoue and Toshio Matsumoto :
Reduced AP-1 mediated transcription of interleukin-11 gene in marrow stromal cells as a mechanism of senile Osteoprosis: lessons from SAMP6,
International Congress Series, Vol.1260, No.C, 61-65, 2004.
(DOI: 10.1016/S0531-5131(03)01692-3,   Elsevier: Scopus)
120.Nobuyuki Takamori, Hiroyuki Azuma, Midori Kato, Shunji Hashizume, Ken-ichi Aihara, Masashi Akaike, Katsuya Tamura and Toshio Matsumoto :
High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention,
Circulation, Vol.109, No.4, 481-486, 2004.
(DOI: 10.1161/01.CIR.0000109695.39671.37,   PubMed: 14744972)
121.Naoko Matsui, Takao Mitsui, Itsuro Endo, Yasushi Oshima, Makoto Kunishige and Toshio Matsumoto :
Dermatomyositis with peripheral nervous system involvement: activation of vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) in vasculitic lesions,
Internal Medicine, Vol.42, No.12, 1233-1239, 2003.
(DOI: 10.2169/internalmedicine.42.1233,   PubMed: 14714966,   Elsevier: Scopus)
122.Yukiko Hiasa, Makoto Kunishige, Takao Mitsui, Shunsuke Kondo, Rika Kuriwaka, Shizuka Shigekiyo, Takanori Kanematsu, Nobuo Satake, Yoshimi Bando, Akira Kondo, Itsuro Endo, Yasushi Oshima and Toshio Matsumoto :
Complicated paraneoplastic neurological syndromes: a report of two patients with small cell or non-small cell lung cancer,
Clinical Neurology and Neurosurgery, Vol.106, No.1, 47-49, 2003.
(DOI: 10.1016/S0303-8467(03)00059-3,   PubMed: 14643918,   Elsevier: Scopus)
123.Itsuro Endo, Daisuke Inoue, Takao Mitsui, Yoshifumi Umaki, Masashi Akaike, Tatsuya Yoshizawa, Shigeaki Kato and Toshio Matsumoto :
Deletion of Vitamin D Receptor Gene in Mice Results in Abnormal Skeletal Muscle Development with Deregulated Expression of Myoregulatory Transcription Factors,
Endocrinology, Vol.144, No.12, 5138-5144, 2003.
(DOI: 10.1210/en.2003-0502,   PubMed: 12959989)
124.Ken-ichi Aihara, Hiroyuki Azuma, Masashi Akaike, 藤村 光則, 吉田 智則, 橋詰 俊二, 加藤 みどり, 山口 普史, Yasumasa Ikeda, 加藤 茂明 and Toshio Matsumoto :
ビタミンD-ビタミンD受容体システムは生体における血液凝固調節因子である,
第25回日本血栓止血学会学術集会, Vol.14, No.5, 420, 2003.
125.Yuichi Fujinaka, 福永 絵里, 鈴木 康博, Daisuke Inoue and Toshio Matsumoto :
重篤な内分泌異常,骨代謝異常を認めた重症潰瘍性大腸炎の一例,
Folia endocrinologica Japonica, Vol.79, No.0, 51-54, 2003.
(CiNii: 10011593170)
126.Takao Mitsui, Yoshifumi Umaki, Masakazu Nagasawa, Masashi Akaike, Satoshi Ohtsuka, Masaaki Odomi, Kenji Aki and Toshio Matsumoto :
Motor neuron involvement in a patient with long-term corticosteroid administration,
Internal Medicine, Vol.42, No.9, 862-866, 2003.
(DOI: 10.2169/internalmedicine.42.862,   PubMed: 14518677,   CiNii: 130000766885)
127.Yoshiko Kanezaki, Rie Matsushima, Toshiyuki Obata, Yutaka Nakaya, Toshio Matsumoto and Yousuke Ebina :
Injection of the Insulin receptor alpha subunit increases blood glucose levels in mice,
Biochemical and Biophysical Research Communications, Vol.309, No.3, 572-577, 2003.
(DOI: 10.1016/j.bbrc.2003.08.028,   PubMed: 12963028)
128.Makoto Kunishige, Takao Mitsui, Masashi Akaike, Masakazu Kawajiri, Masayuki Shono, Hisaomi Kawai and Toshio Matsumoto :
Overexpressions of myoglobin and antioxidant enzymes in ragged-red fibers of skeletal muscle from patients with mitochondrial encephalomyopathy,
Muscle & Nerve, Vol.28, No.4, 484-492, 2003.
(DOI: 10.1002/mus.10466,   PubMed: 14506721)
129.Emiko Tohjima, Daisuke Inoue, Nobuchika Yamamoto, Shinsuke Kido, Yuji Ito, Shuji Kato, Yasuhiro Takeuchi, Seiji Fukumoto and Toshio Matsumoto :
Decreased AP-1 activity and interleukin-11 expression by bone marrow stromal cells may be associated with impaired bone formation in aged mice,
Journal of Bone and Mineral Research, Vol.18, No.8, 1461-1470, 2003.
(DOI: 10.1359/jbmr.2003.18.8.1461,   PubMed: 12929935,   Elsevier: Scopus)
130.Mitsunori Fujimura, Masashi Akaike, Midori Kato, Nobuyuki Takamori, Masahiro Abe, Takeshi Nishiuchi, Hiroyuki Azuma and Toshio Matsumoto :
Aggressive antiplatelet therapy before coronary stent implantation in acute coronary syndrome with essential thrombocythemia--a case report,
Angiology, Vol.54, No.4, 485-490, 2003.
(DOI: 10.1177/000331970305400414,   PubMed: 12934770)
131.Nami Inoue, Makoto Kunishige, Sumiko Yoshida, Yasushi Oshima, Yoshiaki Ohnishi, Yasuhiro Kuroda, Atsuko Asano, Hiide Yoshino, Toshio Matsumoto and Takao Mitsui :
Dissociation between titer of anti-ganglioside antibody and severity of symptoms in a case of Guillain-Barre syndrome with treatment-related fluctuation,
Journal of the Neurological Sciences, Vol.210, No.1-2, 105-108, 2003.
(DOI: 10.1016/S0022-510X(03)00031-5,   PubMed: 12736098)
132.新谷 保実, Sumiko Yoshida, 鈴木 康博, 加藤 修司, Yuichi Fujinaka, Daisuke Inoue, Toshio Matsumoto, 宮 恵子, 長田 淳一 and 小阪 昌明 :
絶食試験後の食事再開時に著しい高血糖をきたしたBulimia nervosaの1例,
ホルモンと臨床, Vol.51, No.6, 575-579, 2003.
(CiNii: 10011602750)
133.T Shigekiyo, O Fujino, Y Kanagawa and Toshio Matsumoto :
Prekallikrein (PK) Tokushima: PK deficiency caused by a Gly401-->Glu mutation,
Journal of Thrombosis and Haemostasis, Vol.1, No.6, 1314-1316, 2003.
(DOI: 10.1046/j.1538-7836.2003.00154.x,   PubMed: 12871337,   Elsevier: Scopus)
134.Shinsuke Kido, Daisuke Inoue, Kenji Hiura, Wilde Javier, Yuji Ito and Toshio Matsumoto :
Expression of RANK is dependent upon differentiation into the macrophage/osteoclast lineage: induction by 1alpha,25-dihydroxyvitamin D3 and TPA in a human myelomonocytic cell line, HL60,
Bone, Vol.32, No.6, 621-629, 2003.
(DOI: 10.1016/S8756-3282(03)00049-8,   PubMed: 12810169,   Elsevier: Scopus)
135.Soichi Honda, Chisato Kosugi, Shozo Yamada, Toshiaki Sano, Toshio Matsumoto, Mitsuo Itakura and Katsuhiko Yoshimoto :
Human Pituitary Adenomas Infrequently Contain Inactivation of Retinoblastoma 1 Gene and Activation of Cyclin Dependent Kinase 4 Gene.,
Endocrine Journal, Vol.50, No.3, 309-318, 2003.
(Tokushima University Institutional Repository: 111695,   DOI: 10.1507/endocrj.50.309,   PubMed: 12940460)
136.Takahiko Iuchi, Masashi Akaike, Takao Mitsui, Yasushi Ohshima, Yasumi Shintani, Hiroyuki Azuma and Toshio Matsumoto :
Glucocorticoid Excess Induces Superoxide Production in Vascular Endothelial Cells and Elicits Vascular Endothelial Dysfunction,
Circulation Research, Vol.92, No.1, 81-87, 2003.
(DOI: 10.1161/01.RES.0000050588.35034.3C,   PubMed: 12522124)
137.新谷 保実, 加藤 修司, Yuichi Fujinaka, Daisuke Inoue, 宮 恵子 and Toshio Matsumoto :
血糖コントロールに解離して糖化蛋白が異常高値を示した胃切除後糖尿病患者の1例,
内分泌・糖尿病科, Vol.16, No.4, 389-394, 2003.
138.新谷 保実, Yuichi Fujinaka, 高橋 幸志, 伊藤 祐司, 加藤 修司, Daisuke Inoue, Toshio Matsumoto, Nobuhiro Kurita, Seiki Tashiro, Yoshimi Bando, Toshiaki Sano and 宮 恵子 :
空腹時の血漿インスリン濃度は常に低値で,グルカゴンにより著明なインスリン分泌反応が誘導されたインスリノーマの1例,
糖尿病, Vol.46, No.8, 679-684, 2003.
139.Yuichi Fujinaka, Daisuke Inoue and Toshio Matsumoto :
重篤な骨粗鬆症および内分泌異常を認めた潰瘍性大腸炎の1例,
治療学, Vol.37, No.12, 1315-1319, 2003.
140.Yasuhiro Takeuchi, Sumiyo Watanabe, Genichiro Ishii, Shu Takeda, Konosuke Nakayama, Seiji Fukumoto, Yasuyuki Kaneta, Daisuke Inoue, Toshio Matsumoto, Kenichi Harigaya and Toshiro Fujita :
Interleukin-11 as a Stimulatory Factor for Bone Formation Prevents Bone Loss with Advancing Age in Mice*,
The Journal of Biological Chemistry, Vol.277, No.50, 49011-49018, 2002.
(DOI: 10.1074/jbc.M207804200,   PubMed: 12384500,   CiNii: 80015737527,   Elsevier: Scopus)
141.Itsuro Endo, Takao Mitsui and Toshio Matsumoto :
Diurnal fluctuation of edema synchronized with plasma VEGF concentration in patient with POEMS syndrome.,
Internal Medicine, Vol.41, No.12, 1196-1198, 2002.
(DOI: 10.2169/internalmedicine.41.1196,   CiNii: 130000767282,   Elsevier: Scopus)
142.Y Oshima, Takao Mitsui, H Yoshino, I Endo, M Kunishige, A Asano and Toshio Matsumoto :
Central motor conduction in patients with anti-ganglioside antibody associated neuropathy syndromes and hyperreflexia,
Journal of Neurology, Neurosurgery, and Psychiatry, Vol.73, No.5, 568-573, 2002.
(DOI: 10.1136/jnnp.73.5.568,   PubMed: 12397153,   Elsevier: Scopus)
143.E Fukunaga, M Kunishige, Takao Mitsui, I Endo, Y Oshima, Y Ohnishi, Y Kuroda, S Hara and Toshio Matsumoto :
Severe dermatomyositis with rhabdomyolysis and paralytic ileus: a case successfully treated with plasmapheresis and intravenous immunoglobulin,
European Journal of Neurology, Vol.9, No.6, 697-698, 2002.
(DOI: 10.1046/j.1468-1331.2002.00447_10.x,   PubMed: 12453096,   Elsevier: Scopus)
144.Masahiro Abe, Kenji Hiura, Javier Wilde, Keiji Moriyama, Toshihiro Hashimoto, Shuji Ozaki, Shingo Wakatsuki, Masaaki Kosaka, Shinsuke Kido, Daisuke Inoue and Toshio Matsumoto :
Role for macrophage inflammatory protein (MIP)-1α and MIP-1β in the development of osteolytic lesions in multiple myeloma,
Blood, Vol.100, No.6, 2195-2202, 2002.
(PubMed: 12200385,   Elsevier: Scopus)
145.Masashi Akaike, Hiroyuki Azuma, Ayako Kagawa, Kazuya Matsumoto, Ikuro Hayashi, Katsuya Tamura, Takeshi Nishiuchi, Takahiko Iuchi, Nobuyuki Takamori, Ken-ichi Aihara, Tomonori Yoshida, Yasuhiko Kanagawa and Toshio Matsumoto :
Effect of Aspirin Treatment on Serum Concentrations of Lipoprotein(a) in Patients with Atherosclerotic Diseases,
Clinical Chemistry, Vol.48, No.9, 1454-1459, 2002.
(PubMed: 12194922)
146.Takao Mitsui, Yoshifumi Umaki, Masakazu Nagasawa, Masashi Akaike, Kenji Aki, Hiroyuki Azuma, Shuji Ozaki, Masaaki Odomi and Toshio Matsumoto :
Mitochondrial damage in patients with long-term corticosteroid therapy: development of oculoskeletal symptoms similar to mitochondrial disease,
Acta Neuropathologica, Vol.104, No.3, 260-266, 2002.
(DOI: 10.1007/s00401-002-0553-5,   PubMed: 12172911)
147.Masahiro Abe, Yasumi Shintani, Yuzuru Eto, Kazuyo Harada, Masaaki Kosaka and Toshio Matsumoto :
Potent induction of activin A secretion from monocytes and bone marrow stromal fibroblasts by cognate interaction with activated T cells,
Journal of Leukocyte Biology, Vol.72, No.2, 347-352, 2002.
(PubMed: 12149426,   Elsevier: Scopus)
148.Takao Mitsui, Hiroyuki Azuma, Masakazu Nagasawa, Takahiko Iuchi, Masashi Akaike, Masaaki Odomi and Toshio Matsumoto :
Chronic corticosteroid administration causes mitochondrial dysfunction in skeletal muscle,
Journal of Neurology, Vol.249, No.8, 1004-1009, 2002.
(DOI: 10.1007/s00415-002-0774-5,   PubMed: 12195445)
149.Toshio Matsumoto, N Nagata, N Horikoshi, I Adachi and Y Ohashi :
Comparative study of incadronate and elcatonin in patients with malignancy-associated hypercalcaemia,
The Journal of International Medical Research, Vol.30, No.3, 230-243, 2002.
(PubMed: 12166339,   Elsevier: Scopus)
150.Ryo Okazaki, Daisuke Inoue, Minako Shibata, Mieko Saika, Shinsuke Kido, Hikari Ooka, Hirofumi Tomiyama, Yoshikazu Sakamoto and Toshio Matsumoto :
Estrogen Promotes Early Osteoblast Differentiation and Inhibits Adipocyte Differentiation in Mouse Bone Marrow Stromal Cell Lines that Express Estrogen Receptor (ER) α or ß,
Endocrinology, Vol.143, No.6, 2349-2356, 2002.
(DOI: 10.1210/endo.143.6.8854,   PubMed: 12021200)
151.Rika Kuriwaka, Takao Mitsui, Soichiro Fujiwara, Yoshihiko Nishida and Toshio Matsumoto :
Loss of postural reflexes in long-term occupational solvent exposure,
European Neurology, Vol.47, No.2, 85-87, 2002.
(DOI: 10.1159/000047958,   PubMed: 11844896,   Elsevier: Scopus)
152.Yoshifumi Umaki, Takao Mitsui, Itsuro Endo, Masashi Akaike and Toshio Matsumoto :
Apoptosis-related changes in skeletal muscles of patients with mitochondrial diseases,
Acta Neuropathologica, Vol.103, No.2, 163-170, 2002.
(DOI: 10.1007/s004010100446,   PubMed: 11810183)
153.Naoko Yagishita, Yoko Yamamoto, Tatsuya Yoshizawa, Keisuke Sekine, Yoshikatsu Uematsu, Hisashi Murayama, Yumiko Nagai, Wojciech Krezel, Pierre Chambon, Toshio Matsumoto and Shigeaki Kato :
Aberrant Growth Plate Development in VDR/RXR Double Null Mutant Mice,
Endocrinology, Vol.142, No.12, 5332-5341, 2001.
(DOI: 10.1210/endo.142.12.8544,   PubMed: 11713233,   Elsevier: Scopus)
154.Masahiro Abe, Yasumi Shintani, Yuzuru Eto, Kazuyo Harada, Yuichi Fujinaka, Masaaki Kosaka and Toshio Matsumoto :
Interleukin-1 β enhances and interferon-γ suppresses activin A actions by reciprocally regulating activin A and follistatin secretion from bone marrow stromal fibroblasts,
Clinical and Experimental Immunology, Vol.126, No.1, 64-68, 2001.
(DOI: 10.1046/j.1365-2249.2001.01644.x,   PubMed: 11678900,   Elsevier: Scopus)
155.Y Kuroda, Takao Mitsui, Masashi Akaike, Hiroyuki Azuma and Toshio Matsumoto :
Homozygous deletion mutation of the parkin gene in patients with atypical parkinsonism,
Journal of Neurology, Neurosurgery, and Psychiatry, Vol.71, No.2, 231-234, 2001.
(DOI: 10.1136/jnnp.71.2.231,   PubMed: 11459900)
156.Toshihiro Hashimoto, Makoto Takishita, Masaki Kosaka, Toshiaki Sano and Toshio Matsumoto :
Superantigens and autoantigens may be involved in the pathogenesis of gastric mucosa-associated lymphoid tissue lymphoma,
International Journal of Hematology, Vol.74, No.2, 197-204, 2001.
(DOI: 10.1007/BF02982005,   PubMed: 11594522,   Elsevier: Scopus)
157.Masahiro Abe, Y Shintani, Y Eto, K Harada, Y Fujinaka, M Kosaka and Toshio Matsumoto :
Interleukin 1β enhances and interferon-γ suppresses activin A actions by reciprocally regulating activin A and follistatin secretion from bone marrow stromal fibroblasts,
Clinical and Experimental Immunology, Vol.126, 64-68, 2001.
158.Mieko Saika, Daisuke Inoue, Shinsuke Kido and Toshio Matsumoto :
17β-Estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-α,
Endocrinology, Vol.142, No.6, 2205-2212, 2001.
(DOI: 10.1210/endo.142.6.8220,   PubMed: 11356664,   Elsevier: Scopus)
159.Ken-ichi Aihara, Hiroyuki Azuma, Yasumasa Ikeda, Masashi Akaike, Masahiro Abe, Takashi Sugihara and Toshio Matsumoto :
Successful combination therapy--flunarizine,pentoxifylline, and cholestyramine--for spur cell anemia,
International Journal of Hematology, Vol.73, No.3, 351-355, 2001.
(PubMed: 11345202)
160.A Nakano, Takao Mitsui, I Endo, Y Takeda, Shuji Ozaki and Toshio Matsumoto :
Solitary plasmacytoma with VEGF overproduction: report of a patient with polyneuropathy,
Neurology, Vol.56, No.6, 818-819, 2001.
(DOI: 10.1212/WNL.56.6.818,   PubMed: 11274332,   Elsevier: Scopus)
161.Yasuhiko Kanagawa, Toshio Shigekiyo, Ken-ichi Aihara, Masashi Akaike, Hiroyuki Azuma and Toshio Matsumoto :
Molecular mechanism of type I congenital heparin cofactor (HC) II deficiency caused by a missense mutation at reactive P2 site: HC II Tokushima,
Thrombosis and Haemostasis, Vol.85, No.1, 101-107, 2001.
(PubMed: 11204559,   Elsevier: Scopus)
162.Masashi Akaike, 井内 貴彦, 加藤 みどり, 吉田 智則, 橋詰 俊二, 高森 信行, 藤村 光則, 金川 泰彦, Hiroyuki Azuma and Toshio Matsumoto :
冠動脈疾患の予防ならびに治療の観点からみた高コレステロール血症治療の現状とその問題点,
診断と治療, Vol.89, No.3, 527-532, 2001.
163.Yasushi Oshima, Takao Mitsui, Itsuro Endo, Yoshifumi Umaki and Toshio Matsumoto :
Corticospinal tract involvement in a variant of Guillain-Barre syndrome,
European Neurology, Vol.46, No.1, 39-42, 2001.
(DOI: 10.1159/000050754,   Elsevier: Scopus)
164.Takamasa Ohnishi, Eiji Takeda, Shiro Yogita, Hidenori Miyake, Takafumi Kinoshita, Yoshiyasu Terashima, Toshio Matsumoto and Seiki Tashiro :
Effects of alendronate on bone metastases and hypercarcemia after surgery for hepatocellular carcinoma,
Japanese Journal of Clinical Oncology, Vol.30, No.9, 410-413, 2000.
(DOI: 10.1093/jjco/hyd105,   PubMed: 11095140,   Elsevier: Scopus)
165.Takao Mitsui, Masakazu Kawajiri, Makoto Kunishige, Takenori Endo, Masashi Akaike, Kenji Aki and Toshio Matsumoto :
Functional association between nicotinic acetylcholine receptor and sarcomeric proteins via actin and desmin filaments,
Journal of Cellular Biochemistry, Vol.77, No.4, 584-595, 2000.
166.Ayako Kagawa, Hiroyuki Azuma, Masashi Akaike, Yasuhiko Kanagawa and Toshio Matsumoto :
Aspirin Reduces Apolipoprotein(a) (Apo(a)) Production in Human Hepatocytes by Suppression of Apo(a) Gene Transcription,
The Journal of Biological Chemistry, Vol.274, No.48, 34111-34115, 1999.
(DOI: 10.1074/jbc.274.48.34111,   PubMed: 10567380,   Elsevier: Scopus)
167.Ryuzo Tani, Shuji Ozaki, Masaaki Kosaka, Soichiro Fujiwara, Hironobu Shibata, Shingo Wakatsuki and Toshio Matsumoto :
Fas ligand-induced apoptosis of hepatocytes in natural killer cell leukaemia,
British Journal of Haematology, Vol.106, No.3, 709-712, 1999.
(PubMed: 10468861,   Elsevier: Scopus)
168.Masashi Akaike, Hiroyuki Azuma, Ayako Kagawa, Yasuhiko Kanegawa, Ken-ichi Aihara, Madoka Matsuyama, Takahiko Iuchi, Nobuyuki Takamori, Tomonori Yoshida, Toshio Matsumoto, 松本 和也, Ikuro Hayashi, Katsuya Tamura and Takeshi Nishiuchi :
Effect of Aspirin Treatment on Serum Levels of Lipoprotein(a), --- Analysis From the Apolipoprotein(a)Isoforms ---,
Shikoku Acta Medica, Vol.55, No.3, 109-114, 1999.
(Tokushima University Institutional Repository: 112143)
169.Shuji Ozaki, Masaaki Kosaka, Yuji Wakahara, Yasuko Ozaki, Masayuki Tsuchiya, Yasuo Koishihara, Tetsuya Goto and Toshio Matsumoto :
Humanized anti-HM1.24 antibody mediates myeloma cell cytotoxicity that is enhanced by cytokine stimulation of effector cells,
Blood, Vol.93, No.11, 3922-3930, 1999.
(PubMed: 10339501,   Elsevier: Scopus)
170.Tomoko Hara, Shuji Ozaki, Masaaki Kosaka, Soichiro Fujiwara, Yuji Wakahara, Hideko Endo, shingo Wakatsuki and Toshio Matsumoto :
Biclonal lymphoplasmacytic immunocytoma associated with Crohn's disease,
Internal Medicine, Vol.38, No.6, 500-503, 1999.
(DOI: 10.2169/internalmedicine.38.500,   PubMed: 10411357)
171.M. Kawajiri, Takao Mitsui, Masayuki Shono and Toshio Matsumoto :
Quantitative analysis of immunofluorescent signals for dystrophin, beta-dystroglycan and myosin skeletal muscle by epifluorescence microscopy.,
Biotech-Histochem, Vol.74, No.2, 92-97, 1999.
172.Shuji Ozaki, Masaaki Kosaka, Masafumi Harada, Hiromu Nishitani, Masaaki Odomi and Toshio Matsumoto :
Radioimmunodetection of human myeloma xenografts with a monoclonal antibody directed against a plasma cell specific antigen, HM1.24,
Cancer, Vol.82, No.11, 2184-2190, 1998.
173.Shuji Ozaki, Koji Ogasahara, Masaaki Kosaka, Toshi Inoshita, Shingo Wakatsuki, Hisanori Uehara and Toshio Matsumoto :
Hepatosplenic gamma delta T-cell lymphoma associated with hepatitis B virus infection,
The Journal of Medical Investigation : JMI, Vol.44, No.3-4, 215-217, 1998.
(Tokushima University Institutional Repository: 110670,   PubMed: 9597812)
174.Shuji Ozaki, Masaaki Kosaka, Shingo Wakatsuki, Masahiro Abe, Yasuo Koishihara and Toshio Matsumoto :
Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24,
Blood, Vol.90, No.8, 3179-3186, 1997.
175.板東 浩, 藤中 真一, 斎藤 晴比古, 島 健二, 斎藤 史郎, Mitsuo Itakura, Toshio Matsumoto, Masamichi Kuwajima, Ken Saito, 川島 周, 鶴尾 美穂, 杉本 紀子, 杉本 順子, 清水 寛, 江藤 和子, 桜井 えつ, 近藤 彰, 林 健司, 福島 康江, 赤池 瞳, 岩田 坤, 住友 辰次, 小川 紘一, 松村 光博, 矢野 勇人, 川内 茂徳, 福田 克之, 竹田 勝則, 筒井 芳彦, 橋本 吉弘, 米田 弘, 土橋 孝之, 溝渕 樹, 石川 雅康, 木村 建彦, 大倉 敏裕, 高田 幸伸, 高橋 秀夫, 石川 由子, 曽根 佳世子, 阿部 多賀子, 和田 美智子 and 十枝 紀巳代 :
プライマリ·ケア医による糖尿病合併症の調査,
日本プライマリ·ケア学会誌, Vol.20, No.1, 46-51, 1997.

Academic Paper (Unrefereed Paper):

1.Shingen Nakamura, Masahiro Abe and Toshio Matsumoto :
Part7. 2. 新規治療薬の開発と臨床応用の可能性を探る (抗RANKL抗体などを中心に). がん骨転移治療 ビスフォスフォネート治療によるBone Management,
先端医学者 高橋俊二 編集, 206-214, 2012.
2.Itsuro Endo, Masahiro Abe and Toshio Matsumoto :
骨転移の分子標的治療薬 骨転移のバイオロジーとマネージメント,
医薬ジャーナル社 米田俊之 編集, 215-224, 2012.
3.Naoko Matsui, Takao Mitsui, Yasushi Ohshima, Kenji Yokoi, Makoto Kunishige, Fumikazu Yagi, Steven Vernino, Toshio Matsumoto and Ryuji Kaji :
Anti-neuronal antibodies in acute pandysautonomia.,
Internal Medicine, Vol.49, No.1, 73-77, 2010.
(DOI: 10.2169/internalmedicine.49.2788,   PubMed: 20046006,   CiNii: 130000142263)
4.Takashi Iwase, Hirotsugu Kurobe, Shusuke Yagi, 原 朋子, 長楽 雅仁, 藤村 光則, Shuji Ozaki, Masashi Akaike, 安部 正博, Yutaka Masuda, Hiroyuki Azuma, Toshio Matsumoto and Tetsuya Kitagawa :
末梢単核球細胞を用いた抹消動脈閉塞症に対する新たな血管新生治療の試み,
Shikoku Acta Medica, Vol.62, No.3,4, 137-141, 2006.
(Tokushima University Institutional Repository: 49311)
5.七條 加奈, 関本 悦子, 三原 愛, 大田 加与, 田中 洋一, 大島 隆志, 柴田 泰伸, Toshihiro Hashimoto, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto and 若槻 真吾 :
Successful treatment of relapsed/refractory Hodgkin's lymphoma with tandem transplantation,
The Journal of the Japanese Society of Internal Medicine, Vol.93, No.10, 2210-2212, 2004.
(DOI: 10.2169/naika.93.2210,   CiNii: 10014293411)
6.Masahiro Abe, Toshio Matsumoto and 小阪 昌明 :
Effect of bisphosphonate on myeloma bone disease,
The Japanese Journal of Clinical Hematology, Vol.43, No.5, 349-352, 2002.
(CiNii: 10010364770)

Review, Commentary:

1.Itsuro Endo and Toshio Matsumoto :
骨粗鬆症・甲状腺機能異常治療薬,
重要薬マニュアル, 140-143,
2.Takeshi Kondo, Itsuro Endo and Toshio Matsumoto :
[The pathology, diagnosis and therapy on osteoporosis].,
Nihon Rinsho. Japanese Journal of Clinical Medicine, Vol.72, No.10, 1774, Oct. 2014.
(PubMed: 25509801)
3.Takeshi Kondo, Itsuro Endo and Toshio Matsumoto :
骨粗鬆症の病態,診断,治療,
日本臨床, Vol.72, No.10, 1774-1779, Oct. 2014.
4.Itsuro Endo and Toshio Matsumoto :
副甲状腺機能低下症,
内科, Vol.113, No.6, 1571-1573, Jun. 2014.
5.Itsuro Endo and Toshio Matsumoto :
副甲状腺機能亢進症,
内科, Vol.113, No.6, 1568-1570, Jun. 2014.
6.Itsuro Endo and Toshio Matsumoto :
RANKL,
最新医学, Vol.69, No.2, 257-261, Feb. 2014.
7.Itsuro Endo and Toshio Matsumoto :
チアマゾール,
重要薬マニュアル, 158-159, Jan. 2014.
8.Itsuro Endo and Toshio Matsumoto :
レボチロキシンナトリウム,
重要薬マニュアル, 156-157, Jan. 2014.
9.Itsuro Endo and Toshio Matsumoto :
テリパラチド(遺伝子組換え,合成),
重要薬マニュアル, 154-155, Jan. 2014.
10.Itsuro Endo and Toshio Matsumoto :
ラロキシフェン,
重要薬マニュアル, 152-153, Jan. 2014.
11.Itsuro Endo and Toshio Matsumoto :
エルデカルシトール,
重要薬マニュアル, 150-151, Jan. 2014.
12.Itsuro Endo and Toshio Matsumoto :
ミノドロン酸水和物,
重要薬マニュアル, 148-149, Jan. 2014.
13.Itsuro Endo and Toshio Matsumoto :
リセドロン酸ナトリウム,
重要薬マニュアル, 146-147, Jan. 2014.
14.Itsuro Endo and Toshio Matsumoto :
アレンドロ酸ナトリウム,
重要薬マニュアル, 144-145, Jan. 2014.
15.鈴木 麗子, 大和 光, Kazuyoshi Kawazoe, Ken-ichi Aihara, Itsuro Endo, 安芸 菜奈子, 倉橋 清衛, Toshio Matsumoto, Akio Kuroda and Munehide Matsuhisa :
インスリン注射により生じた皮下硬血を有する患者の実態調査とその介入の有用性の検討,
Practice, Vol.31, No.6, 815-821, 2014.
16.Itsuro Endo and Toshio Matsumoto :
[Bone Structural Properties and Bone Strength. Bone architecture and strength on unloading].,
Clinical Calcium, Vol.23, No.7, 1013-1019, Jul. 2013.
(PubMed: 23811590)
17.Itsuro Endo and Toshio Matsumoto :
ビスホスホネート,
The Lipid, Vol.24, No.4, 73-78, Apr. 2013.
18.Itsuro Endo and Toshio Matsumoto :
新しい骨粗鬆症治療薬,
Internal Medicine, Vol.111, No.4, 671-676, Apr. 2013.
19.Itsuro Endo and Toshio Matsumoto :
開発中の薬剤,
Hormone Frontier in Gynecology, Vol.20, No.3, 51-56, Mar. 2013.
20.Itsuro Endo and Toshio Matsumoto :
現在開発中あるいは今後開発される予定の骨粗鬆症治療薬にはどのようなものがありますか?,
骨粗鬆症治療, Vol.12, No.2, 67-70, Feb. 2013.
21.Itsuro Endo and Toshio Matsumoto :
BSAP(骨型ALP),
Nihon Rinsho. Japanese Journal of Clinical Medicine, Vol.71, No.supple, 258-260, 2013.
22.Itsuro Endo and Toshio Matsumoto :
[Space flight/bedrest immobilization and bone. Bisphosphonate and the loss of bone mineral due to space flight or prolonged bed rest].,
Clinical Calcium, Vol.22, No.12, 1863-1870, Dec. 2012.
(PubMed: 23187079)
23.Itsuro Endo and Toshio Matsumoto :
副甲状腺,
内分泌代謝専門医ガイドブック, 56-57, Nov. 2012.
24.Takeshi Kondo, Itsuro Endo and Toshio Matsumoto :
ビスホスホネート製剤,
Medicina, Vol.49, No.11, 348-350, Nov. 2012.
25.Itsuro Endo and Toshio Matsumoto :
活性型ビタミンD3およびその誘導体,
Medical Practice, Vol.29, No.11, 1949-1953, Nov. 2012.
26.Itsuro Endo and Toshio Matsumoto :
Effect of vitamin D on bone and immune system,
Journal of Clinical and Experimental Medicine, Vol.242, No.9, 751-757, Sep. 2012.
(CiNii: 40019389769)
27.Itsuro Endo and Toshio Matsumoto :
新規活性型ビタミンD誘導体エルデカルシトールの副作用としての高Ca血症・高Ca尿症の頻度や程度は従来の活性型ビタミンD3製剤とは違いますか?,
ファーマナビゲーター 活性型ビタミンD3製剤編, 326-331, Jul. 2012.
28.Itsuro Endo and Toshio Matsumoto :
エルデカルシトールの使用上の注意点,
ファーマナビゲーター 活性型ビタミンD3製剤編, 294-301, Jul. 2012.
29.Itsuro Endo and Toshio Matsumoto :
エルデカルシトールの開発の経緯,
ファーマナビゲーター 活性型ビタミンD3製剤編, 260-269, Jul. 2012.
30.Itsuro Endo and Toshio Matsumoto :
活性型ビタミンD3製剤の治療上の注意点,
ファーマナビゲーター 活性型ビタミンD3製剤編, 252-259, Jul. 2012.
31.Itsuro Endo and Toshio Matsumoto :
ビタミンDの代謝,
ファーマナビゲーター 活性型ビタミンD3製剤編, 26-33, Jul. 2012.
32.Shusuke Yagi, Ken-ichi Aihara, Yasumasa Ikeda, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Effects of Statins on Cardiorenal Syndrome.,
International Journal of Vascular Medicine, Vol.2012, 162545, Jun. 2012.
(DOI: 10.1155/2012/162545,   PubMed: 22792467)
33.Itsuro Endo and Toshio Matsumoto :
[New approved drugs for osteoporosis in Japan].,
Clinical Calcium, Vol.22, No.6, 870-876, Jun. 2012.
(PubMed: 22653027)
34.Itsuro Endo and Toshio Matsumoto :
副甲状腺疾患,
Medical Practice, Vol.29, 171-178, May 2012.
35.Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, Masashi Akaike and Toshio Matsumoto :
Effects of androgens on cardiovascular remodeling.,
The Journal of Endocrinology, Apr. 2012.
(DOI: 10.1530/JOE-12-0126,   PubMed: 22493003)
36.Itsuro Endo and Toshio Matsumoto :
骨粗鬆症治療薬,
The Japanese journal of clinical and experimental medicine, Vol.89, No.4, 461-465, Apr. 2012.
37.Itsuro Endo and Toshio Matsumoto :
抗スクレロスチン抗体,
骨粗鬆症治療, Vol.11, No.3, 47-51, Mar. 2012.
38.Itsuro Endo and Toshio Matsumoto :
骨粗鬆症治療薬としてのビタミンD製剤の位置づけ-新規薬剤の承認を受けて,
腎と骨代謝, Vol.25, No.3, 243-249, Mar. 2012.
39.Kumiko Kagawa, Masahiro Abe and Toshio Matsumoto :
がん治療における骨の管理の重要性 がん骨転移治療 ビスフォスフォネート治療によるBone Management,
先端医学者 高橋俊二 編集, 16-21, 2012.
40.Itsuro Endo and Toshio Matsumoto :
[Frontiers in vitamin D; basic research and clinical application. Eldecalcitol: the effect on bones and calcium metabolism].,
Clinical Calcium, Vol.21, No.11, 103-110, Nov. 2011.
(PubMed: 22040826)
41.Itsuro Endo and Toshio Matsumoto :
続発性骨粗鬆症,
診断と治療, Vol.99, No.10, 1661-1667, Oct. 2011.
42.Itsuro Endo and Toshio Matsumoto :
骨粗鬆症,
医学スーパーラーニングスリーズ 内分泌・糖尿病内科学, 129-134, Sep. 2011.
43.Itsuro Endo and Toshio Matsumoto :
Progress and perspectives in bone research,
Nihon Rinsho. Japanese Journal of Clinical Medicine, Vol.69, No.7, 1175-1180, Jul. 2011.
(CiNii: 40018884214,   Elsevier: Scopus)
44.Itsuro Endo and Toshio Matsumoto :
癌と関連した高カルシウム血症,
腎と透析, Vol.71, No.5, 662-666, May 2011.
45.Itsuro Endo and Toshio Matsumoto :
Parathyroid neoplasms: a state and view of clinical research,
Nihon Rinsho. Japanese Journal of Clinical Medicine, Vol.69, 455-460, Mar. 2011.
(PubMed: 21834160,   CiNii: 40018749414,   Elsevier: Scopus)
46.Itsuro Endo and Toshio Matsumoto :
ビタミンD新規合成誘導体の展望,
THE BONE, Vol.25, No.3, 135-139, Mar. 2011.
47.Itsuro Endo and Toshio Matsumoto :
PTHの生理作用,
骨粗鬆症治療, Vol.10, No.2, 10-14, Feb. 2011.
48.Itsuro Endo and Toshio Matsumoto :
電解質異常の診断の進め方-Ca, P, Mg-,
Mebio, Vol.28, No.1, 27-33, Jan. 2011.
49.Itsuro Endo and Toshio Matsumoto :
[Eldecalcitol (ED-71)].,
Clinical Calcium, Vol.21, No.1, 53-58, Jan. 2011.
(PubMed: 21187594)
50.Ken-ichi Aihara, Yasumasa Ikeda, Shusuke Yagi, Masashi Akaike and Toshio Matsumoto :
Transforming Growth Factor-1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome.,
Cardiology Research and Practice, Vol.2011, 175381, Dec. 2010.
(DOI: 10.4061/2011/175381,   PubMed: 21234356)
51.Itsuro Endo and Toshio Matsumoto :
[Secondary osteoporosis UPDATE. Drugs under development for metabolic bone disease].,
Clinical Calcium, Vol.20, No.5, 700-708, May 2010.
(PubMed: 20445281)
52.Itsuro Endo and Toshio Matsumoto :
Drugs for osteoporosis under development,
Clinic All-Round, Vol.59, No.4, 599-605, Apr. 2010.
(CiNii: 40017077518)
53.Itsuro Endo and Toshio Matsumoto :
骨粗鬆症の臨床,
糖尿病・代謝・内分泌 Annual Review 2010, 246-255, Jan. 2010.
54.Itsuro Endo and Toshio Matsumoto :
電解質異常の診断の進め方ーCa, P, Mg-,
Mebio, Vol.28, No.1, 27-33, Jan. 2010.
55.Ken-ichi Aihara, Hiroyuki Azuma, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Heparin Cofactor II as a Novel Vascular Protective Factor Against Atherosclerosis.,
Journal of Atherosclerosis and Thrombosis, Vol.16, No.5, 523-531, Sep. 2009.
(DOI: 10.5551/jat.1552,   PubMed: 19729870)
56.Yuichi Fujinaka and Toshio Matsumoto :
メタボリックシンドロームと骨粗鬆症,
Keywordで学ぶメタボリックシンドローム, 2008.
57.Masashi Akaike and Toshio Matsumoto :
NO bioavailability,
CLINICAL CALCIUM, Vol.17, No.6, 864-870, 2007.
58.Ken-ichi Aihara, Hiroyuki Azuma and Toshio Matsumoto :
Vitamin D-vitamin D receptor system regulates antithrombogenicity in vivo.,
Clinical Calcium, Vol.16, No.7, 1173-1179, Jul. 2006.
(PubMed: 16816478)
59.Yuichi Fujinaka and Toshio Matsumoto :
トピックス: メタボリックシンドロームと骨粗鬆症,
最新医学, Vol.61, No.6, 1421-1427, Jun. 2006.
60.Ken-ichi Aihara, Yasumasa Ikeda and Toshio Matsumoto :
【慢性心不全の分子機構 新しい治療戦略を求めて】 性ステロイドと心保護作用,
Cardioangiology, Vol.59, No.6, 579-584, 2006.
61.Masashi Akaike and Toshio Matsumoto :
血管内皮細胞に対するステロイドの影響と大腿骨頭壊死,
整形外科, Vol.48, 25-29, 2005.
62.Ken-ichi Aihara, Masashi Akaike, Daisuke Inoue, Hiroyuki Azuma and Toshio Matsumoto :
副甲状腺機能亢進症,
ホルモンと臨床, Vol.52, No.5, 93(483)-96(486), May 2004.
63.新谷 保実, Yuichi Fujinaka and Toshio Matsumoto :
検査値異常から読む病態と診断計画,
臨床医, Vol.28, 1586-1589, 2002.
64.Toshio Matsumoto, Masashi Akaike and Daisuke Inoue :
内分泌疾患,
Internal Medicine, Vol.86, No.6, 1119-1127, Dec. 2000.
65.Toshio Matsumoto and Masashi Akaike :
骨と脈管系との関わり,
骨と骨代謝, Vol.12, No.4, 319-323, 1999.
66.Yuichi Fujinaka, 新谷 保実 and Toshio Matsumoto :
癌遺伝子と癌抑制遺伝子 ヒト癌と癌遺伝子・癌抑制遺伝子,
New Horizon for Medicine, Vol.30, No.7, 1999-2004, 1998.

Proceeding of International Conference:

1.Mohannad Ashtar, Hirofumi Tenshin, Jumpei Teramachi, Masahiro Hiasa, Kotaro Tanimoto, Oda Asuka, Iwasa Masami, Takeshi Harada, Bat-Erdene Ariunzaya, Kimiko Sogabe, Masahiro Oura, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Toshio Matsumoto, Masahiro Abe and Eiji Tanaka :
Peri-implantitis and the role of Febuxostat in osteoclast differentiation.,
AEEDC Dubai World Orthodontic Conference, Dubai, UAE, Feb. 2019.
2.Bingzi Dong, Itsuro Endo, Yukiyo Ohnishi, Zhengju Fu, Toshio Matsumoto and Yangang Wang :
Calcilytic, calcium-sensing receptor antagonist, enhances bone remodeling and increases bone mineral density without increasing urinary calcium excretion.,
ASBMR 2018 Annual Meeting, Mnrtial, QU, Oct. 2018.
3.Yuichi Takashi, Yuka Kinoshita, Nobuaki Ito, Shun Sawatsubashi, Hidetaka Kosako, Masahiro Abe, Munehide Matsuhisa, Toshio Matsumoto and Seiji Fukumoto :
FGF receptor 1c works as a phosphate-sensor to regulate FGF23 production,
ASBMR 2018 Annual Meeting Registration Confirmation, Sep. 2018.
4.Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa, Oda Asuka, Bat-Erdene Ariunzaya, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Disruption of a progressive vicious cycle between myeloma tumor growth and bone destruction by TAK1 inhibition,
ASBMR 2018 Annual Meeting, Montreal, Sep. 2018.
5.Hirofumi Tenshin, Jumpei Teramachi, Masahiro Hiasa, Oda Asuka, Ashtar Mohannad, Kotaro Tanimoto, Iwasa Masami, Bat-Erdene Ariunzaya, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Opposite effects of TRAIL on the Sp-1-c-FLIP survival pathway in myeloma cells and osteoclasts.,
ASBMR 2018 Annual Meeting, Montreal, Sep. 2018.
6.Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa, Oda Asuka, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Tatsuji Haneji, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Therapeutic impact of TAK1 inhibition on myeloma tumor progression and bone destruction,
8th International Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone and other Musculoskeletal Diseases and Cancer and Bone Society 2018 Meeting, Oxford, Jun. 2018.
7.Hirofumi Tenshin, Jumpei Teramachi, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Toshio Matsumoto, Masahiro Abe and Eiji Tanaka :
Apoptosis inducer TRAIL stimulates osteoclast differentiation and survival via TAK1 activation.,
1st International Conference of Biophysical Technology in Dentistry (+10th International Scientific Meeting in Dentistry),, Makassar, Indonesia., Apr. 2018.
8.Hirofumi Tenshin, Jumpei Teramachi, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Toshio Matsumoto, Masahiro Abe and Eiji Tanaka :
Apoptosis inducer TRAIL stimulates osteoclast differentiation and survival via TAK1 activation.,
The 4th ASEAN plus Tokushima Joint International Conference, Bali, Indonesia, Dec. 2017.
9.Itsuro Endo, Dong Bingzi, Ohnishi Yukiyo, Kondo Takeshi, Masahiro Hiasa, Jumpei Teramachi, Toshio Matsumoto, Masahiro Abe, Seiji Fukumoto and Tatsuji Haneji :
Decreased bone strength induced by persistent activation of calcium-sensing receptor,
American Society for Bone and Mineral Research (ASBMR) 2017 Annual Meeting, Denver, Sep. 2017.
10.Jumpei Teramachi, Masahiro Hiasa, Oda Asuka, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
TAK1 inhibition impairs myeloma cell-bone marrow interaction to reduce myeloma tumor growth and bone destruction,
American Society for Bone and Mineral Research (ASBMR) 2017 Annual Meeting, Denver, Sep. 2017.
11.Jumpei Teramachi, Masahiro Hiasa, Oda Asuka, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Therapeutic impact of TAK1 inhibition on myeloma tumor progression and bone destruction,
International Society for Experimental Hematology 46th Annual Scientific Meeting, Frankfurt, Aug. 2017.
12.Hirofumi Tenshin, Jumpei Teramachi, A Oda, Ryota Amachi, Masahiro Hiasa, A Baterdene, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Osteoclasts utilize TRAIL for their NF-B activation, but TAK1 inhibition resumes TRAIL-induced apoptosis in osteoclasts.,
Australian and New Zealand Bone and Mineral Society 2017, Brisbane, Australia., Jun. 2017.
13.Jumpei Teramachi, Masahiro Hiasa, Oda Asuka, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Akihito Yamamoto, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Therapeutic impact of TAK1 inhibition on myeloma tumor progression and bone destruction,
Cancer and Bone Society Conference 2017, Indianapolis, May 2017.
14.Ryota Amachi, Masahiro Hiasa, Oda Asuka, Bat-Erdene Ariunzaya, Jumpei Teramachi, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shiroh Fujii, Toshio Matsumoto, Eiji Tanaka and Masahiro Abe :
Osteoblast Creates a Non-permissive Niche for Myeloma Cells,
95th General Session & Exhibition of the IADR program book, San Francisco, Mar. 2017.
15.Hirofumi Tenshin, Jumpei Teramachi, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Toshio Matsumoto, Masahiro Abe and Eiji Tanaka :
TRAIL Stimulates Osteoclast Differentiation and Survival via TAK1 Activation.,
95th General Session & Exhibition of the IADR program book, San Francisco, Mar. 2017.
16.Kiyoe Kurahashi, Itsuro Endo, Nakamura Maiko, Ohnishi Yukiyo, Takeshi Kondo, Aizawa Shinichi, Toshio Matsumoto, Seiji Fukumoto and Masahiro Abe :
Glucose intolerance induced by persistent activation of calcium-sensing receptor,
American Society for Bone and Mineral Research 2016 Annual Meeting, Atlanta, Sep. 2016.
17.Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Kiyoe Kurahashi, Takeshi Kondo, Hirokazu Miki, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
TAK-1 inhibition disrupts Pim-2-associated and Pim-2-independent key signaling pathways to effectively suppress tumor growth and restore bone formation in myeloma,
American Society for Bone and Mineral Research 2016 Annual Meeting, Atlanta, Sep. 2016.
18.Hirofumi Tenshin, Jumpei Teramachi, A Oda, Ryota Amachi, Bingzi Dong, Masahiro Hiasa, Keiichiro Watanabe, Ryota Amachi, S Nakamura, H Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Osteoclasts utilize an apoptosis-inducer TRAIL as a stimulator for osteoclastogenesis Critical roles of the TAK-1-Pim-2 signaling induced by RANK ligand and TRAIL.,
ANZBMS 2016 Annual Meeting, Gold Coast, Aug. 2016.
19.Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Therapeutic impact of TAK-1 inhibition on tumor growth and bone destruction in myeloma,
21st Congress European Hematology Association, Copenhagen, Jun. 2016.
20.Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Derek Hanson, Keiichiro Watanabe, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Pim inhibition suppresses osteoclastogenesis and tumor growth in myeloma,
57th ASH Annual Meeting and Exposition, Orlando, Dec. 2015.
21.Hirofumi Tenshin, Jumpei Teramachi, A Oda, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, S Nakamura, H Miki, I Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TRAIL is not a proapoptotic but rather anti-apoptotic mediator for osteoclasts to stimulate their differentiation and survival,
ASBMR 2015 Annual Meeting, Seattle, Oct. 2015.
22.Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, Asuka Oda, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shiroh Fujii, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Up-regulation of the pH sensor TRPV1 in myeloma cells and their adaption to an acidic microenvironment,
ASBMR 2015 Annual Meeting, Seattle, Oct. 2015.
23.Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Keiichiro Watanabe, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Pivotal role of TAK-1 in tumor growth and bone destruction in myeloma: Therapeutic impact of TAK-1 inhibition,
American Society for Bone and Mineral Research 2015 Annual Meeting, Oct. 2015.
24.Takeshi Kondo, Itsuro Endo, Ken-ichi Aihara, nishi Oh Yukiyo, Bingzi Dong, Kiyoe Kurahashi, Sumiko Yoshida, Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, Masahiro Abe, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Serum carboxy-terminal telopeptide of type I collagen, as a marker for systemic atherosclerosis,
ANZBMS 2015 Annual Meeting, Hobart, Sep. 2015.
25.Kiyoe Kurahashi, 森 智子, 宮本 千伸, 津川 和江, Miho Oyadomari, Kazuna Takahara, 木村 千寿子, Masato Miyake, Toshio Matsumoto and Seiichi Oyadomari :
Saturated Fatty Acids Predominantly Activate PERK Pathway via Altered Composition of the Endoplasmic Reticulum Membrane, and Reduce Insulin Secretion in Pancreatic Cell by Translation Attenuation,
75th ADA scientific sessions, Jun. 2015.
26.Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Kumiko Kagawa, Hirokazu Miki, Shiroh Fujii, Keiichiro Watanabe, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Critical role of Pim-2 in NF-B-mediated suppression of osteoblastogenesis and stimulation of osteoclastogenesis: Therapeutic impact of Pim inhibition on myeloma bone disease.,
2014 ASBMR Annual Meeting, Houston, Sep. 2014.
27.Akiko Hata, Yosuke Shikama, Nanako Aki, Chisato Kosugi, Hiroya Kobayashi, Masashi Miyoshi, Takayuki Nakao, Ayako Tamura, Takako Ichihara, Takako Minagawa, Yumi Kuwamura, Toshio Matsumoto and Makoto Funaki :
Serum Adipocyte Fatty Acid-binding Protein Is Related to the Development of Metabolic Syndrome in Japanese Male Workers,
Diabetes, Vol.63, No.Suppl.1, A.388, Jun. 2014.
28.Dong Bingzi, Takeshi Kondo, Itsuro Endo, 大西 幸代, 尾松 卓, Masahiro Abe, 相澤 慎一 and Toshio Matsumoto :
educed bone formation and increased adiposity with insulin resistance in interleukin-11 deficient mice,
European Calcified Tissue Society Annual Meeting 2014, Prague, May 2014.
29.Ken-ichi Aihara, Sumiko Yoshida, Uemoto Ryoko, Ishikawa Kazue and Toshio Matsumoto :
Plasma Heparin Cofactor II Activities are Inversely Associated with Aberrant Glucose Metabolism in Humans and Mice,
American Heart Associations Scientific Sessions 2013 Dallas, Texas, Nov. 2013.
30.Ryota Amachi, Masahiro Abe, Masahiro Hiasa, Keiichiro Watanabe, S Fujii, T Harada, H Miki, S Nakamura, I Endo, Eiji Tanaka and Toshio Matsumoto :
Acidic conditions epigenetically repress the TRAIL receptor DR4 in myeloma cells to confer their resistance to TRAIL,
ASBMR 2013 Annual Meeting,, Baltimore, Oct. 2013.
31.Keiichiro Watanabe, Masahiro Abe, H Mori, Ryota Amachi, Masahiro Hiasa, T Harada, S Fujii, S Nakamura, H Miki, K Kagawa, I Endo, Eiji Tanaka and Toshio Matsumoto :
Potent induction of bone formation in myeloma bone lesions by the cathepsin K inhibitor KK1-300-01 in combination with the proteasome inhibitor bortezomib,
ASBMR 2013 Annual Meeting,, Baltimore, Oct. 2013.
32.Akio Kuroda, Takeshi Kondo, Ken-ichi Aihara, Itsuro Endo, T Yasuda, H Kaneto, T Matsuoka, Toshio Matsumoto and Munehide Matsuhisa :
The characteristics of type 1 diabetes patients who use insulin pump with square-wave bolus insulin.,
73th America Diabetes Association (poster), Jun. 2013.
33.Sumiko Yoshida, Ken-ichi Aihara, Yasumasa Ikeda and Toshio Matsumoto :
Androgen receptor promotes angiogenesis in response to ischemia via activation of VEGF receptor signaling pathway regardless of sex,
ENDO 2013;The Endocrine Society's 95th Annual Meeting & Expo, San Francisco, Jun. 2013.
34.Ken-ichi Aihara, Sumiko Yoshida, 上元 良子, 石川 カズ江 and Toshio Matsumoto :
Plasma Heparin Cofactor II Activities are Inversely Associated with Aberrant Glucose Metabolism in Humans and Mice.,
American Heart Association, Scientific Sessions 2013, Dallas, Jun. 2013.
35.Keiichiro Watanabe, Masahiro Abe, Ryota Amachi, Masahiro Hiasa, T Harada, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, H Mori, Itsuro Endo, Eiji Tanaka and Toshio Matsumoto :
Induction of bone formation in myeloma osteolytic lesions by cathepsinK inhibition,
Kyoto, Apr. 2013.
36.Ryota Amachi, Keiichiro Watanabe, Shiroh Fujii, T Harada, Hirokazu Miki, Shingen Nakamura, A Oda, Masahiro Hiasa, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
An acidic milieu suppersses histone acetylation in myeloma cells to down-regulate the TRAIL receptor DR4 expression.,
Kyoto, Apr. 2013.
37.Itsuro Endo, Toshio Matsumoto and 福本 誠二 :
FGF(),
厚生労働省科学研究費補助金 難治性疾患克服研究事業 ホルモン受容機構異常に関する調査研究 平成24年度班会議 東京都 2013年1月, Jan. 2013.
38.Harada Takeshi, Ozaki Shuji, Oda Asuka, Iwasa Masami, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Masahiro Abe, Shibata Hironobu, Akishige Ikegame, Daisuke Tsuji, Ito Kohji, Ri Masaki, Iida Shinsuke, Shiotsu Yukimasa, Kawai Shigeto, Yamada-Okabe Hisafumi and Toshio Matsumoto :
Combination therapy of a defucosylated anti-HM1.24 monoclonal antibody plus Ienalidomide induces marked antibody-dependent cellular cytotoxicity and inhibits the clonogenic potential of myeloma cancer stem-like cells. Atlanta, Dec. 2012.,
The 54th Annual Meeting of the American Society of Hamatology, Dec. 2012.
39.T Harada, Shuji Ozaki, A Oda, M Iwasa, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Masahiro Abe, Hirofumi Shibata, Akishige Ikegame, Daisuke Tsuji, Kouji Itou, M Ri, S Iida, Y Shiotsu, S Kawai, H Yamada-Okabe and Toshio Matsumoto :
Combination Therapy of a Defucosylated Anti-HM1.24 Monoclonal Antibody Plus Lenalidomide Induces Marked Antibody-Dependent Cellular Cytotoxicity and Inhibits the Clonogenic Potential of Myeloma Cancer Stem-Like Cells.,
54th ASH Annual Meeting and Exposition, USA, Atlanta, Dec. 2012.
40.Ryota Amachi, Masahiro Abe, Ryota Amachi, Keiichiro Watanabe, S Fujii, T Harada, H Miki, S Nakamura, A Oda, Masahiro Hiasa, Eiji Tanaka and Toshio Matsumoto :
An acidic milieu suppresses DR4 editing to cause myeloma resistance to TRAIL,
ASEAN plus and Tokushima Joint International Conference, Yogjakarta, Indonesia, Dec. 2012.
41.Masahiro Abe, Masahiro Hiasa, Watanabe ken-ichiro, Nakamura Shingen, Harada Takeshi, Itsuro Endo and Toshio Matsumoto :
Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition,
12th CIBD International Meeting on Cancer Induced Bone Disease (CIBD) Lyon, Nov. 2012, Nov. 2012.
42.Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Harada Takeshi, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition,
12th Int'l Meeting on Cancer Induced Bone Disease, Lyon, Nov. 2012.
43.Ken-ichi Aihara, Sumiko Yoshida, Mizuho Kinouchi, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto :
Diabetes Spoils the Favorable Effect of HDL-Cholesterol on Endothelial Function in the Elderly with Cardiovascular Risk Factors,
American Heart Association Scientific Sessions 2012, ロサンゼルス, Nov. 2012.
44.Sumiko Yoshida, Ken-ichi Aihara, Takayuki Ise, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Androgen Receptor is Required for Cellular Survival and Angiogenesis in Response to Ischemia via Activation of VEGF Receptor Signaling Pathway Regardless of Sex,
American Heart Association Scientific Session 2012, Nov. 2012.
45.Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, Masataka Sata, Masashi Akaike, Toshio Matsumoto and Toshiaki Tamaki :
Heparin Cofactor II Promotes Angiogenesis in Response to Ischemic Hindlimb via an AMPK-eNOS-dependent Manner,
American Heart Association Scientific Sessions 2012, Nov. 2012.
46.Sumiko Yoshida, Ken-ichi Aihara, Takayuki Ise, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Eicosapentaenoic acid administration ameliorates cardiac remodeling in humans and protects against Ang II-induced cardiovascular remodeling via attenuation of oxidative stress in mice.,
American Heart Association Scientific Sessions 2012, ロサンゼルス, Nov. 2012.
47.Masahiro Hiasa, Ryota Amachi, Keiichiro Watanabe, Harada Takeshi, Fujii Shirou, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Pim-2 suppresses BMP-2 signaling as a common inhibitory mediator of osteoblastogenesis in myeloma,
ASBMR 2012 Anuual Meeting, Minneapolis, Oct. 2012.
48.Keiichiro Watanabe, Masahiro Abe, Ryota Amachi, Masahiro Hiasa, T Harada, S Fujii, S Nakamura, H Miki, K Kagawa, H Mori, I Endo, Eiji Tanaka and Toshio Matsumoto :
Restoration of bone formation in myeloma osteolytic lesions by the cathepsin K inhibitor KK1-300-01,
34th ASBMR meeting, Minneapolis, MN, USA., Oct. 2012.
49.Masahiro Hiasa, Masahiro Abe and Toshio Matsumoto :
RelB attenuates the activation of the classical NF-kB pathway to facilitate osteoblastogenesis,
Sep. 2012.
50.Masahiro Hiasa, Masahiro Abe, Rieko Arakaki, Akiko Yamada, Kenzo Asaoka, Toshio Matsumoto, Yoshio Hayashi and Naozumi Ishimaru :
RelB attenuates the activation of the classical NF-κB pathway to facilitate osteoblastogenesis,
ANZBMS Annual Scientific Meeting, Perth, Sep. 2012.
51.Takeshi Kondo, Omatsu Takashi, Dong Bingzi, Ohnishi Yukiyo, Aizawa Shin-ichi, Itsuro Endo and Toshio Matsumoto :
Interleukin(IL)-11 is required for mechanical stress-induced bone formation,
Australian and New Zealand Bone and Mineral Society, Gold Coast, Sep. 2012.
52.Keiichiro Watanabe, Masahiro Abe, Hiroyo Mori, Ryota Amachi, Masahiro Hiasa, T Harada, S Fujii, S Nakamura, H Miki, K Kagawa, I Endo, Eiji Tanaka and Toshio Matsumoto :
The cathepsin K inhibitor KK1-300-01 prevents bone destruction and resumes bone formation in myeloma osteolytic lesions,
Australian & New Zealand Bone & Mineral Society 22th Annual Scientific Meeting with 1st Asia-Pacific Bone and Mineral Research meeting, Perth, Australia., Sep. 2012.
53.Akio Kuroda, YASUDA TETSUYUKI, TAKAHARA MITSUYOSHI, SAKAMOTO FUMIE, KASAMI RYUUICHI, MIYASHITA KAZUYUKI, MATSUOKA TAKA-AKI, Sumiko Yoshida, KONDO ERI, Itsuro Endo, Ken-ichi Aihara, KANETO HIDEAKI, Toshio Matsumoto, SHIMOMURA IICHIRO and Munehide Matsuhisa :
Carbohydrate-to-Insulin Ratio is Calculated to be 300-400 Divided by Total Daily Insulin Dose in Type 1 Diabetic Patients Who Are on Insulin Pump Therapy,
American Diabetes Association 72nd Scieentific Sessions, Philadelphia, Jun. 2012.
54.Ken-ichi Aihara, Sumiko Yoshida, Yasumasa Ikeda, Masashi Akaike and Toshio Matsumoto :
Heparin cofactor II, a serine protease inhibitor, is a novel regulating factor for glucose metabolism and albuminuria,
Keystone Symposia: Complications of Diabetes: Mechanisms of Injury and Failure of Repair, Mar. 2012.
55.Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, Yoshitaka Kihira, Keisuke Ishizawa, Yuki Izawa-Ishizawa, Shuhei Tomita, Masataka Sata, Masashi Akaike, Shigeki Kato, Toshio Matsumoto and Toshiaki Tamaki :
Heparin Cofactor Promotes Angiogenesis via an AMPK-eNOS Signaling Pathway,
High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions, Orlando, Sep. 2011.
56.Keiichiro Watanabe, Masahiro Abe, M Kawatani, Masahiro Hiasa, A Kawano, T Jinno, T Harada, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, H Osada and Toshio Matsumoto :
Aggravation of myeloma growth and drug resistance by an acidic created in myeloma-osteoclast interaction.,
ASBMR 2011 Annual Meeting, San Diego, Sep. 2011.
57.Masahiro Hiasa, nakano ayako, Keiichiro Watanabe, C Qu, T Harada, Shiroh Fujii, Hirokazu Miki, Shingen Nakamura, Kumiko Kagawa, Kyoko Takeuchi, Eiji Tanaka, Kenzo Asaoka, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition.,
ASBMR 2011 Annual Meeting, San Diego, Sep. 2011.
58.Masahiro Hiasa, nakano ayako, Keiichiro Watanabe, C Qu, T Harada, Shiroh Fujii, Hirokazu Miki, Shingen Nakamura, Kumiko Kagawa, Kyoko Takeuchi, Eiji Tanaka, Kenzo Asaoka, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Dual effects of Pim inhibition on myeloma: induction of bone formation and tumor suppression.,
IOF-ANZBMS 2011 Annual Meeting, Gold Coast, Sep. 2011.
59.Takeshi Kondo, Takashi Omatsu, Yukiyo Ohnishi, Toshio Matsumoto and Itsuro Endo :
Interleukin-11 is required for the maintenance of axial bone mass in mice.,
International Osteoporosis Foundation Annual Meeting 2011, Sep. 2011.
60.Itsuro Endo, Seiji Fukumoto and Toshio Matsumoto :
FGF23-related hypophosphatemic diseases in Japan.,
oint Meeting of International Bone and Mineral Society and The Japanese Society of Bone Mineral Research, Jul. 2011.
61.Keiichiro Watanabe, Masahiro Abe, Cui Qu, Kawatani Makoto, Masahiro Hiasa, Nakano Ayako, Jinno Tadashi, Harada Takeshi, Shiroh Fujii, Shingen Nakamura, Miki Hirokazu, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, Osada Hiroyuki and Toshio Matsumoto :
An Acidic Mileu Created In Myeloma-Osteoclast Interaction Enhances Tumor Growth, but Triggers Anti-Myeloma Activity of Reveromycin A, a Novel Anti-Resorptive Agent,
52th American Society of Hematology, Orlando, Dec. 2010.
62.Cui Qu, Masahiro Abe, Miki Hirokazu, Shingen Nakamura, Keiichiro Watanabe, Akishige Ikegame, Masahiro Hiasa, Nakano Ayako, Harada Takeshi, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
Lenalidomide In Combination with Zoledronic Acid Restores the Activation and Anti-Myeloma Effects of γδT Cells Attenuated by the Bone Marrow Microenvironment,
52th American Society of Hematology, Orlando, Dec. 2010.
63.Sumiko Yoshida, Ken-ichi Aihara, Takayuki Ise, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Androgen receptor is essential for cell survival and neovascularization after ischemia.,
American Heart Association Scientific Sessions 2010, Chicago, Nov. 2010.
64.Itsuro Endo, Toshio Matsumoto and Ken-ichi Aihara :
Serum ICTP can be a surrogate marker of coronary unstable plaques,
ASBMR annual meeting, Tronto, Canada, Oct. 2010.
65.Keiichiro Watanabe, Masahiro Abe, Cui Qu, Kawatani Makoto, Masahiro Hiasa, Nakano Ayako, Jinno Tadashi, Harada Takeshi, Shiroh Fujii, Shingen Nakamura, Miki Hirokazu, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, Osada Hiroyuki and Toshio Matsumoto :
A Novel Anti-resorptive Agent, Reveromycin A, Ameliorates Bone Destruction and Tumor Growth in Myeloma,
ASBMR 2010 Annual Meeting, Toronto, Oct. 2010.
66.Masahiro Hiasa, Masahiro Abe, nakano ayako, oda aska, amo hiroe, Keiichiro Watanabe, Shingen Nakamura, miki hirokazu, Kyoko Takeuchi, Kumiko Kagawa, Shuji Ozaki, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Bone Marrow Stromal Cells Suppress TACE-mediated M-CSFR and RANK Shedding to Facilitate Osteoclastogenesis and Suppress DC Differentiation from Monocytes.,
ASBMR 2010 Annual Meeting, Toronto, Oct. 2010.
67.Sumiko Yoshida, Ken-ichi Aihara, Takayuki Ise, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Androgen receptor participants in ischemia-induced tissue damage and angiogenesis in male mice,
23rd Scientific Meeting of the International Society of Hypertension Vancouver, Vancouver, Sep. 2010.
68.Masahiro Abe, Masahiro Hiasa, Nakano A, Shingen Nakamura, Miki H, Qu C, Keiichiro Watanabe, Harada T, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
TIMP-3 up-regulation facilitates osteoclastogenesis and suppresses DC differentiation from monocytes in the bone marrow microenvironment in myeloma,
10th International Conference Cancer-induced Bone Disease, Sep. 2010.
69.Keiichiro Watanabe, Masahiro Abe, Cui Qu, Kawatani Makoto, Masahiro Hiasa, Nakano Ayako, Jinno Tadashi, Harada Takeshi, Shiroh Fujii, Shingen Nakamura, Miki Hirokazu, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, Osada Hiroyuki and Toshio Matsumoto :
The novel anti-resorptive agent reveromycin A ameliorates bone destruction and tumor growth in myeloma,
10th International Conference Cancer-induced Bone Disease, Sheffield (United Kingdom), Sep. 2010.
70.Masahiro Hiasa, Masahiro Abe, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Stroma inhibit DC differentiation through the suppression of M-CSFR shedding,
88th IADR, Barcelona, Jul. 2010.
71.Ken-ichi Aihara, Takayuki Ise, Yuka Ueda, Sumiko Yoshida, Yasumasa Ikeda, Uemoto Ryoko, Shusuke Yagi, Takashi Iwase, Hirata Yoichiro, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Plasma heparin cofactor II activity is an independent determinant for cardiac remodeling in subjects with cardiovascular risk factors,
20th International Society for Heart Research(ISHR), Kyoto, May 2010.
72.Ken-ichi Aihara, Yuka Ueda, Takayuki Ise, Sumiko Yoshida, Yasumasa Ikeda, Uemoto Ryoko, Shusuke Yagi, Takashi Iwase, Hirata Yoichiro, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Heparin cofactor II is a novel anticardiac remodeling factor against angiotensin II excess,
20th International Society for Heart Research(ISHR), Kyoto, May 2010.
73.Sumiko Yoshida, Ken-ichi Aihara, Takayuki Ise, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Exacerbation of cell survival and impaired neovascularization after hindlimb ischemia in male androgen receptor null mice,
20th International Society for Heart Research(ISHR), Kyoto, May 2010.
74.Ken-ichi Aihara, Sumiko Yoshida, Kurahashi Kiyoe, Mizuho Kinouchi, Itsuro Endo, Yuichi Fujinaka and Toshio Matsumoto :
Increased serum triglyceride is associated with left ventricular diastolic dysfunction.,
14th International Congress of Endocrinology, Kyoto, Mar. 2010.
75.Ken-ichi Aihara, Yuichi Fujinaka, Mizuho Kinouchi, Sumiko Yoshida, Yuka Ueda, Kurahashi Kiyoe, Itsuro Endo, Uemoto Ryoko, Shusuke Yagi, Takashi Iwase, Hirata Yoichiro, Suzuki Reiko, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Albuminuria is an independent aggravating factor for visceral fat obesity regardless of diabetes mellitus: a study using abdominal CT scan imaging,
14th International Congress of Endocrinology, Kyoto, Mar. 2010.
76.Masahiro Hiasa, Masahiro Abe, I Endo, A Nakano, Shuji Ozaki, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Myeloma-bone marrow stromal cell interaction enhances osteoclastogenesis and suppresses dendritic cell differentiation from monocytes,
14th International Congress of Endocrinology, Kyoto, Mar. 2010.
77.Ken-ichi Aihara, Yuichi Fujinaka, Mizuho Kinouchi, Sumiko Yoshida, Takashi Iwase, Masashi Akaike, Yuka Ueda, Kurahashi Kiyoe, Itsuro Endo, Uemoto Ryoko, Shusuke Yagi, Takashi Iwase, Hirata Yoichiro, Suzuki Reiko, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Albuminuria is an independent aggravating factor for visceral fat obesity regardless of diabetes mellitus: a study using abdominal CT scan imaging,
14th International Congress of Endocrinology, Kyoto, Japan, Mar. 2010.
78.Ken-ichi Aihara, Sumiko Yoshida, Yuka Ueda, Uemoto Ryoko, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Rosuvastatin attenuates left ventricular mass even in subjects without cardiac hypertrophy,
14th International Congress of Endocrinology, Kyoto, Japan, Mar. 2010.
79.Ken-ichi Aihara, Sumiko Yoshida, Kurahashi Kiyoe, Mizuho Kinouchi, Itsuro Endo, Yuichi Fujinaka and Toshio Matsumoto :
Increased serum triglyceride is associated with left ventricular diastolic dysfunction,
14th International Congress of Endocrinology, Kyoto, Japan, Mar. 2010.
80.Akishige Ikegame, Shuji Ozaki, Daisuke Tsuji, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Ayako Nakano, Kumiko Kagawa, Kyoko Takeuchi, Ken-ichiro Yata, Masahiro Abe, Kouji Itou and Toshio Matsumoto :
A recombinant HLA class I-specifi single-chain Fv diabody can target cancer stem cell-like side population cells in multiple myeloma,
51th Annual Meeting of the American Society of Hematolog, New Orleans, Louisiana, USA, Dec. 2009.
81.Yuka Ueda, Ken-ichi Aihara, Takayuki Ise, Sumiko Yoshida, Shusuke Yagi, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Exacerbation of Angiotensin ll-induced Cardiac Remodeling through Enhancement of NADPH oxidase-TGF- 1 Pathway in Heparin Cofactor ll-Deficient Mice,
Scientific Sessions 2009, American Heart Association, Florida, Nov. 2009.
82.Sumiko Yoshida, Ken-ichi Aihara, Takayuki Ise, Yuka Ueda, Shusuke Yagi, Yasumasa Ikeda, Takashi Iwase, Kurahashi Kiyoe, Itsuro Endo, Yuichi Fujinaka, Nishio Susumu, Hirotsugu Yamada, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Dehydroepiandrosterone sulfate is an endothelial function-independent protective factor against carotid atherosclerosis.,
Scientific Sessions 2009, American Heart Association, Florida, Nov. 2009.
83.Ken-ichi Aihara, Mizuho Kinouchi, Yuichi Fujinaka, Sumiko Yoshida, Yuka Ueda, Kurahashi Kiyoe, Itsuro Endo, Uemoto Ryoko, Shusuke Yagi, Takashi Iwase, Masashi Akaike and Toshio Matsumoto :
Albuminuria is an independent aggravating factor for visceral fat obesity regardless of diabetes mellitus: a study using abdominal CT scan imaging,
Scientific Sessions 2009, American Heart Association, Florida, Nov. 2009.
84.Masahiro Hiasa, Masahiro Abe, A Nakano, Kyoko Takeuchi, K Watanabe, Kumiko Kagawa, Ken-ichiro Yata, Kenzo Asaoka, Eiji Tanaka and Toshio Matsumoto :
Bone marrow stromal cells inhibit dendritic cell differentiation and facilitate osteoclastogenesis in myeloma through the suppression of M-CSF receptor shedding in monocytes,
第26回 内藤コンファレンス, Nov. 2009.
85.S Nakamura, Masahiro Abe, Cui Qui, A Nakano, Oda A., Amou H., Ikegame A., Harada T., Masahiro Hiasa, H Miki, Kumiko Kagawa, Kyoko Takeuchi, Ken-ichiro Yata, Shuji Ozaki and Toshio Matsumoto :
Facilitation of Osteoblast Differentiation by ATF-4 Accumulation through Proteasome Inhibition.,
ASH Annual Meeting, Nov. 2009.
86.Itsuro Endo, Onishi Yukiyo, Kido Rika, Kurahashi Kiyoe, Ito Yuuji, Yuichi Fujinaka, Ken-ichi Aihara, Sumiko Yoshida, Masahiro Abe, Fukumoto S and Toshio Matsumoto :
A new calcilytic compound,JTT-305,inhibits enhanced signaling by activating mutations of calcium-sensing receptor in autosomal dominant hypocalcemia (ADH),
ASBMR 31st Annual Meeting, Denver, Sep. 2009.
87.A Nakano, Asano J., Masahiro Abe, Masahiro Hiasa, S Nakamura, H Miki, Kumiko Kagawa, Kyoko Takeuchi, Ken-ichiro Yata, Itsuro Endo, Shuji Ozaki and Toshio Matsumoto :
Up-regulation of Pim-2 in myeloma cells by an interaction with bone marrow microenvironment enhances myeloma cell survival via stimulating Bad phosphorylation,
ASBMR Annual Meeting, Denver, Sep. 2009.
88.Masahiro Abe, A Oda, Shinsuke Kido, A Nakano, Masahiro Hiasa, H Amou, S Nakamura, Kyoko Takeuchi, H Miki, Kumiko Kagawa, Ken-ichiro Yata, Shuji Ozaki, Itsuro Endo and Toshio Matsumoto :
Bortezomib, a proteasome inhibitor with anti-myeloma activity, stimulates osteoblast differentiation by enhancing ATF4 accumulation in osteoblastic cells.,
ASBMR Annual Meeting, Denver, Sep. 2009.
89.Shusuke Yagi, Masashi Akaike, Takashi Iwase, Kenya Kusunose, T Niki, Y Hirata, Koji Yamaguchi, Kunihiko Koshiba, N Tomita, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, S Yoshida, Y Sumitomo, Ken-ichi Aihara, Toshio Matsumoto and Masataka Sata :
Bosentan, an Endothelin Receptor Antagonist, Exerts Protective Actions against Systemic Sclerosis-related Peripheral Circulation Insufficiency.,
73th Annual scientific meeting of the Japanese circulation society, Mar. 2009.
90.Shusuke Yagi, Masashi Akaike, Ken-ichi Aihara, S Yoshida, Y Sumitomo, Kenya Kusunose, T Niki, Y Hirata, Koji Yamaguchi, Kunihiko Koshiba, Takashi Iwase, N Tomita, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Toshio Matsumoto and Masataka Sata :
Pitavastatin Exerts LDL Cholesterol Reduction-independent Protective Action for Cardiac and Renal Function in Patients with Dyslipidemia.,
73th Annual scientific meeting of the Japanese circulation society, Mar. 2009.
91.Shusuke Yagi, Masashi Akaike, Ken-ichi Aihara, S Yoshida, Y Sumitomo, Kenya Kusunose, T Niki, Y Hirata, Koji Yamaguchi, Kunihiko Koshiba, Takashi Iwase, N Tomita, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Toshio Matsumoto and Masataka Sata :
Plasma Aldosterone Concentration is Associated with Cognitive Impairement in Patients with Hypertension.,
73th Annual scientific meeting of the Japanese circulation society, Mar. 2009.
92.Ken-ichiro Yata, Masahiro Abe, Oda A., Amou H., takeuchi K., Masahiro Hiasa, Nakano A., Miki H., Nakamura S., Tanaka O., Kumiko Kagawa, Shuji Ozaki and Toshio Matsumoto :
Anti-myeloma effects of γδ T cells are hampered by bone marrow stromal cells but resumed by stromal cell-derived osteoblasts,
Annual Meeting of the American Society of Hematology, San Francisco, Dec. 2008.
93.Ken-ichi Aihara, Sumiko Yoshida, Takayuki Ise, Sumitomo Yuka, Shusuke Yagi, Takashi Iwase, Kurahashi Kiyoe, Itsuro Endo, Yuichi Fujinaka, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Increased serum triglyceride but not LDL cholesterol is associated with left ventricular diastolic dysfunction.,
Scientific Sessions 2008, American Heart Association, New Orleans, Nov. 2008.
94.Takayuki Ise, Ken-ichi Aihara, Sumiko Yoshida, Sumitomo Yuka, Shusuke Yagi, Takashi Iwase, Ishikawa Kazue, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Plasma Heparin Cofactor II Activity Is Inversely Associated with Left Atrial Volume and Left Ventricular Diastolic Dysfunction.,
Scientific Sessions 2008, American Heart Association, New Orleans, Nov. 2008.
95.Sumiko Yoshida, Ken-ichi Aihara, Takayuki Ise, Sumitomo Yuka, Shusuke Yagi, Takashi Iwase, Kurahashi Kiyoe, Itsuro Endo, Yuichi Fujinaka, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Dehydroepiandrosterone sulfate is an antivascular remodeling factor in elderly individuals.,
Scientific Sessions 2008, American Heart Association, New Orleans, Nov. 2008.
96.Takashi Iwase, Hirotsugu Kurobe, Masashi Akaike, Shunji Nakano, Sumiko Yoshida, Sumitomo Yuka, Shusuke Yagi, Ken-ichi Aihara, Shuji Ozaki, Masahiro Abe, Natsuo Yasui, Toshio Matsumoto, Tetsuya Kitagawa and Masataka Sata :
Erythropoietin administration with autologous blood donation - a novel strategy to enhance mobilization of circulating progenitor cells,
American Heart Association Sessions 2008, New Orleans, Nov. 2008.
97.Masashi Akaike, Ken-ichi Aihara, Yasumasa Ikeda, Shusuke Yagi, Ishikawa Kazue, Sumitomo Yuka, Sumiko Yoshida, Takashi Iwase, Toshio Matsumoto and Masataka Sata :
Pitavastatin, an HMG-CoA Reductase Inhibitor, Prevents Glucocorticoid-induced Hypertension through Ameliorating Imbalance of Oxidative Stress and Nitric Oxide Production,
American Heart Association Sessions 2008, New Orleans, Nov. 2008.
98.Masahiro Abe, Masahiro Hiasa, Oda A., Amou H., takeuchi K., Tanaka O., Nakamura S., Miki H., Kumiko Kagawa, Ken-ichiro Yata, Shuji Ozaki, Kido S. and Toshio Matsumoto :
Bone marrow stromal cells up-regulate M-CSF receptor in monocytes to disrupt dendritic cell differentiation while facilitating osteoclastogenesis in myeloma,
ASBMR, Montreal, Sep. 2008.
99.Takeuchi K., Masahiro Abe, Oda A., Amou H., Masahiro Hiasa, Tanaka O., Nakamura S., Miki H., Kumiko Kagawa, Ken-ichiro Yata, Hashimoto T., Shuji Ozaki, Kido S. and Toshio Matsumoto :
TGF-β Suppresses Adipocytic Differentiation and Enhances Accumulation of Stromal Cells in Myeloma Bone Lesions,
ASBMR, Montreal, Sep. 2008.
100.Masahiro Abe, Masahiro Hiasa, Kido S., Oda A., Amou H., takeuchi K., Ken-ichiro Yata, Shuji Ozaki and Toshio Matsumoto :
TACE up-regulation in monocytes by GM-CSF and IL-4 disrupts myeloma cell-induced osteoclastogenesis while inducing dendritic cell differentiation,
International Meeting on Cancer Induced Bone Disease, Scotland, Jun. 2008.
101.Masashi Akaike, Ken-ichi Aihara, Shusuke Yagi, Yasumasa Ikeda, Ishikawa Kazue, Takayuki Ise, Sumiko Yoshida, Sumitomo Yuka, Takashi Iwase and Toshio Matsumoto :
Pitavastatin, an HMG-CoA Reductase Inhibitor, Prevents Glucocorticoid-induced Hypertension through Increased Nitric Oxide Production as a Pleiotropic Effect on Vascular Endothelial Cells,
Hypertension 2008 18th Scientific Meeting of the European Society of Hypertension 22nd Scientific Meeting of the International Society of Hypertension, Berlin, Jun. 2008.
102.Takashi Iwase, Masashi Akaike, Shunji Nakano, Takayuki Ise, Sumiko Yoshida, Sumitomo Yuka, Shusuke Yagi, Ken-ichi Aihara, Natsuo Yasui and Toshio Matsumoto :
Single erythropoietin administration with autologous blood donation - a novel strategy to enhance mobilization of endothelial progenitor cells,
22nd Scientific Meeting of the International Society of Hypertension 2008, Berlin, Germany, Berlin, Jun. 2008.
103.Sumitomo Yuka, Ken-ichi Aihara, Takayuki Ise, Sumiko Yoshida, Shusuke Yagi, Takashi Iwase, Masashi Akaike and Toshio Matsumoto :
Acceleration of angiotensin II-induced cardiac remodeling through enhancement of oxidative stress in heparin cofactor II knockout mice,
22nd Scientific Meeting of the International Society of Hypertension 2008, Berlin, Germany, Berlin, Jun. 2008.
104.Sumiko Yoshida, Ken-ichi Aihara, Takayuki Ise, Sumitomo Yuka, Shusuke Yagi, Takashi Iwase, Masashi Akaike and Toshio Matsumoto :
Dehydroepiandrosterone sulfate regulates carotid blood flow in elderly individuals,
22nd Scientific Meeting of the International Society of Hypertension 2008, Berlin, Germany, Berlin, Jun. 2008.
105.Ken-ichi Aihara, Takayuki Ise, Sumiko Yoshida, Sumitomo Yuka, Shusuke Yagi, Takashi Iwase, Masashi Akaike and Toshio Matsumoto :
Serum Lipid Disorder is Associated with Left Ventricular Diastolic Dysfunction in Elderly Individuals,
22nd Scientific Meeting of the International Society of Hypertension 2008, Berlin, Germany, Berlin, Jun. 2008.
106.Ken-ichi Aihara, Takayuki Ise, Sumiko Yoshida, Sumitomo Yuka, Shusuke Yagi, Takashi Iwase, Masashi Akaike and Toshio Matsumoto :
The active form of vitamin D, 1,25(OH)2D3, prevents vascular remodeling and glucose intolerance in elderly individuals,
22nd Scientific Meeting of the International Society of Hypertension 2008, Berlin, Germany, Berlin, Jun. 2008.
107.Takako Miyamoto, Shinsuke Kido, Masahiro Abe, Toshio Matsumoto and Hisaaki Taniguchi :
Expression Profiling by Quantitative and Large-scale Proteomics in Differentiating Osteoblasts,
HUPO 5th Annual World Congress, Los Angeles, Nov. 2006.
108.Ken-ichi Aihara, Hiroyuki Azuma, Masashi Akaike, Yasumasa Ikeda, Shusuke Yagi, Takashi Iwase, Sumitomo Yuka, Masataka Sata, Kato Shigeaki and Toshio Matsumoto :
Heparin Cofactor II Deficiency Causes Accelerated Thrombosis and Atherosclerosis in Mice,
American Heart Association Scientific Sessions 2006, Chicago, USA, Nov. 2006.
109.Ken-ichi Aihara, Masashi Akaike, Yasumasa Ikeda, Fujimura Mitsunori, Hashizume Shunji, Takashi Iwase, Shusuke Yagi, Kondo Akira, Hiroyuki Azuma and Toshio Matsumoto :
Valsartan Enhances Nitric Oxide Bioavailability and Reduces Arterial Stiffness in Patients with Essential Hypertension,
The 21st Scientific Meeting of the International Society of Hypertension, 2006, Fukuoka, Japan, Oct. 2006.
110.Takako Miyamoto, Shinsuke Kido, Toshio Matsumoto and Hisaaki Taniguchi :
Proteomic Analysis of Osteoblast Differentiation,
20th IUBMB International Congress of Biochemistry and Molecular Biology and 11th FAOBMB Congress, Kyoto, Jul. 2006.
111.Hirotsugu Kurobe, Yuki Izawa, Y Fukuhara, Tamotsu Kanbara, A Kurushima, Ken-ichi Aihara, Masashi Akaike, Masashi Kano, Takashi Kitaichi, Yutaka Masuda, Hiroyuki Azuma, Toshiaki Tamaki, Toshio Matsumoto, Tetsuya Kitagawa, Shuhei Tomita and Masanori Yoshizumi :
HIF-ARNT transcriptional system in Tcells has a pivotal role in vascular inflammation and remodeling,
XIL International Symposium on Atherosclerosis, Italy, Jun. 2006.
112.Yutaka Masuda, H Kurobe, Takashi Kitaichi, Masashi Kano, A Kurushima, Tetsuya Kitagawa, T Iwase, Masashi Akaike, M Abe and Toshio Matsumoto :
Erythropoietin induced peripheral stem cell transplantation for severe ischemic limbs,
The 14th Annual Meeting of the Asian Society for Cardiovascular Surgery, Osaka, Jun. 2006.
113.Ken-ichi Aihara, Hiroyuki Azuma, Masashi Akaike, Hirotsugu Kurobe, Fujimura Mitsunori, Shusuke Yagi, Hashizume Shunji, Yasumasa Ikeda, Takashi Iwase, Takamori Nobuyuki, Tetsuya Kitagawa and Toshio Matsumoto :
Plasma Heparin Cofactor II Activity is a Predictor for Incidence of Peripheral Arterial Disease in Patients with Cardiovascular Risk Factors,
XIV International Symposium on Atherosclerosis, 2006 Rome, Italy, Jun. 2006.
114.Ken-ichi Aihara, Mihara Masatomo, Hiroyuki Azuma, Masashi Akaike, Takaya Matsushita, Yasumasa Ikeda, Shusuke Yagi, Takashi Iwase, Hashizume Shunji, Fujimura Mitsunori and Toshio Matsumoto :
Argatroban, a synthetic thrombin antagonist, can reduce insulin resistance though thrombin inactivation in the db/db mouse model of type 2 diabetes mellitus,
XIV International Symposium on Atherosclerosis, 2006 Rome, Italy, Jun. 2006.
115.Hirotsugu Kurobe, Yuki Izawa, Yayoi Fukuhara, Tamotsu Kanbara, Ken-ichi Aihara, Masashi Akaike, Hiroyuki Azuma, Tetsuya Kitagawa, Toshiaki Tamaki, Toshio Matsumoto, Masaki Ueno, Shuhei Tomita and Masanori Yoshizumi :
T Cell-specific HIF-1α-deficient Mice, but Not ARNT-deficient Mice, Exhibit Exacerbated Inflammation and Vascular Remodeling in Response to Cuff Injury,
American Heart Association 2005 Scientifc Sessions, Dallas, Nov. 2005.
116.Takamori Nobuyuki, Masashi Akaike, Ken-ichi Aihara, Hirono Akira, Yamaguchi Hiroshi, Hiroyuki Azuma, Tamura Katsuya and Toshio Matsumoto :
Plasma Heparin Cofactor II Activities Predict Cardiovascular Risk in Patients with Coronary Heart Disease,
American Heart Associations Scientific Sessions 2005, Dallas, USA, Nov. 2005.
117.Ali Jalili, Shuji Ozaki, Tomoko Hara, Etsuko Sekimoto, Yoichi Tanaka, Takashi Ohshima, Hironobu Shibata, Toshihiro Hashimoto, Masahiro Abe, Yasuhiko Nishioka and Toshio Matsumoto :
Generation of HM1.24-specific cytotoxic T lymphocytes from peripheral blood stem cell harvests of patients with multiple myeloma,
46th Annual Meeting: American Society of Hematology, San Francisco, Dec. 2004.
118.Atsushi Shioyasono, Yasuo Oba, Hiura Kenji, Masahiro Abe, Toshio Matsumoto and Keiji Moriyama :
MIP-1alpha is upregulated during experimental tooth movement,
IADR 82nd General Session, Honolulu, Mar. 2004.
119.Ken-ichi Aihara, Takamori Nobuyuki, Yasuhiko Kanagawa, Masashi Akaike, Fujimura Mitsunori, Yoshida Tomonori, Hashizume Shunji, Kato Midori, Yasumasa Ikeda, Hiroyuki Azuma and Toshio Matsumoto :
Heparin cofactor II is inversely related to the severity of carotid atherosclerosis,
American Heart Association, Scientific Sessions 2003 Orland Florida USA, Nov. 2003.

Proceeding of Domestic Conference:

1.Masahiro Hiasa, Masahiro Abe, 中野 綾子, Keiichiro Watanabe, Shingen Nakamura, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Pimキナーゼの阻害は骨芽細胞分化を促進し,骨髄腫骨病変の形成と腫瘍進展を抑制する,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 178,
2.Keiichiro Watanabe, Masahiro Abe, 川谷 誠, Masahiro Hiasa, Shingen Nakamura, Eiji Tanaka, 長田 裕之 and Toshio Matsumoto :
リベロマイシンAによる酸性環境がもたらす骨髄腫薬剤耐性の克服と骨病変形成の抑制,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 208,
3.Shinsuke Kido, 中川 航司, 遠藤 逸郎, 坂田 雅映, 橋本 由衣, Sawako Tatsumi, Toshio Matsumoto and Ken-ichi Miyamoto :
糖尿病症骨症の発症機序の解析:終末糖化産物(AGEs)にんよるCanonical,
第1回骨バイオサイエンス研究会,
4.Mai Kanai, 松岡 飛翔, Itsuro Endo, 大西 幸代, Yuichi Takashi, Kiyoe Kurahashi, Sumiko Yoshida, Ken-ichi Aihara, Masahiro Abe, Seiji Fukumoto and Toshio Matsumoto :
鉄製剤投与によるFGF23関連低リン血症モデル作成の試み,
日本内分泌学会雑誌, Vol.95, No.1, 422, May 2019.
5.Yuichi Takashi, Hidetaka Kosako, Shun Sawatsubashi, Yuka Kinoshita, 伊東 伸朗, Masahiro Abe, Munehide Matsuhisa, Shigeaki Kato, Toshio Matsumoto and Seiji Fukumoto :
FGFR1はFGF23濃度調節を媒介するリン感知受容体である,
日本内分泌学会雑誌, Vol.95, No.1, 333, May 2019.
6.鶴尾 美穂, Akio Kuroda, Tomoyuki Yuasa, Mizuho Kinouchi, Kimiko Sogabe, 加部 一行, 瀬尾 浩二, Masaharu Nishi, Naoya Matsumoto, Yasuhiko Kanagawa, Masahiro Abe, Toshio Matsumoto, 寺澤 敏秀 and Munehide Matsuhisa :
リブレ使用糖尿病患者の検討,
日本糖尿病学会中国四国地方会第56回総会, Oct. 2018.
7.Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa, Oda Asuka, Bat-Erdene Ariunzaya, Takeshi Harada, Iwasa Masami, Shiroh Fujii, Kimiko Sogabe, Shingen Nakamura, Hirokazu Miki, Masahiro Oura, Kumiko Kagawa, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Mechanisms of TAK1 over-activation in myeloma cells and TAK1-mediated myeloma growth and bone destruction,
第80回日本血液学会学術集会, Oct. 2018.
8.Ashtar Mohannad, Hirofumi Tenshin, Jumpei Teramachi, Masahiro Hiasa, Kotaro Tanimoto, Oda Asuka, Iwasa Masami, Takeshi Harada, Ariunzaya Erdene Bat, Kimiko Sogabe, Oura Masahiro, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Roles of ROS in induction of bone disease and cancer treatment-induced bone loss in myeloma.,
The 80th Annual Meeting of the Japanese Society of Hematology, Oct. 2018.
9.Hirofumi Tenshin, Jumpei Teramachi, Masahiro Hiasa, Kotaro Tanimoto, Mohannad Ashtar, Ariunzaya Bat-Erdene, Iwasa Masami, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Kimiko Sogabe, Oura Masahiro, Shiroh Fujii, Kumiko Kagawa, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Inverse regulation of c-FLIP-mediated survival in myeloma cells and osteoclasts by TRAIL.,
The 80th Annual Meeting of the Japanese Society of Hematology, Oct. 2018.
10.Kotaro Tanimoto, Masahiro Hiasa, Hirofumi Tenshin, Jumpei Teramachi, Oda Asuka, Mohannad Ashtar, Ariunzaya Bat-Erdene, Iwasa Masami, Kimiko Sogabe, Oura Masahiro, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Impact of denervation-induced paralysis and mechanical unloading on tumor expansion in myeloma.,
The 80th Annual Meeting of the Japanese Society of Hematology, Oct. 2018.
11.Masahiro Hiasa, Jumpei Teramachi, Hirofumi Tenshin, Kotaro Tanimoto, Ariunzaya Bat-Erdene, Mohannad Ashtar, Masami Iwasa, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Kimiko Sogabe, Oura Masahiro, Shiroh Fujii, Kumiko Kagawa, Oda Asuka, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
The effects of cathepsin K inhibition on osteocytes: its role in bone restoration in MM bone disease.,
The 80th Annual Meeting of the Japanese Society of Hematology, Oct. 2018.
12.Yuichi Takashi, Masashi Ishizu, 脇野 修, 水口 斉, 島久 登, 田代 学, 宮 恵子, 水口 潤, Akio Kuroda, Toshio Matsumoto, Munehide Matsuhisa and Seiji Fukumoto :
血液透析患者における心不全・動脈硬化・感染のリスク因子としてのFGF23,
第18回日本内分泌学会四国支部学術集会, Sep. 2018.
13.Itsuro Endo, 大西 幸代, Kiyoe Kurahashi, Jumpei Teramachi, Masahiro Hiasa, Hirofumi Tenshin, Seiji Fukumoto, Masahiro Abe and Toshio Matsumoto :
カルシウム感知受容体活性型変異マウスにおける骨強度の低下,
第36回日本骨粗鬆症学会各術集会, Jul. 2018.
14.Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
TAK1 inhibition impairs myeloma cell-bone marrow interaction to reduce myeloma growth and bone destruction,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, Jul. 2018.
15.Masahiro Hiasa, Jumpei Teramachi, Hirofumi Tenshin, Kotaro Tanimoto, Mohannad Ashtar, Ariunzaya Bat-Erdene, Masami Iwasa, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
カテプシンK阻害による多発性骨髄腫骨病変部の骨量 回復プロセスにおける骨細胞の役割.,
第36回日本骨代謝学会学術集会, Jul. 2018.
16.Hirofumi Tenshin, Jumpei Teramachi, Masahiro Hiasa, Kotaro Tanimoto, Mohannad Ashtar, Ariunzaya Bat-Erdene, Masami Iwasa, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TAK1阻害はTRAILによる破骨細胞活性化作用を遮断 させると同時にTRAILの抗骨髄腫作用を増強する,
第36回日本骨代謝学会学術集会, Jul. 2018.
17.Hirofumi Tenshin, Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, Kotaro Tanimoto, Mohannad Ashtar, Ariunzaya Bat-Erdene, Masami Iwasa, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TAK1による破骨細胞に対するTRAILの生存・細胞死シグナル制御機構.,
第4回日本骨免疫学会, Jun. 2018.
18.Kotaro Tanimoto, Masahiro Hiasa, Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Mohannad Ashtar, Ariunzaya Bat-Erdene, Masami Iwasa, Kimiko Sogabe, 大浦 雅弘, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
神経切断による麻痺と免荷の骨髄腫の進展への影響.,
第4回日本骨免疫学会, Jun. 2018.
19.Itsuro Endo, Dong Bingzi, Ohnishi Yukiyo, Sumiko Yoshida, Ken-ichi Aihara, 相澤 慎一, Seiji Fukumoto, Masahiro Abe and Toshio Matsumoto :
常染色体優性低Ca血症1型モデルマウスにおける骨強度の低下,
第91回日本内分泌学会学術総会, Apr. 2018.
20.斎村 玉緒, 鶴尾 美穂, Akio Kuroda, Tomoyuki Yuasa, 加部 一行, Mizuho Kinouchi, Sumiko Yoshida, Hiroki Yamagami, Takeshi Kondo, 西 正晴, 松本 直也, Toshio Matsumoto, Masahiro Abe, 寺澤 敏秀 and Munehide Matsuhisa :
フラッシュグルコースモニタリングシステムにより施設入所可能となった高齢1型糖尿病の一例,
日本糖尿病学会中国四国地方会第55回総会抄録集, Nov. 2017.
21.鶴尾 美穂, Toshio Matsumoto, Akio Kuroda, Tomoyuki Yuasa, 加部 一行, Takeshi Kondo, Mizuho Kinouchi, 井野口 卓, Hiroki Yamagami, 松本 直也, 西 正晴, 寺澤 敏秀, Masahiro Abe and Munehide Matsuhisa :
SLADHを発症した高齢1型糖尿病の一例,
日本糖尿病学会中国四国地方会第55回総会抄録集, Nov. 2017.
22.Jumpei Teramachi, Masahiro Hiasa, Oda Asuka, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Masami Iwasa, Masahiro Oura, Yusaku Maeda, Shiroh Fujii, Kumiko Kagawa, Hirokazu Miki, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Disruption of myeloma cell-bone marrow interaction by TAK-1 inhibition,
第80回日本血液学会学術集会, Oct. 2017.
23.Jumpei Teramachi, Masahiro Hiasa, Oda Asuka, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Masami Iwasa, Masahiro Ohhra, Yusaku Maeda, Shiroh Fujii, Kumiko Kagawa, Hirokazu Miki, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Disruption of myeloma cell-bone marrow interaction by TAK-1 inhibition,
第80回日本血液学会学術集会, Oct. 2017.
24.Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Ariunzaya Baterdene, Masami Iwasa, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TRAILは破骨細胞を活性化させるが,TAK1阻害により骨髄腫細胞とともに破骨細胞にもTRAILのアポトーシス誘導活性が惹起できる,
The 35th Annual Meeting of the Japanese Society for Bone and Mineral Research (oral talk), Jul. 2017.
25.Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Baterdene Ariunzaya, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TAK1阻害はTRAILの抗骨髄腫作用を増強するともに骨吸収促進活性を抑制活性に変換する.,
第42回日本骨髄腫学会, May 2017.
26.鶴尾 美穂, Akio Kuroda, Tomoyuki Yuasa, Takeshi Kondo, Mizuho Kinouchi, Naoko Matsui, 細井 恵美子, Masahiro Abe, Toshio Matsumoto, Munehide Matsuhisa and 寺澤 敏秀 :
γグロブリン療養後に一過性のGAD抗体価上昇がみられた糖尿病の一例,
日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
27.Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
30. 天真寛文, 寺町順平, 小田明日香, 天知良太, , ,破骨細胞系細胞はアポトーシス誘引因子TRAILを生存促進・破骨細胞形成誘導因子として利用する:TAK1-Pim-2経路の役割,
第19回日本癌と骨病変研究会, Nov. 2016.
28.斎村 玉緒, 鶴尾 美穂, Akio Kuroda, Takeshi Kondo, Tomoyuki Yuasa, Mizuho Kinouchi, Masahiro Abe, Toshio Matsumoto, 寺澤 敏秀 and Munehide Matsuhisa :
インスリンポンプの院内検定の試み,
日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
29.Jumpei Teramachi, Hiroshi Mori, Yasuo Ochi, Ryota Amachi, Asuka Oda, Masahiro Hiasa, Takeshi Harada, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Potent induction of bone formation by anti-resorptive cathepsin K inhibitor in myeloma.,
The 77th Annual Meeting of the Japanese Society of Hematology, Oct. 2016.
30.Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TAK1 inhibition subverts TRAIL-mediated osteoclastogenesis.,
第77回日本血液学会学術集会,, Oct. 2016.
31.Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, 小田 明日香, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shiroh Fujii, 遠藤 逸郎, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Mechanism of the TRPV1 up-regulatation in myeloma cells and adaptation to an acidic microenvironment.,
第77回日本血液学会学術集会,, Oct. 2016.
32.Keiichiro Watanabe, Jumpei Teramachi, Ryota Amachi, 小田 明日香, Hirofumi Tenshin, 岩浅 正美, Masahiro Hiasa, Shingen Nakamura, 遠藤 逸郎, 川谷 誠, 長田 裕之, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Amelotin gene expression is temporarily being upregulated at the initiation of apoptosis induced by TGFb1 in mouse gingival epithelial cells,
第77回日本血液学会学術集会,, Oct. 2016.
33.Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Kiyoe Kurahashi, Takeshi Kondo, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
TAK-1 inhibition disrupts Pim-2-associated and Pim-2-independent key signaling pathways to effectively suppress tumor growth and restore bone formation in myeloma,
第78回 日本血液学会学術集会, Oct. 2016.
34.Keiichiro Watanabe, Jumpei Teramachi, Ryota Amachi, 小田 明日香, Hirofumi Tenshin, Masahiro Hiasa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, 川谷 誠, 長田 裕之, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
リベロマイシンAによる酸性環境での骨髄腫細胞の治療抵抗性の克服,
日本骨代謝学会学術集会プログラム抄録集 (1349-0761)34回 Page183(2016.07), 183, Jul. 2016.
35.Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
破骨細胞はTAK1の発現誘導を介しアポトーシスを抑制しTRAILにより成熟活性化される,
日本骨代謝学会学術集会プログラム抄録集 (1349-0761)34回 Page183(2016.07), 183, Jul. 2016.
36.Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, Hirofumi Tenshin, Ryota Amachi, 原田 武志, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
骨髄腫腫瘍進展と骨破壊病変形成におけるTAK1-Pim-2経路の役割,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, Jul. 2016.
37.Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, 原田 武志, Hirofumi Tenshin, Shingen Nakamura, Ryota Amachi, Shiroh Fujii, Keiichiro Watanabe, Kumiko Kagawa, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Pim-2は骨髄腫における破骨細胞形成促進の 必須媒介因子である,
第41回日本骨髄腫学会学術集会, May 2016.
38.Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TRAILは破骨細胞に細胞死を誘導せず,破骨細胞分化・生存を促進する.,
第41回日本骨髄腫学会, May 2016.
39.布村 俊幸, Sumiko Yoshida, Kana Morimoto, Kiyoe Kurahashi, Takeshi Kondo, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa, Toshio Matsumoto and Masahiro Abe :
副腎に接する神経線維腫を合併したレックリングハウゼン病の1例,
第114回日本内科学会四国地方会, May 2016.
40.橋本 晶慶, 鶴尾 美穂, 秋田 賢子, 森岡 隆子, Akio Kuroda, Tomoyuki Yuasa, Takeshi Kondo, Mizuho Kinouchi, Toshio Matsumoto, Masahiro Abe, Munehide Matsuhisa and 寺澤 敏秀 :
糖尿病教室のスタッフ間の相互評価による改善効果,
第59回日本糖尿病学会年次学術集会, May 2016.
41.Ken-ichi Aihara, Masashi Akaike, Sumiko Yoshida and Toshio Matsumoto :
グルココルコイド過剰誘導酸化ストレスの臨床的評価とeNOSの有無におけるピタバスタチンの虚血臓器保護効果機構の差異,
平成27年度 第1回班会議, Dec. 2015.
42.鶴尾 美穂, Akio Kuroda, Takeshi Kondo, Tomoyuki Yuasa, Mizuho Kinouchi, Masahiro Abe, Toshio Matsumoto, Munehide Matsuhisa and 寺澤 敏秀 :
Sensor Angmented Pump(SAP)療法が有効であった高齢1型糖尿病の1例,
第53回日本糖尿病学会中国四国地方会, Oct. 2015.
43.森岡 隆子, 鶴尾 美穂, Akio Kuroda, Tomoyuki Yuasa, Takeshi Kondo, Mizuho Kinouchi, Toshio Matsumoto, Munehide Matsuhisa and 寺澤 敏秀 :
SGLT2阻害薬が著効したprader,
第53回日本糖尿病学会中国四国地方会 米子コンベンションセンター, Oct. 2015.
44.Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, A Oda, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, H Miki, Kumiko Kagawa, Shiroh Fujii, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Mechanism of the TRPV1 up-regulatation in myeloma cells and adaptation to an acidic microenvironment,
第77回日本血液学会学術集会, Oct. 2015.
45.Keiichiro Watanabe, Jumpei Teramachi, H Mori, Y Ochi, Ryota Amachi, A Oda, Masahiro Hiasa, T Harada, Shiroh Fujii, Shingen Nakamura, H Miki, Kumiko Kagawa, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Potent induction of bone formation by anti-resorptive cathepsin K inhibitor in myeloma,
第77回日本血液学会学術集会, Oct. 2015.
46.Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Keiichiro Watanabe, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Potent suppression of osteoclastogenesis in myeloma by Pim inhibition,
第77回日本血液学会学術集会, Oct. 2015.
47.Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Keiichiro Watanabe, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Tumor reduction and bone restoration in myeloma by TAK-1 inhibition,
第77回日本血液学会学術集会, Oct. 2015.
48.Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, Hirofumi Tenshin, Ryota Amachi, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Pim阻害による骨髄種骨病変の治療:破骨細胞形成の抑制,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, Jul. 2015.
49.Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, Hirofumi Tenshin, Ryota Amachi, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
骨髄腫腫瘍進展と骨破壊病変形成における TAK-1の枢軸的役割,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, Jul. 2015.
50.Ken-ichi Aihara, Sumiko Yoshida, 上元 良子, 石川 カズ江 and Toshio Matsumoto :
内因性血清尿酸値およびフェブキソスタットによる頸動脈硬化への影響,
第47回日本動脈硬化学会総会・学術集会, Jul. 2015.
51.Sumiko Yoshida, Yasumasa Ikeda, Ken-ichi Aihara and Toshio Matsumoto :
心血管病におけるアンドロゲン-AR系の役割,
第33回 内分泌代謝学サマーセミナー, Jul. 2015.
52.Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TRAILは破骨細胞分化・生存を促進する:TAK-1による生と死の運命制御,
第1回日本骨免疫学会, 137, Jul. 2015.
53.Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, 小田 明日香, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, Kumiko Kagawa, Hirokazu Miki, Shiroh Fujii, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
酸環境での骨髄腫細胞のDR4発現抑制:酸によるエピジェネティックな遺伝子発現制御,
第1回日本骨免疫学会, 108, Jul. 2015.
54.Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, 小田 明日香, Keiichiro Watanabe, Hirofumi Tenshin, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Takeshi Kondo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
酸性環境での骨髄腫細胞のTRPV1の発現亢進と酸環境への適応,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 165, Jul. 2015.
55.Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
アポトーシス誘導因子TRAILによる破骨細胞分化・生存の促進,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 164, Jul. 2015.
56.Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, Masashi Akaike, Toshiaki Tamaki and Toshio Matsumoto :
心血管疾患における男性ホルモンの意義,
第15回日本抗加齢医学会総会 シンポジウム「知って得するテストステロンアップデート」, May 2015.
57.後藤 廣平, 鶴尾 美穂, Akio Kuroda, 伊澤 真弓, Mizuho Kinouchi, Takeshi Kondo, Tomoyuki Yuasa, Toshio Matsumoto, Munehide Matsuhisa and 寺澤 敏秀 :
SGLT2阻害薬の強化インスリン療法への併用効果の検討,
第58回日本糖尿病学会年次学術集会 口演, May 2015.
58.Ken-ichi Aihara, Sumiko Yoshida, 大黒 由加里, Motoyuki Tamaki, Takeshi Kondo, 倉橋 清衛, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto :
ARB基盤高血圧治療の長期心腎保護効果における糖尿病の影響,
第58回総会日本糖尿病学会年次学術集会, May 2015.
59.Kiyoe Kurahashi, 森 智子, 宮本 千伸, 津川 和江, Miho Oyadomari, Kazuna Takahara, 木村 千寿子, Masato Miyake, Toshio Matsumoto and Seiichi Oyadomari :
膵β細胞での脂肪毒性における小胞体ストレス応答の役割の解明,
第58回日本糖尿病学会年次学術集会, May 2015.
60.Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, 原田 武志, Ryota Amachi, Hirofumi Tenshin, Hirokazu Miki, Shingen Nakamura, Shiroh Fujii, Kumiko Kagawa, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Pim阻害による骨髄腫骨吸収亢進の抑制,
第40回日本骨髄腫学会学術集会, May 2015.
61.Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, 原田 武志, Ryota Amachi, Hirofumi Tenshin, Hirokazu Miki, Shingen Nakamura, Shiroh Fujii, Kumiko Kagawa, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
TAK-1は骨髄腫腫瘍進展と骨破壊病変形成の枢軸的な媒介因子である,
第40回日本骨髄腫学会学術集会, May 2015.
62.Ken-ichi Aihara, Sumiko Yoshida, 大黒 由加里, 倉橋 清衛, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto :
本態性高血圧患者におけるアンジオテンシンII受容体拮抗薬単独およびカルシウム拮抗薬併用による長期心筋保護効果の検証,
第88回日本内分泌学会学術総会, Apr. 2015.
63.Bingzi Dong, Itsuro Endo, Takeshi Kondo, 大西 幸代, Hiroshi Sakaue, 相澤 慎一, Masahiro Abe and Toshio Matsumoto :
Interleukin-11は脂肪細胞分化を抑制する,
第88回日本内分泌学会, Apr. 2015.
64.Takeshi Kondo, Itsuro Endo, 大黒 由加里, 倉橋 清衛, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
遠位尿細管性アシドーシスの確定診断としてアミノ レバンRは有用である.,
第112回日本内科学会総会・講演会, Apr. 2015.
65.大黒 由加里, Akio Kuroda, Motoyuki Tamaki, 倉橋 清衛, Takeshi Kondo, 安芸 菜奈子, Itsuro Endo, Ken-ichi Aihara, Toshio Matsumoto and Munehide Matsuhisa :
皮下注射による強化インスリン療養中の1型糖尿病患者における基礎インスリン比率の検討,
第250回徳島医学会学術集会(大塚講堂), Feb. 2015.
66.Akio Kuroda, Takeshi Kondo, 安田 哲行, 高原 充佳, Ken-ichi Aihara, Itsuro Endo, 金藤 秀明, 下村 伊一郎, Toshio Matsumoto and Munehide Matsuhisa :
インスリンポンプ療法での追加インスリン注入時間を規定する因子の検討,
第14回日本先進糖尿病治療研究会(あわぎんホール), Dec. 2014.
67.大黒 由加里, Akio Kuroda, Motoyuki Tamaki, 倉橋 清衛, Takeshi Kondo, 安芸 菜奈子, Itsuro Endo, Ken-ichi Aihara, Toshio Matsumoto and Munehide Matsuhisa :
皮下注射による強化インスリン療法1型糖尿病患者における基礎インスリン比率の検討,
第12回1型糖尿病研究会(イーグレ姫路), Nov. 2014.
68.倉橋 清衛, 森 智子, 宮本 千伸, 津川 和江, Miho Oyadomari, Kazuna Takahara, Ryosuke Sato, 木村 千寿子, Masato Miyake, Toshio Matsumoto and Seiichi Oyadomari :
飽和脂肪酸は膵β細胞の小胞体膜の組成を変化させ,PERK 経路の活性化による翻訳抑制を介してインスリン分泌を低下させる,
第9回臨床ストレス応答学会大会, Nov. 2014.
69.Jumpei Teramachi, Masahiro Hiasa, 原田 武志, Ryota Amachi, Kumiko Kagawa, Hirokazu Miki, Shingen Nakamura, Shiroh Fujii, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Therapeutic impact of Pim inhibition on myeloma bone disease: blockade of NF-B-mediated suppression of osteoblastogenesis and stimulation of osteoclastogenesis,
日本血液学会, Oct. 2014.
70.浅井 廣平, 鶴尾 美穂, Akio Kuroda, Tomoyuki Yuasa, 伊澤 真弓, Takeshi Kondo, Mizuho Kinouchi, Toshio Matsumoto, Munehide Matsuhisa and 寺澤 敏秀 :
SGLT阻害薬の臨床効果の検討,
日本糖尿病学会中国四国地方会第52回総会, Oct. 2014.
71.鶴尾 美穂, Akio Kuroda, Tomoyuki Yuasa, 松本 直也, Takeshi Kondo, Mizuho Kinouchi, Toshio Matsumoto, Munehide Matsuhisa and 寺澤 敏秀 :
SGLT2阻害薬が著効したPrader Willi syndrome 合併糖尿病の1例,
日本糖尿病学会中国四国地方会第52回総会, Oct. 2014.
72.荒木 迪子, Motoyuki Tamaki, Akio Kuroda, 大黒 由加里, 倉橋 清衛, Takeshi Kondo, Ken-ichi Aihara, Itsuro Endo, 安芸 菜奈子, Toshio Matsumoto and Munehide Matsuhisa :
2型糖尿病患者におけるeGFRの妥当性について,
日本糖尿病学会中国四国地方会第52回総会, Oct. 2014.
73.Ken-ichi Aihara, Sumiko Yoshida, 大黒 由加里, 倉橋 清衛, Takeshi Kondo, Itsuro Endo and Toshio Matsumoto :
アンジオテンシン受容体拮抗薬およびカルシウム拮抗薬併用による心筋リモデリング抑制の長期効果,
第37日本高血圧学会総会, Oct. 2014.
74.Motoyuki Tamaki, 荒木 迪子, 野崎 綾音, 大黒 由加里, 倉橋 清衛, Takeshi Kondo, Ken-ichi Aihara, Itsuro Endo, 安芸 菜奈子, Toshio Matsumoto, Munehide Matsuhisa and Akio Kuroda :
肥満2型糖尿病患者のeGFRは24hrCCrと比較して過小評価されている,
第29回日本糖尿病合併症学会, Oct. 2014.
75.森本 佳奈, Ken-ichi Aihara, 大黒 由加里, 倉橋 清衛, Takeshi Kondo, Motoyuki Tamaki, 安藝 菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto :
多剤併用降圧療法と臓器障害モニタリングにより長期にわたり心腎大血管障害の改善が得られた加速型高血圧-悪性高血圧の1例,
第14回日本内分泌学会四国支部学術集会, Sep. 2014.
76.白川 光雄, 本田 壮一, Katsuhiko Yoshimoto and Toshio Matsumoto :
抗ランクル抗体を投与した原発性副甲状腺機能亢進症の1例,
第14回日本内分泌学会四国地方会 徳島, Sep. 2014.
77.Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Jumpei Teramachi, 小田 明日香, Keiichiro Watanabe, Shingen Nakamura, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
酸が惹起する骨髄腫細胞の酸感受と生存シグナルの悪循環,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 225, Jul. 2014.
78.Dong Bingzi, Itsuro Endo, Takeshi Kondo, 大西 幸代, Masahiro Abe, Seiji Fukumoto, 網塚 憲生, 長谷川 智香, 相澤 慎一 and Toshio Matsumoto :
常染色体優性低Ca血症モデルマウスに対するcalcilyticsの効果,
第32回日本骨代謝学会学術集会, Jul. 2014.
79.Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, Ryota Amachi, Shingen Nakamura, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Pim-2キナーゼはTNF-αによる骨芽細胞分化抑制および破骨細胞形成促進の必須媒介因子である:Pim阻害薬の骨髄腫骨病変改善効果,
第32回日本骨代謝学会学術集会, Jul. 2014.
80.Itsuro Endo, Masahiro Abe and Toshio Matsumoto :
骨転移に対するdenosumab療法:低Ca血症発現の実態と対策,
第32回日本骨代謝学会, Jul. 2014.
81.Itsuro Endo, Masahiro Abe and Toshio Matsumoto :
骨転移に対するdenosumab療法,
第32回 日本骨代謝学会学術集会, Jul. 2014.
82.Ken-ichi Aihara, Sumiko Yoshida, Yasumasa Ikeda, 上元 良子, 石川 カズ江, Masashi Akaike and Toshio Matsumoto :
動脈硬化および虚血に対するeNOS非依存的なピタバスタチンの臓器保護効果の検討,
第46回日本動脈硬化学会総会・学術集会, Jul. 2014.
83.Ken-ichi Aihara, 大黒 由加里, 倉橋 清衛, Takeshi Kondo, Mizuho Kinouchi, Itsuro Endo, Toshio Matsumoto, Motoyuki Tamaki, Akio Kuroda and Munehide Matsuhisa :
エゼチミブとコレスチミドの併用で脂質プロフィルが改善した多発性筋炎合併家族性高コレステロール血症へテロ接合体の一例,
第110回日本内科学会四国地方会, Jun. 2014.
84.森本 佳奈, Ken-ichi Aihara, 大黒 由加里, 倉橋 清衛, Mizuho Kinouchi, Motoyuki Tamaki, 安藝 菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto :
多剤併用降圧療法により長期的な心・腎・大血管障害の改善が得られた高レニン性高血圧症の1例,
第3回臨床高血圧フォーラム, May 2014.
85.大黒 由加里, Akio Kuroda, Motoyuki Tamaki, 倉橋 清衛, Takeshi Kondo, Mizuho Kinouchi, 近藤 絵里, Sumiko Yoshida, 安芸 菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
皮下注射による強化インスリン療法1型糖尿病患者における基礎インスリン比率の検討,
第57回日本糖尿病学会年次学術集会 口演, May 2014.
86.松本 幸恵, 鶴尾 美穂, Akio Kuroda, Tomoyuki Yuasa, 秋田 賢子, Mizuho Kinouchi, Takeshi Kondo, Munehide Matsuhisa, Toshio Matsumoto and 寺澤 敏秀 :
糖尿病患者の考える指示エネルギー量,指示主食量の調査とその介入,
第57回日本糖尿病学会年次学術集会 口演, May 2014.
87.松本 幸恵, 鶴尾 美穂, Akio Kuroda, Tomoyuki Yuasa, 秋田 賢子, Mizuho Kinouchi, Takeshi Kondo, Munehide Matsuhisa, Toshio Matsumoto and 寺澤 敏秀 :
-,
第57回 日本糖尿病学会年次学術集会, May 2014.
88.Akiko Hata, Yosuke Shikama, 安藝 菜奈子, Chisato Kosugi, 小林 寛也, 三好 雅士, 中尾 隆之, Ayako Tamura, Takako Ichihara, Takako Minagawa, Yumi Kuwamura, Toshio Matsumoto and Makoto Funaki :
徳島県における血清脂肪細胞特異的脂肪酸結合蛋白質とメタボリックシンドローム発症との関連,
Journal of the The Japan Diabetes Society, Vol.Vol.57, No.Suppl.1, May 2014.
89.Itsuro Endo, Dong Bingzi, 長谷川 智香, 網塚 憲生, Seiji Fukumoto and Toshio Matsumoto :
Ca感知受容体関連疾患の最新の知見とその治療,
第87回日本内分泌学会, Apr. 2014.
90.Ken-ichi Aihara, Mizuho Kinouchi, 大黒 由加里, 倉橋 清衛, Takeshi Kondo, 安藝 菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto :
生活習慣病治療薬が血管内皮機能 に及ぼす影響の検証,
第111回日本内科学会講演会, Apr. 2014.
91.菅澤 典子, 中山 泰介, Hirotsugu Kurobe, 宅見 央子, 東口 文治, Hajime Kinoshita, Mikio Sugano, Tamotsu Kanbara, Eiki Fujimoto, Ken-ichi Aihara, Takashi Kitaichi, Toshio Matsumoto and Tetsuya Kitagawa :
動脈硬化病巣進展に対する糖転移ヘスペリジンの抑制効果についての検討,
第44回日本心臓血管外科学会学術総会, Feb. 2014.
92.Shusuke Yagi, Ken-ichi Aihara, Masashi Akaike, Sachiko Matsumoto, Daiju Fukuda, 松浦 朋美, Takayuki Ise, Koji Yamaguchi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Michio Shimabukuro, Toshio Matsumoto and Masataka Sata :
DPP-4阻害薬の血糖降下作用に対する有効性予測因子,
第248回徳島医学会学術集会, Feb. 2014.
93.森本 佳奈, Ken-ichi Aihara, 大黒 由加里, 倉橋 清衛, Takeshi Kondo, Mizuho Kinouchi, Motoyuki Tamaki, 安芸 菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto :
6年間にわたる多剤併用降圧療法が心・腎・大血管障害の改善に寄与した高レニン性高血圧症の1例,
第248回徳島医学会学術集会, Feb. 2014.
94.大黒 由加里, Takeshi Kondo, 倉橋 清衛, 安芸 菜奈子, Akio Kuroda, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
下垂体の経時的な変化を捉えたシーハン症候群の一例,
第23回臨床内分泌代謝Update, Jan. 2014.
95.Hwa In, Akio Kuroda, Yuu Tamaki, Masato Tagi, Hiroki Moriguchi, Toshio Matsumoto, Yuichi Fujinaka, 安藝 宏信, Tomiaki Morikawa and Munehide Matsuhisa :
ITを活用した徳島県糖尿病医療連携システム構築のこころみ,
日本先進糖尿病治療研究会雑誌, Vol.9, 47, Jan. 2014.
96.Akio Kuroda, Takeshi Kondo, 安田 哲行, 高原 充佳, Ken-ichi Aihara, Itsuro Endo, 金藤 秀明, 下村 伊一郎, Toshio Matsumoto and Munehide Matsuhisa :
インスリンポンプ療法での追加インスリン注入時間を規定する因子の検討,
第13回日本先進糖尿病治療研究会, Nov. 2013.
97.大和 光, 瀧川 稲子, Akiko Matsumura, 山田 静恵, 谷 佳子, Ken-ichi Aihara, Toshio Matsumoto, Hwa In, Akio Kuroda and Munehide Matsuhisa :
徳島大学病院における糖尿病透析予防指導の有用性の検討,
日本糖尿病学会中国四国地方会第51回総会, Nov. 2013.
98.大黒 由加里, Takeshi Kondo, Akio Kuroda, 倉橋 清衛, Mizuho Kinouchi, 安芸 菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
過剰基礎インスリン量が不適切な間食摂取に関連したインスリンポンプ使用1型糖尿病の2例,
日本糖尿病学会中国四国地方会第51回総会, Nov. 2013.
99.松本 幸恵, Akio Kuroda, 秋田 賢子, 鶴尾 美穂, Mizuho Kinouchi, Takeshi Kondo, Tomoyuki Yuasa, Munehide Matsuhisa, Toshio Matsumoto and 寺澤 敏秀 :
主食の摂取状況調査,
日本糖尿病学会中国四国地方会第51回総会, Nov. 2013.
100.Takeshi Kondo, 大黒 由加里, Akio Kuroda, 倉橋 清衛, Mizuho Kinouchi, 安芸 菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
テストステロン補充で速やかにインスリン抵抗性が改善した汎下垂体機能低下症合併糖尿病例,
日本糖尿病学会中国四国地方会第51回総会, Nov. 2013.
101.Ken-ichi Aihara, Mizuho Kinouchi, 大黒 由加里, Takeshi Kondo, 倉橋 清衛, 安藝 菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto :
メタボリックシンドロームおよび糖尿病の有無が血管内皮機能に及ぼす影響,
日本糖尿病学会 中国四国地方会第51回総会, Nov. 2013.
102.Takeshi Kondo, 大黒 由加里, Akio Kuroda, 倉橋 清衛, Mizuho Kinouchi, 安芸 菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
テストステロン補充で速やかにインスリン抵抗性が改善した汎下垂体機能低下症合併糖尿病例,
日本糖尿病学会中国四国地方会第51回総会, Nov. 2013.
103.Ken-ichi Aihara, Mizuho Kinouchi, Sumiko Yoshida, 大黒 由加里, 倉橋 清衛, Takeshi Kondo, 安藝 菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto :
糖代謝異常の血管機能評価に及ぼす効果,
第36回日本高血圧学会総会, Oct. 2013.
104.Keiichiro Watanabe, Masahiro Abe, H Mori, K Udaka, M Iwasa, D Hanson, Ryota Amachi, Masahiro Hiasa, T Harada, Shiroh Fujii, Shingen Nakamura, H Miki, Kumiko Kagawa, Itsuro Endo, Eiji Tanaka and Toshio Matsumoto :
Bone restoration and tumor suppression in myeloma by cathepsin K inhibition with Bortezomib,
第75回日本血液学会学術集会, Oct. 2013.
105.Ryota Amachi, Keiichiro Watanabe, Masahiro Hiasa, Masahiro Abe, Toshio Matsumoto and Eiji Tanaka :
酸性環境が骨髄腫細胞の破骨細胞活性に及ぼす影響,
第72回日本矯正歯科学会大会プログラム・抄録集, Oct. 2013.
106.Kiyoe Kurahashi, 森 智子, 野村 明利, Atsushi Ogura, 津川 和江, 宮本 千伸, Masato Miyake, Miho Oyadomari, Toshio Matsumoto and Seiichi Oyadomari :
飽和脂肪酸は小胞体膜の流動性低下によるPERK経路の活性化を介して膵β細胞におけるインスリン分泌を低下させる,
第86回日本生化学会大会, Sep. 2013.
107.Kiyoe Kurahashi, 森 智子, Akitoshi Nomura, Atsushi Ogura, 津川 和江, 宮本 千伸, Masato Miyake, Miho Oyadomari, Toshio Matsumoto and Seiichi Oyadomari :
ポスター発表 飽和脂肪酸は小胞体膜の流動性低下によるPERK経路の活性化を介して膵β細胞におけるインスリン分泌を低下させる,
第86回日本生化学会大会, Sep. 2013.
108.大黒 由加里, Takeshi Kondo, Shiroh Fujii, Shingen Nakamura, 倉橋 清衛, Akio Kuroda, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
著名な汎血球減少と肝筋逸脱酵素高値を呈した神経性食欲不振症の一例,
第13回日本内分泌学会四国支部学術集会, Sep. 2013.
109.Takeshi Kondo, 岩佐 昌美, 大黒 由加里, 倉橋 清衛, Akio Kuroda, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
不動が惹起した高カルシウム血症で頻回の意識障害を来たした一例,
第13回日本内分泌学会四国支部学術集会, Sep. 2013.
110.鈴木 麗子, 大和 光, 瀧川 稲子, Ken-ichi Aihara, Itsuro Endo, 安芸 菜奈子, 倉橋 清衛, Toshio Matsumoto, Akio Kuroda and Munehide Matsuhisa :
フットケア外来におけるインスリン皮下硬結の実態調査と皮下硬血患者への介入の結果報告,
第13回日本糖尿病情報学会年次学術集会, Aug. 2013.
111.本田 壮一, 小原 聡彦, 橋本 崇代, Katsuhiko Yoshimoto and Toshio Matsumoto :
長期臥床の入院患者の増加—骨粗鬆症—,
第247回徳島医学会学術集会, Aug. 2013.
112.Mizuho Kinouchi, Ken-ichi Aihara, Sumiko Yoshida, 大黒 由加里, 倉橋 清衛, Takeshi Kondo, 安藝 菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto :
臨床血管機能における糖代謝異常の影響の解析,
第247回徳島医学会学術集会, Aug. 2013.
113.Ken-ichi Aihara, Mizuho Kinouchi, Sumiko Yoshida, 岩佐 昌美, 倉橋 清衛, Takeshi Kondo, 安藝 菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto :
Evaluation for influence of diabetes on clinical vascular function,
第45回日本動脈硬化学会総会・学術集会, Jul. 2013.
114.Ken-ichi Aihara, Toshio Matsumoto, Munehide Matsuhisa and 大和 光 :
血管年齢を正確に知ってアンチエイジング!,
第13回日本抗加齢医学会総会, Jun. 2013.
115.Michihiro Nakamura, Koichiro Hayashi, Hirokazu Miki, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto and Kazunori Ishimura :
有機シリカ・マルチ蛍光ナノプローブによるSeamless蛍光イメーシング,
第8回日本分子イメージング学会学術集会, May 2013.
116.Ryota Amachi, Keiichiro Watanabe, Shiroh Fujii, T Harada, H Miki, S Nakamura, A Oda, Masahiro Hiasa, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
An acdic milieu confers the resistance to TRAIL in myeloma cells through the PI3K-Akt-mediated epigenetic down-regulation of the TRAIL receptor DR4,
International Bone and Mineral Society 2013, May 2013.
117.Keiichiro Watanabe, Masahiro Abe, H Mori, Ryota Amachi, Masahiro Hiasa, T Harada, Shiroh Fujii, S Nakamura, H Miki, K Kagawa, I Endo, Eiji Tanaka and Toshio Matsumoto :
Induction of cathepsin K induce bone formation in myeloma osteolytic lesions,
International Bone and Mineral Society 2013, May 2013.
118.鈴木 麗子, 瀧川 稲子, 大和 光, 菊恵 木田, Ken-ichi Aihara, Itsuro Endo, 安芸 菜奈子, 倉橋 清衛, Toshio Matsumoto, Akio Kuroda and Munehide Matsuhisa :
フットケア外来におけるインスリン皮下硬結の実態調査と皮下硬結患者への介入の有用性検討,
第56回日本糖尿病学会年次学術集会, May 2013.
119.藤島 周子, 森岡 隆子, 高田 妙子, 岩谷 沙紀, 斎村 玉緒, 秋田 賢子, 松本 幸恵, Takeshi Kondo, Sumiko Yoshida, Tomoyuki Yuasa, 鶴尾 美穂, Akio Kuroda, Munehide Matsuhisa, Toshio Matsumoto and 寺澤 敏秀 :
当院の参加型糖尿病教室の取り組み,
第56回日本糖尿病学会年次学術集会, May 2013.
120.伊澤 真弓, Akio Kuroda, 上野 裕子, 堀筋 富士子, 鶴尾 美穂, Sumiko Yoshida, Takeshi Kondo, Tomoyuki Yuasa, Munehide Matsuhisa, Toshio Matsumoto and 寺澤 敏秀 :
インスリン注入器に関する患者の意識調査,
第56回日本糖尿病学会年次学術集会, May 2013.
121.Kiyoe Kurahashi, 三浦 直子, 宮本 千伸, 津川 和江, 森 智子, Miho Oyadomari, Masato Miyake, Atsushi Ogura, Toshio Matsumoto and Seiichi Oyadomari :
膵β細胞における飽和脂肪酸による脂肪毒性に小胞体膜流動性の低下とPERK経路が影響する,
第56回日本糖尿病学会年次学術集会, May 2013.
122.鶴尾 美穂, Akio Kuroda, Sumiko Yoshida, Takeshi Kondo, Tomoyuki Yuasa, Toshio Matsumoto, Munehide Matsuhisa and 寺澤 敏秀 :
インスリン治療患者に対するチーム医療で行う段階的糖尿病療養指導の試み,
第56回日本糖尿病学会年次学術集会, May 2013.
123.Akio Kuroda, 鶴尾 美穂, Ken-ichi Aihara, Itsuro Endo, 安芸 菜奈子, Sumiko Yoshida, Takeshi Kondo, Toshio Matsumoto and Munehide Matsuhisa :
1型糖尿病患者におけるインスリングラルギンからインスリンデグルデッグへの同量での切り替え:CGMSを用いた検討,
第56回日本糖尿病学会年次学術集会, May 2013.
124.Takeshi Kondo, Akio Kuroda, Sumiko Yoshida, 安芸 菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
頻回インスリン療法による厳格な血糖管理下におけるシダグリプチン併用のインスリン所要量現象効果の検討,
第56回日本糖尿病学会年次学術集会 ポスター, May 2013.
125.奥村 滋子, Akio Kuroda, 片田 英子, 澤井 敏子, 鶴尾 美穂, Sumiko Yoshida, Takeshi Kondo, Tomoyuki Yuasa, Munehide Matsuhisa, Toshio Matsumoto and 寺澤 敏秀 :
運転中の低血糖についての意識調査,
第56回日本糖尿病学会年次学術集会, May 2013.
126.Akiko Hata, Yukiko Bandou, Yosuke Shikama, 安藝 菜奈子, Chisato Kosugi, 西村 美穂, 阿部 房代, 佐藤 美子, 中奥 真理子, 片山 りか, 赤松 康代, Tohru Sakai, Emi Shuto, Rie Tsutsumi, Ayako Tamura, Takako Ichihara, Takako Minagawa, Yumi Kuwamura, 中尾 隆之, 三好 雅士, Hiroki Moriguchi, Yuu Tamaki, Toshio Matsumoto and Makoto Funaki :
徳島県におけるadiponectinや高感度CRPとメタボリックシンドロームとの関連,
Journal of the The Japan Diabetes Society, Vol.Vol.56, No.Suppl.1, S.208, May 2013.
127.Takeshi Kondo, Akio Kuroda, 曽我部 公子, Sumiko Yoshida, 安藝 菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
術前後で持続血糖測定(CGM)を比較しえたアドレナリン優位褐色細胞腫の1例,
第56回日本糖尿病学会年次学術集会, May 2013.
128.Takeshi Kondo, 尾松 卓, 董 冰子, 大西 幸代, 相澤 慎一, Itsuro Endo and Toshio Matsumoto :
インターロイキン(IL)-11は骨形成促進に必要である,
第86回日本内分泌学会学術集会, Apr. 2013.
129.Sumiko Yoshida, Ken-ichi Aihara, Yasumasa Ikeda, Matomo Sakari, Takahiro Matsumoto, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
アンドロゲン受容体は性差非依存的にVEGF受容体を介して虚血反応性血管新生を促進する,
第86回日本内分泌学会学術総会, Apr. 2013.
130.秦 明子, Yukiko Bandou, Yosuke Shikama, 安藝 菜奈子, Chisato Kosugi, 西村 美穂, 阿部 房代, 佐藤 美子, 中奥 真理子, 片山 りか, 赤松 康代, 丹下 幸子, Tohru Sakai, Emi Shuto, Rie Tsutsumi, Ayako Tamura, Takako Ichihara, Takako Minagawa, Yumi Kuwamura, Yumi Kuwamura, Takayuki Nakao, Masashi Miyoshi, Hiroki Moriguchi, Yuu Tamaki, Toshio Matsumoto and Makoto Funaki :
徳島県におけるadiponectinや高感度CRPとメタボリックシンドロームとの関連,
Journal of the The Japan Diabetes Society, Vol.56, Apr. 2013.
131.松本 和久, Sumiko Yoshida, Ken-ichi Aihara, 岩佐 昌美, Takeshi Kondo, 倉橋 清衛, Mizuho Kinouchi, Itsuro Endo, 安芸 菜奈子, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto :
膵臓の鉄過剰沈着とインスリン分泌不全を呈した無セルロプラスミン血症合併糖尿病の1例,
第86回日本内分泌学会学術総会, Apr. 2013.
132.三橋 威史, Ken-ichi Aihara, Sumiko Yoshida, 上元 良子, 石川 カズ江 and Toshio Matsumoto :
粥状動脈硬化モデルにおけるピタバスタチンの臓器保護効果の検討,
第86回日本内分泌学会学術総会, Apr. 2013.
133.松本 和久, Ken-ichi Aihara, Sumiko Yoshida, Mizuho Kinouchi, Takeshi Kondo, 倉橋 清衛, 安藝 菜奈子, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto :
膵臓の鉄過剰沈着とインスリン分泌不全を呈した無セルロプラスミン血症合併糖尿病の1例,
第86回日本内分泌学会学術総会, Apr. 2013.
134.Ken-ichi Aihara, Sumiko Yoshida, 上元 良子, 石川 カズ江, Masashi Akaike and Toshio Matsumoto :
重症下肢虚血壊死に対するピタバスタチンの組織保護効果に関する検討,
第86回日本内分泌学会学術総会, Apr. 2013.
135.Ryota Amachi, Keiichiro Watanabe, Shiroh Fujii, T Harada, H Miki, S Nakamura, A Oda, Masahiro Hiasa, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
An acdic milieu suppresses histone acetylation in myeloma cells to down-regulate the TRAIL receptor DR4 expression,
14th International Myeloma Workshop, Apr. 2013.
136.Keiichiro Watanabe, Masahiro Abe, Ryota Amachi, Masahiro Hiasa, T Harada, Shiroh Fujii, S Nakamura, H Miki, K Kagawa, I Endo, Eiji Tanaka and Toshio Matsumoto :
Induction of bone formation in myeloma osteolytic lesions by cathepsin K inhibition,
14th International Myeloma Workshop, Apr. 2013.
137.曽我部 公子, Takeshi Kondo, Akio Kuroda, Sumiko Yoshida, Nanako Kataoka, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
術前後で持続血糖測定(CGM)を比較しえた褐色細胞腫の一例,
第22回臨床内分泌代謝Update, Jan. 2013.
138.牟田口 惇, Takeshi Kondo, Itsuro Endo, Sumiko Yoshida, Nanako Kataoka, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
尿細管性アシドーシスの診断にアミノレバンが有用であった一例,
第22回臨床内分泌代謝Update, Jan. 2013.
139.幸田 舞子, Takeshi Kondo, Itsuro Endo, Sumiko Yoshida, Nanako Kataoka, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
悪性症候群様の症状から診断されたACTH分泌低下症の一例,
第22回臨床内分泌代謝Update, Jan. 2013.
140.Itsuro Endo, Toshio Matsumoto and 福本 誠二 :
FGF23関連低リン血症性疾患の全国疫学調査(最終報告),
厚生労働科学研究費補助金 難治疾患克服研究事業 ホルモン受容機構異常に関する調査研究, Jan. 2013.
141.Kiyoe Kurahashi, 森 智子, Hiroshi Inoue, Atsushi Ogura, 津川 和江, Masato Miyake, Hiroshi Inoue, Toshio Matsumoto and Seiichi Oyadomari :
飽和脂肪酸による膵β細胞のインスリン分泌低下には小胞体膜流動性の変化による小胞体ストレスが関与し,PERK経路の活性化により改善される,
第85回日本生化学会大会, Dec. 2012.
142.Hirokazu Miki, Shingen Nakamura, 竹内 恭子, 原田 武志, 岩佐 昌美, Shiroh Fujii, Kumiko Kagawa, Masahiro Abe and Toshio Matsumoto :
赤芽球癆を合併した多中心性Castleman病の1例,
日本内科学会第107回四国地方会, Dec. 2012.
143.松崎 苑美, Ken-ichi Aihara, Sumiko Yoshida, 倉橋 清衛, Takeshi Kondo, Itsuro Endo, Toshio Matsumoto, Nanako Kataoka, Akio Kuroda and Munehide Matsuhisa :
血栓性微小血管障害症様の病態を示したメタボリックシンドロームの1例,
第107回日本内科学会四国地方会, Dec. 2012.
144.佐埜 弘樹, Ken-ichi Aihara, Sumiko Yoshida, Takeshi Kondo, 倉橋 清衛, Itsuro Endo, Toshio Matsumoto, Akio Kuroda, Munehide Matsuhisa and Nanako Kataoka :
正常MRI所見を示し,ADH放出障害が主因と考えられた中枢性尿崩症の1例,
日本内科学会第107回四国地方会, Dec. 2012.
145.Akio Kuroda, 新居 沙央里, Sumiko Yoshida, 近藤 絵里, Itsuro Endo, Ken-ichi Aihara, 松本 友里, Nanako Kataoka, Toshio Matsumoto and Munehide Matsuhisa :
新たなインスリンポンプParadigm722によってカーボカウントのみで血糖管理が可能となった1症例,
第12回日本先進糖尿病治療学会研究会, Dec. 2012.
146.Akio Kuroda, 高原 充佳, 安田 哲行, 松岡 孝昭, Takeshi Kondo, Itsuro Endo, Ken-ichi Aihara, Sumiko Yoshida, Toshio Matsumoto, 下村 伊一郎, 金藤 秀明 and Munehide Matsuhisa :
日本人1型糖尿病患者における「500ルールとは?」,
第12回日本先進糖尿病治療研究会, Dec. 2012.
147.Toshio Matsumoto :
新時代の骨粗鬆症治療,
第85回日本内分泌学会学術総会 ランチョンセミナー12, Dec. 2012.
148.Sumiko Yoshida, Takeshi Kondo, 倉橋 清衛, Itsuro Endo, Ken-ichi Aihara, 高島 啓, Koji Yamaguchi and Toshio Matsumoto :
難治性冠攣縮性狭心症を合併した無痛性甲状腺炎の1例,
第55回日本甲状腺学会学術集会, Vol.88, No.2, 516, Nov. 2012.
149.幸田 舞子, Takeshi Kondo, Akio Kuroda, Sumiko Yoshida, 安芸 菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
シタグリプチン投与によりインスリン所要量の減少効果が得られた高齢2型糖尿病の一例,
日本糖尿病学会中国四国地方会第50回総会, Nov. 2012.
150.Takeshi Kondo, Akio Kuroda, 曽我部 公子, Sumiko Yoshida, 安芸 菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
術前後で持続血糖測定(CGM)を比較しえたアドレナリン優位褐色細胞腫の一例,
日本糖尿病学会中国四国地方会第50回総会, Nov. 2012.
151.Takeshi Kondo, Akio Kuroda, 曽我部 公子, Sumiko Yoshida, 安芸 菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
アドレナリン優位の褐色細胞腫の術前後で持続血糖測定(CGM)により血糖変動を比較した一例,
日本糖尿病学会中国四国地方会第50回総会, Nov. 2012.
152.伊澤 真弓, Akio Kuroda, 上野 裕子, 鶴尾 美穂, Sumiko Yoshida, Takeshi Kondo, Tomoyuki Yuasa, Munehide Matsuhisa, Toshio Matsumoto and 寺澤 敏秀 :
インスリン注入器に関する患者の意識調査,
日本糖尿病学会中国四国地方会第50回総会, Nov. 2012.
153.幸田 舞子, Takeshi Kondo, Akio Kuroda, Sumiko Yoshida, Nanako Kataoka, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
シタグリプチン投与によりインスリン所要量の減少効果が得られた高齢2型糖尿病の一例,
日本糖尿病学会中国四国地方会第50回総会, Nov. 2012.
154.岩佐 昌美, Akio Kuroda, Sumiko Yoshida, Takeshi Kondo, Nanako Kataoka, Itsuro Endo, Ken-ichi Aihara, 福島 泰江, Munehide Matsuhisa and Toshio Matsumoto :
血糖管理基準を満たすために分割食を必要としなかった2型糖尿病合併妊娠の1例,
日本糖尿病学会中国四国地方会第50回総会, Nov. 2012.
155.奥村 滋子, Akio Kuroda, 片田 英子, 鶴尾 美穂, Sumiko Yoshida, Takeshi Kondo, Tomoyuki Yuasa, 松本 直也, 笠松 哲司, Munehide Matsuhisa, Toshio Matsumoto and 寺澤 敏秀 :
運転中の低血糖についての意識調査,
日本糖尿病学会中国四国地方会第50回総会, Nov. 2012.
156.小田 直輝, 悦子 李, 松本 真弓, 高松 典道, Hirokazu Miki and Toshio Matsumoto :
輸血後7日目にIgG抗E抗体を酵素法にて強く検出した一症例,
第45回中四国支部医学検査学会, Nov. 2012.
157.Itsuro Endo, 大薗 卓也, 斉藤 光恵, Toshio Matsumoto and Masahiro Abe :
骨転移に対するdenosumab 120mg皮下注後の重症低Ca血症発現の実態,
癌と骨代謝研究会, Nov. 2012.
158.Shiroh Fujii, Masahiro Abe, Ryota Amachi, Keiichiro Watanabe, Masahiro Hiasa, 竹内 恭子, 岩佐 昌美, 原田 武志, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa and Toshio Matsumoto :
Pim inhibition preferentially induces anti-myeloma activity in an acidic milien,
第74回日本血液学会学術集会, Oct. 2012.
159.Masahiro Hiasa, Masahiro Abe, Kumiko Kagawa, Hirokazu Miki, Shingen Nakamura, Harada Takeshi, Fujii Shirou, Keiichiro Watanabe, Ryota Amachi, Kenzo Asaoka and Toshio Matsumoto :
Pim-2 acts as a common downstream mediator to suppress bone formation in myeloma.,
第74回に本血液学会, Oct. 2012.
160.Ryota Amachi, Masahiro Abe, Keiichiro Watanabe, Masahiro Hiasa, Eiji Tanaka and Toshio Matsumoto :
An acidic milieu suppresses DR4 editing and induces p22 c-FLIP to cause myeloma resistance to TRAIL,
第74回日本血液学会学術集会, Oct. 2012.
161.Toshio Matsumoto :
骨粗鬆症治療の進歩,
第26回日本臨床内科医学会教育講演, Oct. 2012.
162.Toshio Matsumoto :
骨粗鬆症治療の進歩と高齢者の骨折予防,
平成24年度日本内科学会生涯教育講演会, Sep. 2012.
163.Toshio Matsumoto :
宇宙飛行に伴う骨量減少とその防止対策,
市民公開講演会「震災後の我が国における宇宙開発のあり方」, Sep. 2012.
164.悦子 李, 瀧本 朋美, 松本 真弓, Kazuhisa Maeda, Shuji Ozaki, Hirokazu Miki and Toshio Matsumoto :
血液型検査から無症候性の低ガンマグロブリン血症が判明し,周産期の感染予防に貢献し得た一例,
第57回日本輸血・細胞治療学会中国四国地方会, Sep. 2012.
165.Ken-ichi Aihara, Sumiko Yoshida, 近藤 絵里, Takeshi Kondo, 倉橋 清衛, Itsuro Endo and Toshio Matsumoto :
高尿酸血症は頸動脈プラークおよび血管抵抗を亢進させる,
第35回日本高血圧学会総会, 423, Sep. 2012.
166.白河 綾, Ken-ichi Aihara, Sumiko Yoshida, 倉橋 清衛, Takeshi Kondo, Itsuro Endo, 安藝 菜奈子, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto :
副腎不全症状を呈し,診断に苦慮した両側副腎B細胞リンパ腫の1例,
第12回日本内分泌学会四国支部学術集会, Sep. 2012.
167.原田 武志, Shuji Ozaki, 岩佐 昌美, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, 柴田 泰伸, 重清 俊雄, 岡田 直人, 長尾 多美子, 鈴木 麗子, Shoji Sakiyama, Masahiro Abe and Toshio Matsumoto :
徳島県のエイズ拠点病院におけるHIV感染症及び後天性免疫不全症候群の現状,
第245回徳島県医学会学術総会, Jul. 2012.
168.Toshio Matsumoto :
RANKLシグナルと癌の骨病変,
第30回日本骨代謝学会学術集会ランチョンセミナー9, Jul. 2012.
169.Keiichiro Watanabe, Masahiro Abe, Ryota Amachi, Masahiro Hiasa, Shingen Nakamura, 遠藤 逸郎, 森 裕史, Eiji Tanaka and Toshio Matsumoto :
カテプシンK 阻害剤KK1-300-01 は骨髄腫骨病変部の骨破壊を抑制し骨形成を惹起する,
第30回日本骨代謝学会学術大会, 217, Jul. 2012.
170.Toshio Matsumoto :
骨代謝治療薬としての新規活性型ビタミンD製剤の位置づけ,
第30回日本骨代謝学会集会シンポジウム4, Jul. 2012.
171.Toshio Matsumoto :
宇宙飛行に伴う骨量減少とその防止対策,
第30回日本骨代謝学会学術集会JAXA共催シンポジウム, Jul. 2012.
172.Toshio Matsumoto :
骨代謝治療薬としての新規活性型ビタミンD製剤の位置づけ,
第30回日本骨代謝学会集会シンポジウム4, Jul. 2012.
173.Ken-ichi Aihara, Sumiko Yoshida and Toshio Matsumoto :
シンポジウム11 心・血管病の性差:血管形態と機能解析からみた頸動脈硬化の性差と副腎アンドロゲンDHEASの抗動脈硬化作用,
第44回日本動脈硬化学会・学術総会/ヒルトン福岡シーホーク, Jul. 2012.
174.Ken-ichi Aihara, Sumiko Yoshida and Toshio Matsumoto :
血管形態と機能解析からみた 頸動脈硬化の性差と副腎アンドロゲンDHEASの抗動脈硬化作用,
第44回日本動脈硬化学会総会・学術集会: シンポジウム11 心・血管病の性差, Jul. 2012.
175.Masahiro Hiasa, Masahiro Abe, Rieko Arakaki, Akiko Yamada, Kenzo Asaoka, Toshio Matsumoto, Yoshio Hayashi and Naozumi Ishimaru :
RelB antagonizes the classical NF-κB pathway and its suppression of osteoblastogenesis,
第30回日本骨代謝学会, Jul. 2012.
176.Sumiko Yoshida, Ken-ichi Aihara, Mizuho Kinouchi, 近藤 絵里, Itsuro Endo and Toshio Matsumoto :
Diabetes abolishes protective effect of HDL-cholesterol against endothelial dysfunction.,
第44回日本動脈硬化学会総会・学術集会, Jul. 2012.
177.Toshio Matsumoto :
ビスホスホネート治療の新たな展開,
第30回骨代謝学会学術集会ランチョンセミナー, Jul. 2012.
178.Takeshi Kondo, 尾松 卓, 董 冰子, 大西 幸代, 相澤 慎一, Itsuro Endo and Toshio Matsumoto :
インターロイキン(IL)-11は力学的負荷による骨形成促進に必要である,
第30回日本骨代謝学会学術総会, Jul. 2012.
179.尾松 卓, Takeshi Kondo, 董 冰子, 大西 幸代, Itsuro Endo and Toshio Matsumoto :
PKCδは骨再構築系の制御に重要である,
第30回日本骨代謝学会学術総会, Jul. 2012.
180.Ryota Amachi, Masahiro Abe, Keiichiro Watanabe, Shingen Nakamura, Masahiro Hiasa, Eiji Tanaka and Toshio Matsumoto :
酸性環境は骨髄腫細胞にDR4 の発現抑制とcFLIP の活性化を惹起しTRAIL に対する抵抗性を獲得させる,
第30回日本骨代謝学会学術集会, 259, Jul. 2012.
181.Itsuro Endo, Sumiko Yoshida, 倉橋 清衛, Mizuho Kinouchi, Nanako Kataoka, Takeshi Kondo, 近藤 絵里, Ken-ichi Aihara, Toshio Matsumoto, Akio Kuroda and Munehide Matsuhisa :
Werner症候群に伴う糖尿病の治療経過,
第106回 日本内科学会四国地方会, Jun. 2012.
182.Ken-ichi Aihara, Sumiko Yoshida, 倉橋 清衛, Takeshi Kondo, 近藤 絵里, Nanako Kataoka, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto :
インクレチン関連薬を用いた周術期血糖管理の有用性,
第106回 日本内科学会四国地方会, Jun. 2012.
183.大黒 由加里, Shingen Nakamura, 岩佐 昌美, 原田 武志, Shiroh Fujii, Kumiko Kagawa, Masahiro Abe, Toshio Matsumoto and Hirokazu Miki :
腰痛と副腎不全症状で発症した両側副腎原発DLBCLの1例,
日本内科学会第106回四国地方会, Jun. 2012.
184.李 悦子, 瀧本 朋美, 松本 真弓, 石井 博之, 福森 泰雄, Shuji Ozaki, 竹内 恭子 and Toshio Matsumoto :
亜型遺伝子AelおよびAx03を同時に保有していた非常にまれな亜型症例,
第60回日本輸血・細胞治療学会総会, May 2012.
185.Michihiro Nakamura, Koichiro Hayashi, Aziz Awaad, Hirokazu Miki, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto and Kazunori Ishimura :
有機シリカ粒子技術を用いた近赤外蛍光ナノプローブの作製とユニバーサル蛍光イメージング,
第7回日本分子イメージング学会学術集会, May 2012.
186.Toshio Matsumoto :
骨粗鬆症の進歩,
中外骨粗鬆症セミナー, May 2012.
187.鶴尾 美穂, 寺澤 敏秀, 木戸 里佳, Sumiko Yoshida, Tomoyuki Yuasa, Takeshi Kondo, 笠松 哲司, 近藤 絵里, Mizuho Kinouchi, Akio Kuroda, Munehide Matsuhisa, Toshio Matsumoto and Masashi Akaike :
粥状動脈硬化病変を呈した高Lp(a)血症合併糖尿病の姉妹例,
第55回 日本糖尿病学会年次学術集会, May 2012.
188.上野 裕子, 堀筋 富士子, 森岡 隆子, 鶴尾 美穂, Tomoyuki Yuasa, 木戸 里佳, Sumiko Yoshida, Mizuho Kinouchi, Takeshi Kondo, 近藤 絵里, 笠松 哲司, Akio Kuroda, Munehide Matsuhisa, Toshio Matsumoto and 寺澤 敏秀 :
サイトローテーションシート(SLS)を使用したインスリン自己注射の指導,
第55回 日本糖尿病学会年次学術集会, May 2012.
189.秋田 賢子, 鶴尾 美穂, 木戸 里佳, Sumiko Yoshida, 近藤 絵里, Mizuho Kinouchi, Takeshi Kondo, 笠松 哲司, Tomoyuki Yuasa, Akio Kuroda, Munehide Matsuhisa, Toshio Matsumoto and 寺澤 敏秀 :
カーボカウントを導入した高齢1型糖尿病の3例,
第55回 日本糖尿病学会年次学術集会, May 2012.
190.倉橋 清衛, Taiji Ito, Akitoshi Nomura, 宮本 千伸, 津川 和江, 森 智 子, Miho Oyadomari, Toshio Matsumoto and Seiichi Oyadomari :
膵β細胞におけるグルコース応答性インスリン分泌低下に小胞体膜の流動性変化と小胞体ストレスが応答が影響する,
第55回日本糖尿病学会学術集会, May 2012.
191.Sumiko Yoshida, Ken-ichi Aihara, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
エイコサペントエン酸は酸化ストレス抑制を介して心臓リモデリングを抑制する,
日本高血圧学会 第1回臨床高血圧フォーラム, May 2012.
192.Ken-ichi Aihara, Sumiko Yoshida, Masashi Akaike and Toshio Matsumoto :
血管内皮機能制御における血圧関連指標の意義,
日本高血圧学会 第1回臨床高血圧フォーラム, May 2012.
193.Jun Huang, Shinji Abe, Yuki Morita, Shuji Ozaki, Masatoshi Kishuku, Kazuo Minakuchi, Masaki Hanibuchi, Toshio Matsumoto, Saburo Sone and Yasuhiko Nishioka :
Antibody-dependent cellular cytotoxicity against mesothelioma cells mediated by anti-HM 1.24 antibodies,
第52回日本呼吸器学会学術講演会, Apr. 2012.
194.大黒 由加里, Ken-ichi Aihara, Sumiko Yoshida, 近藤 絵里, Takeshi Kondo, 倉橋 清衛, Mizuho Kinouchi, Itsuro Endo, Nanako Kataoka, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto :
摂食障害による著明な低K血症を呈した視床下部性ACTH分泌低下症の1例,
第85回 日本内分泌学会学術総会, Apr. 2012.
195.Takeshi Kondo, 尾松 卓, 董 冰子, 大西 幸代, 相澤 慎一, Itsuro Endo and Toshio Matsumoto :
インターロイキン(IL)-11は力学的負荷およびPTHによる骨量増加に必要である,
第85回 日本内分泌学会学術総会, Apr. 2012.
196.Toshio Matsumoto :
骨粗鬆症診断の進歩と今後の展望,
第85回日本内分泌学会学術総会, Apr. 2012.
197.Sumiko Yoshida, Ken-ichi Aihara, 近藤 絵里, 倉橋 清衛, Takeshi Kondo, Mizuho Kinouchi, Itsuro Endo, Toshio Matsumoto, Nanako Kataoka, Akio Kuroda and Munehide Matsuhisa :
糖尿病はHDLコレステロールによる血管内皮機改善効果を減弱させる,
第85回 日本内分泌学会学術総会, Apr. 2012.
198.Ken-ichi Aihara, Sumiko Yoshida, 近藤 絵里, Takeshi Kondo, 倉橋 清衛, Mizuho Kinouchi, Itsuro Endo, Nanako Kataoka, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto :
ヘパリンコファクターⅡは耐糖能制御因子である,
第85回 日本内分泌学会学術総会, Apr. 2012.
199.Sumiko Yoshida, Yuichi Fujinaka, Ken-ichi Aihara, 鈴木 麗子, Mizuho Kinouchi, 近藤 絵里, 安藝 菜奈子, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto :
当院検診受診者における耐糖能異常の特徴,
第109回日本内科学会総会・講演会, Apr. 2012.
200.Ken-ichi Aihara, Sumiko Yoshida, 近藤 絵里, Takeshi Kondo, 倉橋 清衛, Itsuro Endo and Toshio Matsumoto :
尿酸は形態および機能的頸動脈硬化症進展のリスク因子である,
第109回日本内科学会総会・講演会, Apr. 2012.
201.原田 武志, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, 中野 綾子, Kumiko Kagawa, 竹内 恭子, Masahiro Abe and Toshio Matsumoto :
徳島県における多発性骨髄腫の治療成績の検討,
第109回日本内科学会総会・講演会, Apr. 2012.
202.Toshio Matsumoto :
あなたの骨は,大丈夫?,
第85回日本内分泌学会学術総会 市民公開講座, Apr. 2012.
203.Ken-ichi Aihara, Sumiko Yoshida, 近藤 絵里, Takeshi Kondo, 倉橋 清衛, Itsuro Endo and Toshio Matsumoto :
尿酸は形態および機能的頸動脈硬化症進展のリスク因子である,
第109回日本内科学会総会・講演会, Apr. 2012.
204.原田 武志, Shuji Ozaki, 小田 明日香, 天羽 宏枝, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, 中野 綾子, Kumiko Kagawa, 竹内 恭子, Masahiro Abe, 柴田 泰伸 and Toshio Matsumoto :
Lenalidomide 治療中の多発性骨髄腫患者におけるCRP上昇の検討,
第51回日本血液学会中国四国地方会, Mar. 2012.
205.Kumiko Kagawa, 原田 武志, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, 竹内 恭子, Masahiro Abe and Toshio Matsumoto :
遺伝子組み替えヒトトロンボモジュリン投与中に硬膜下血腫を来した同腫骨髄移植2症例,
第34回日本造血細胞移植学会, Feb. 2012.
206.Kumiko Kagawa, 原田 武志, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, 竹内 恭子, Masahiro Abe and Toshio Matsumoto :
遺伝子組み換えヒトトロンボモジュリン投与中に硬膜下血腫を来した同腫骨髄移植2症例,
第34回日本造血細胞移植学会, Feb. 2012.
207.立花 綾香, 田岡 志保, 荻野 寛隆, 高橋 真美子, Ken-ichi Aihara, Sumiko Yoshida, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa, 福森 智治 and Toshio Matsumoto :
低血圧で推移したvon Hippel-Lindau 病・褐色細胞腫の1手術例,
第21回臨床内分泌代謝Update in Hamamatsu, Jan. 2012.
208.田岡 志保, 立花 綾香, 荻野 寛隆, 高橋 真美子, Ken-ichi Aihara, Sumiko Yoshida, 近藤 絵里, 倉橋 清衛, Itsuro Endo, Toshio Matsumoto, Nanako Kataoka, Akio Kuroda and Munehide Matsuhisa :
周術期血糖管理にリラグルチドが有用であった2型糖尿病患者の2例,
第21回臨床内分泌代謝Update in Hamamatsu, Jan. 2012.
209.Shinsuke Kido, 橋本 由衣, 藤原 真理奈, Itsuro Endo, Hiroko Segawa, Sawako Tatsumi, Toshio Matsumoto and Ken-ichi Miyamoto :
糖尿病に併存する腎障害・骨障害の発症及び進展におけるFGF23の関与,
第15回日本病態栄養学会年次学術集会, Jan. 2012.
210.Itsuro Endo, 福本 誠二 and Toshio Matsumoto :
FGF23関連性低リン血症性疾患の全国疫学調査 最終報告,
厚生労働科学研究費補助金 ホルモン受容機構異常に関する調査研究 平成23年度 研究報告会, Jan. 2012.
211.Masahiro Hiasa, Rieko Arakaki, Akiko Yamada, Ritsuko 徳永 律子 Oura, Masahiro Abe, Toshio Matsumoto, Yoshio Hayashi, Naozumi Ishimaru and Kenzo Asaoka :
A novel role of NF-B relB in bone remodeling.,
第40回日本免疫学会学術集会, Nov. 2011.
212.Akio Kuroda, 新居 沙央理, Sumiko Yoshida, 近藤 絵里, Itsuro Endo, Ken-ichi Aihara, 松本 友里, Nanako Kataoka, Toshio Matsumoto and Munehide Matsuhisa :
新たなインスリンポンプParadigm722によってカーボカウントのみで血糖管理が可能となった1症例,
第11回 日本先進糖尿病治療研究会, Nov. 2011.
213.橋本 由衣, Shinsuke Kido, 藤原 真理奈, 近藤 剛史, Hiroko Segawa, Itsuro Endo, Sawako Tatsumi, Toshio Matsumoto and Ken-ichi Miyamoto :
糖尿病合併症発症におけるFGF23/Klothoの関与,
第44回日本栄養食糧学会中四国支部大会, Nov. 2011.
214.Keiichiro Watanabe, Masahiro Abe, Q Cui, Masahiro Hiasa, M Kawatani, T Harada, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, A Nakano, K Kagawa, K Takeuchi, H Osada, Eiji Tanaka and Toshio Matsumoto :
Targeting an acidic microenvironment by reveromycin A to overcome drug resistance to myeloma cells and ameliorate bone disease.,
第36回日本骨髄腫研究会総会, Nov. 2011.
215.木戸 里佳, 鶴尾 美穂, Akio Kuroda, Sumiko Yoshida, Tomoyuki Yuasa, 瀬尾 浩二, 笠松 哲司, Toshio Matsumoto, Munehide Matsuhisa and 寺沢 敏秀 :
カーボカウント併用CS11療法が有効であった高齢発症1型糖尿病症例,
日本糖尿病学会 中国四国地方会第49回総会, Nov. 2011.
216.新居 沙央里, Akio Kuroda, Sumiko Yoshida, 近藤 絵里, Itsuro Endo, Ken-ichi Aihara, 松本 友里, Nanako Kataoka, Munehide Matsuhisa and Toshio Matsumoto :
新たなインスリンポンプParadigm722によりカーボカウントのみで血糖管理が可能となった1例,
日本糖尿病学会 中国四国地方会第49回総会, Nov. 2011.
217.堀筋 富士子, 森岡 隆子, 片田 英子, 鶴尾 美穂, 木戸 里佳, Tomoyuki Yuasa, Akio Kuroda, Munehide Matsuhisa, Toshio Matsumoto and 寺沢 敏秀 :
サイトローテーションシート(SLS)を使用したインスリン自己注射の指導,
日本糖尿病学会 中国四国地方会第49回総会, Nov. 2011.
218.秋田 賢子, 木戸 里佳, 鶴尾 美穂, Sumiko Yoshida, Mizuho Kinouchi, Tomoyuki Yuasa, Akio Kuroda, Munehide Matsuhisa, Toshio Matsumoto and 寺沢 敏秀 :
カーボカウントを導入した高齢1型糖尿病の3例,
日本糖尿病学会 中国四国地方会第49回総会, Nov. 2011.
219.Mizuho Kinouchi, Ken-ichi Aihara, Yuichi Fujinaka, 鈴木 麗子, Sumiko Yoshida, 近藤 絵里, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto :
内臓脂肪肥満とアルブミン尿の連関に関する検討,
日本糖尿病学会 中国四国地方会第49回総会, Nov. 2011.
220.鶴尾 美穂, 寺沢 敏秀, 木戸 里佳, Tomoyuki Yuasa, Sumiko Yoshida, 笠松 哲司, Akio Kuroda, Munehide Matsuhisa, Toshio Matsumoto and Masashi Akaike :
粥状動脈硬化病変を呈した糖尿病合併高Lp(a)血症の姉妹例,
日本糖尿病学会 中国四国地方会第49回総会, Nov. 2011.
221.鈴木 麗子, 大和 光, 菊恵 木田, Ken-ichi Aihara, Itsuro Endo, Nanako Kataoka, 近藤 絵里, Toshio Matsumoto, Akio Kuroda and Munehide Matsuhisa :
フットケア外来におけるインスリン皮下硬結の実態調査,
日本糖尿病学会 中国四国地方会第49回総会, Nov. 2011.
222.田岡 志保, Ken-ichi Aihara, Sumiko Yoshida, 近藤 絵里, Itsuro Endo and Toshio Matsumoto :
心血管リスク因子を有する成人の血管内皮機能制御因子に関する臨床的検討,
第34回日本高血圧学会総会, Oct. 2011.
223.Ken-ichi Aihara, Sumiko Yoshida and Toshio Matsumoto :
頸動脈エコー法による心血管リスク評価のための血管形態と機能解析,
第34回日本高血圧学会総会, Oct. 2011.
224.Ken-ichi Aihara, Sumiko Yoshida and Toshio Matsumoto :
Evaluation for cardiovascular risk by multi-method carotid artery ultrasound examinations,
第34回日本高血圧学会総会パネルディスカッション: 非侵襲的血管指標の有用性と課題, Oct. 2011.
225.Sumiko Yoshida, Ken-ichi Aihara, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
エイコサペントエン酸の酸化ストレス抑制を介したアンジオテンシンII刺激による心血管リモデリング抑制効果の検討,
第34回 日本高血圧学会総会, Oct. 2011.
226.Masahiro Hiasa, Masahiro Abe, 中野 綾子, Kyoko Takeuchi, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Eiji Tanaka, Kenzo Asaoka, Ken-ichiro Yata and Toshio Matsumoto :
Pimキナーゼ阻害による腫瘍進展と骨破壊の抑制,
第73回日本血液学会, Oct. 2011.
227.Yuichi Fujinaka, Mizuho Kinouchi, Chisato Kosugi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Hisaaki Taniguchi and Toshio Matsumoto :
Wntシグナル抑制因子sFRP4の肥満・糖代謝との関連性についての検討,
第32回日本肥満学会, Sep. 2011.
228.Ken-ichi Aihara, Yuichi Fujinaka, 鈴木 麗子, Mizuho Kinouchi, Sumiko Yoshida, 近藤 絵里, Nanako Kataoka, 倉橋 清衛, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto :
慢性腎臓病と内臓脂肪蓄積病態の連関,
第32回日本肥満学会, Sep. 2011.
229.Sumiko Yoshida, Yuichi Fujinaka, Ken-ichi Aihara, 鈴木 麗子, Mizuho Kinouchi, 近藤 絵里, Nanako Kataoka, 倉橋 清衛, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto :
メタボリックシンドローム検診受診者における耐糖能異常の検討,
第32回日本肥満学会, Sep. 2011.
230.Sumiko Yoshida, Ken-ichi Aihara, Yasumasa Ikeda and Toshio Matsumoto :
心血管臓器におけるアンドロゲン作用の意義,
第11回日本内分泌学会四国支部学術集会 高知, Sep. 2011.
231.Ken-ichi Aihara, Sumiko Yoshida, 近藤 絵里, 倉橋 清衛, Takeshi Kondo, Mizuho Kinouchi, Itsuro Endo, Toshio Matsumoto, Nanako Kataoka, Akio Kuroda and Munehide Matsuhisa :
慢性腎臓病におけるエイコサペンタエン酸の意義に関する臨床的検討,
第11回日本内分泌学会四国支部学術集会, Sep. 2011.
232.Masahiro Hiasa, A Nakano, Keiichiro Watanabe, C Qu, T Harada, S Fujii, H Miki, S Nakamura, K Kagawa, K Takeuchi, Eiji Tanaka, Kenzo Asaoka, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition,
Bone Biology Forum, 19-21st Aug, 2011, Shizuoka., Aug. 2011.
233.Ken-ichi Aihara, Sumiko Yoshida, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, 久岡 白陽花, 平田 陽一郎, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Eicosapentaenoic acid-to-arachidonic acid ratio is inversely associated with albuminuria in individuals with cardiovascular risk factors,
第75回日本循環器学会総会・学術集会 パシフィコ横浜, Aug. 2011.
234.Sumiko Yoshida, Ken-ichi Aihara, Takayuki Ise, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Eicosapentaenoic acid protects against angiotensin II-induced cardiovascular remodeling via attenuation of oxidative stress.,
第75回 日本循環器学会総会・学術集会 パシフィコ横浜, Aug. 2011.
235.山田 諭, Kojiro Nagai, 上田 恵理子, Taichi Murakami, Motokazu Matsuura, Seiji Kishi, Hideharu Abe, Toshio Doi, 遠藤 逸郎 and Toshio Matsumoto :
活性型ビタミンD3外用剤による高カルシウム血症由来の腎機能障害の一例,
日本腎臓学会雑誌, Vol.53, No.6, 815, Aug. 2011.
236.Masashi Akaike, Koichiro Tsuchiya, Yoshiki Kashiwada, Yoshihisa Takaishi, Toshiaki Tamaki, Takashi Iwase, Masataka Sata, Ken-ichi Aihara, Sumiko Yoshida, Toshio Matsumoto, 佐藤 千穂, 西条 伴香 and Hiroaki Yanagawa :
生活習慣病関連リスクファクターに及ぼすスダチ果皮加工品の効果 ∼探索的臨床試験による検討∼,
第243回徳島医学会学術集会 公開シンポジウム, Jul. 2011.
237.Masashi Akaike, Koichiro Tsuchiya, Yoshiki Kashiwada, Yoshihisa Takaishi, Toshiaki Tamaki, Takashi Iwase, Masataka Sata, Ken-ichi Aihara, 吉田 守実子, Toshio Matsumoto, 佐藤 千穂, 西条 伴香 and Hiroaki Yanagawa :
生活習慣病関連リスクファクターに及ぼすスダチ果皮加工品の効果-探索的臨床試験による検討-,
第243回 徳島医学会学術集会, Jul. 2011.
238.Itsuro Endo, 福本 誠二 and Toshio Matsumoto :
FGF23-relared hypophosphtemic disease in Japan,
第29回日本骨代謝学会学術集会, Jul. 2011.
239.Masahiro Hiasa, Masahiro Abe, 中野 綾子, Keiichiro Watanabe, Shingen Nakamura, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Pimキナーゼの阻害は骨芽細胞分化を促進し,骨髄腫骨病変の形成と腫瘍進展を抑制する,
第29回日本骨代謝学会学術大会, 178, Jul. 2011.
240.Keiichiro Watanabe, Masahiro Abe, 川谷 誠, Masahiro Hiasa, Shingen Nakamura, Eiji Tanaka, 長田 裕之 and Toshio Matsumoto :
リベロマイシンAによる酸性環境がもたらす骨髄腫薬剤耐性の克服と骨病変形成の抑制,
第29回日本骨代謝学会学術大会, 208, Jul. 2011.
241.Seiichi Oyadomari, Kiyoe Kurahashi, Taiji Ito, 森 智子, 村橋 玲那, Miho Oyadomari and Toshio Matsumoto :
小胞体ストレス応答による小胞体膜恒常性の破綻は膵β細胞の脂肪毒性の原因となる,
第54回日本糖尿病学会学術総会, May 2011.
242.木戸 里佳, Mizuho Kinouchi, Sumiko Yoshida, Tomoyuki Yuasa, 瀬尾 浩二, 笠松 哲司, Toshio Matsumoto, Munehide Matsuhisa, 鶴尾 美穂 and 寺沢 敏秀 :
カーボカウント併用CSⅡ療法が用効であった高齢発症1型糖尿病の2症例,
第54回日本糖尿病学会年次学術集会, May 2011.
243.森岡 隆子, 上野 裕子, 堀筋 富士子, 澤井 敏子, 藤島 周子, 奥村 滋子, 伊澤 真弓, 片田 英子, 秋田 賢子, 木戸 里佳, Sumiko Yoshida, Mizuho Kinouchi, 笠松 哲司, Tomoyuki Yuasa, 鶴尾 美穂, 寺沢 敏秀, Munehide Matsuhisa and Toshio Matsumoto :
インスリン治療を行っている高齢糖尿病患者の療養指導について,
第54回日本糖尿病学会年次学術集会, May 2011.
244.高島 啓, Koji Yamaguchi, 坂東 左知子, 林 修司, 久岡 白陽花, 冨田 紀子, 竹内 秀和, Toshiyuki Niki, Kenya Kusunose, Yoshio Taketani, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Sumiko Yoshida, Toshio Matsumoto and Masataka Sata :
甲状腺機能亢進症と腰痛が発症の誘因と考えられた難治性冠攣縮性狭心症の1例,
第98回 日本循環器学会 中国・四国合同地方会, May 2011.
245.Sumiko Yoshida, 大政 暁, Ken-ichi Aihara, 倉橋 清衛, Takeshi Kondo, Nanako Kataoka, Itsuro Endo, Yuichi Fujinaka, Munehide Matsuhisa and Toshio Matsumoto :
強化インスリン療法からGLP-1アナログ製剤少量投与に変更し,良好な血糖コントロールが得られた1例,
第104回日本内科学会四国地方会, May 2011.
246.津川 愛, Ken-ichi Aihara, Sumiko Yoshida, Itsuro Endo, Yuichi Fujinaka, Munehide Matsuhisa and Toshio Matsumoto :
DPP-4阻害薬シタグリプチンの臨床効果の特徴に関する検討,
第84回日本内分泌学会学術総会, Apr. 2011.
247.原 知也, Ken-ichi Aihara, Sumiko Yoshida, 倉橋 清衛, Takeshi Kondo, Mizuho Kinouchi, Nanako Kataoka, Itsuro Endo, Yuichi Fujinaka and Toshio Matsumoto :
血清エイコサペンタエン酸/アラキドン酸比は心血管リスクを有する高齢者のCKDリスクマーカーである,
第84回日本内分泌学会学術総会, Apr. 2011.
248.Ken-ichi Aihara, Sumiko Yoshida, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
フェノフィブラートはアンジオテンシンⅡ負荷による高血圧と心筋リモデリングを抑制する,
第84回 日本内分泌学会学術総会, Apr. 2011.
249.Yuichi Fujinaka, 倉橋 清衛, Mizuho Kinouchi, Sumiko Yoshida, Nanako Kataoka, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
トリロスタン投与により内分泌学的な寛解状態が得られた異所性ACTH症候群一例,
第84回日本内分泌学会学術総会, Apr. 2011.
250.Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, 佐藤 隆史, Masashi Akaike, Toshiaki Tamaki, 加藤 茂明 and Toshio Matsumoto :
心血管リモデリングにおける男性ホルモンの作用,
第84回日本内分泌学会学術集会 シンポジウム「心血管病を内分泌・代謝面から考察する」, Apr. 2011.
251.Itsuro Endo, Seiji Fukumoto and Toshio Matsumoto :
FGF23関連低リン血症性疾患に対する全国疫学調査,
第84回日本内分泌学会学術総会, Apr. 2011.
252.安積 麻衣, Ken-ichi Aihara, Sumiko Yoshida, 倉橋 清衛, Mizuho Kinouchi, Nanako Kataoka, Itsuro Endo and Toshio Matsumoto :
2型糖尿病患者に対する強化インスリン療法は左室リモデリングを改善する,
第84回日本内分泌学会学術総会, Apr. 2011.
253.Itsuro Endo, 福本 誠二 and Toshio Matsumoto :
FGF23関連低リン血症性疾患に関する全国疫学調査,
第84回日本内分泌学会学術総会, Apr. 2011.
254.Masashi Akaike, Ken-ichi Aihara, Yasumasa Ikeda, Shusuke Yagi, 石川 カズ江, Sumiko Yoshida, Yuka Ueda, Takashi Iwase, Masataka Sata and Toshio Matsumoto :
グルココルチコイド誘発性血管内皮細胞障害に対するアルドステロン受容体拮抗薬の効果,
第84回 日本内分泌学会学術総会, Apr. 2011.
255.Sumiko Yoshida, Ken-ichi Aihara, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
エイコサペントエン酸は酸化ストレス抑制を介してアンジオテンシンⅡ刺激による心血管リモデリングを抑制する,
第84回 日本内分泌学会学術総会, Apr. 2011.
256.Sumiko Yoshida, Ken-ichi Aihara, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
虚血ストレスによる骨格筋アポトーシスおよび血管新生におけるアンドロゲン受容体の意義,
第84回 日本内分泌学会学術総会, Apr. 2011.
257.Hirotsugu Kurobe, Ken-ichi Aihara, 平田 陽一郎, 西矢 昌子, 中山 泰介, Tatsuo Motoki, Mikio Sugano, Tamotsu Kanbara, Takashi Kitaichi, Masashi Akaike, Masataka Sata, Tetsuya Kitagawa and Toshio Matsumoto :
エゼチミブ投与による脂質代謝および血管機能改善効果の検討,
第84回 日本内分泌学会学術総会, Apr. 2011.
258.Yasumasa Ikeda, Ken-ichi Aihara, Masashi Akaike, Sumiko Yoshida, Takashi Iwase, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Masataka Sata, Toshio Matsumoto and Toshiaki Tamaki :
Heparin cofactor II enhances vascular endothelial cells function and angiogenesis,
第75回日本循環器学会総会・学術集会, Mar. 2011.
259.近藤 剛史, Itsuro Endo, Ken-ichi Aihara, Yuichi Fujinaka and Toshio Matsumoto :
hCG,FSH製剤の併用によりパートナーの妊娠が確認された低ゴナドトロピン性男性性腺機能低下症の一例,
第20回臨床内分泌Update, Jan. 2011.
260.門田 宗之, Yuichi Fujinaka, 廣野 友理, 倉橋 清衛, Mizuho Kinouchi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto :
低ナトリウム血症で発症したトルコ鞍部腫瘍の一例,
第20回臨床内分泌代謝Update, Jan. 2011.
261.坂田 雅映, Shinsuke Kido, 橋本 由衣, Sawako Tatsumi, Hiroko Segawa, Toshio Matsumoto and Ken-ichi Miyamoto :
FGF23/Klothoを介した新たな腎尿細管リン・カルシウム代謝調節機構の解明,
第14回日本病態栄養学会年次学術集会, Jan. 2011.
262.Keiichiro Watanabe, Masahiro Abe, Cui Qu, Kawatani Makoto, Masahiro Hiasa, Nakano Ayako, Jinno Tadashi, Harada Takeshi, Shiroh Fujii, Shingen Nakamura, Miki Hirokazu, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, Osada Hiroyuki and Toshio Matsumoto :
Reveromycin A prevents bone destruction and suppresses tumor growth in myeloma,
第72回日本血液学会, Dec. 2010.
263.Kiyoe Kurahashi, Taiji Ito, 森 智子, 村橋 玲那, Miho Oyadomari, Toshio Matsumoto and Seiichi Oyadomari :
小胞体ストレス応答を介した膵β細胞における脂肪毒性メカニズムの解析,
第22回 分子糖尿病学シンポジウム, Dec. 2010.
264.Sumiko Yoshida, Ken-ichi Aihara, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
アンドロゲン受容体は虚血後骨格筋細胞のアポトーシスと血管新生を制御する,
第18回日本血管生物医学会学術集会, Dec. 2010.
265.安積 麻衣, Ken-ichi Aihara, Sumiko Yoshida, Toshio Matsumoto and Itsuro Endo :
糖尿病患者の心筋リモデリングおよび左室機能におけつ強化インスリン療法の効果,
第12回徳島臨床脈管研究会, Nov. 2010.
266.近藤 剛史, Itsuro Endo, Yuichi Fujinaka, Toshio Matsumoto and Ken-ichi Aihara :
hCG, FSH製剤の併用によりパートナーの妊娠が確認された低ゴナドトロピン性男性性腺機能低下症の一例,
第16回徳島内分泌研究会, Nov. 2010.
267.Itsuro Endo, Ken-ichi Aihara, Yuichi Fujinaka and Toshio Matsumoto :
hCG, FSH製剤の併用によりパートナーの妊娠が確認された低ゴナドトロピン性男性性腺機能低下症の一例,
第103回日本内科学会四国地方会, Nov. 2010.
268.木戸 里佳, Shinsuke Kido, Itsuro Endo and Toshio Matsumoto :
メカニカルストレスによる骨代謝制御,
第25回日本整形外科学会基礎学術集会, Oct. 2010.
269.Hirotsugu Kurobe, Ken-ichi Aihara, 西矢 昌子, 佐藤 光代, 西尾 進, 中山 泰介, Tatsuo Motoki, Mikio Sugano, Tamotsu Kanbara, Takashi Kitaichi, Toshio Matsumoto and Tetsuya Kitagawa :
エゼチミブ投与による脂質代謝および血管機能改善効果の検討,
第51回日本脈管学会総会, Vol.50, No.Suppl., S153, Oct. 2010.
270.Masashi Akaike, Shusuke Yagi, Ken-ichi Aihara, 石川 カズ江, Yasumasa Ikeda, Sumiko Yoshida, Yuka Ueda, Takashi Iwase, Toshio Matsumoto and Masataka Sata :
ピタバスタチンによる血管内皮細胞での一酸化窒素合成酵素の発現亢進作用とその機序の検討,
第33回日本高血圧学会総会, 390, Oct. 2010.
271.Kumiko Kagawa, Jinno Tasashi, Harada Kakeshi, Cui Qu, Keiichiro Watanabe, Masahiro Hiasa, Oda Asuka, Amo Hiroe, Akishige Ikegame, Miki Hirokazu, Shiroh Fujii, Nakano Ayako, Kyoko Takeuchi, Shuji Ozaki, Masahiro Abe and Toshio Matsumoto :
Sensitization of hematopietic malignant cells to TRAIL with bortezomib and a TACE inhibitor,
第72回日本血液学会, Sep. 2010.
272.Shingen Nakamura, Masahiro Abe, Cui Qu, Keiichiro Watanabe, Akishige Ikegame, Masahiro Hiasa, Miki Hirokazu, Nakano Ayako, Oda Asuka, Amo Hiroe, Jinno Tasashi, Harada Takeshi, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
Bortezomib-induced osteoblast differentiation is hampered by excessive ER stress,
第72回日本血液学会, Sep. 2010.
273.Masahiro Hiasa, Masahiro Abe, 中野 綾子, 小田 明日香, 天羽 宏枝, Kyoko Takeuchi, Kumiko Kagawa, Shingen Nakamura, 三木 浩和, Ken-ichiro Yata, Keiichiro Watanabe, Shuji Ozaki, Kenzo Asaoka, Eiji Tanaka and Toshio Matsumoto :
Bone marrow stromal cells supress TACE activity in monocytes to induce osteoclastogenesis,
第72回日本血液学会, Sep. 2010.
274.Cui Qu, Masahiro Abe, Miki Hirokazu, Shingen Nakamura, Keiichiro Watanabe, Akishige Ikegame, Masahiro Hiasa, Nakano Ayako, Jinnno Tadashi, Harada Takeshi, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
Bone marrow stromal cells attenuate gama delta T,
第72回日本血液学会, Sep. 2010.
275.Masahiro Hiasa, Masahiro Abe, Toshio Matsumoto and Kenzo Asaoka :
骨髄間質細胞は単球のTACE活性を抑制し樹状細胞分化を抑制し破骨細胞分化を誘導する,
第3回ナノ・バイオメディカル学会大会, Sep. 2010.
276.安積 麻衣, Ken-ichi Aihara, Sumiko Yoshida, 倉橋 清衛, Mizuho Kinouchi, Nanako Kataoka, Itsuro Endo, Yuichi Fujinaka, Toshio Matsumoto and Munehide Matsuhisa :
2型糖尿病患者の左室拡張障害に対する強化インスリン療法の効果,
第10回日本内分泌学会四国支部学術集会, Sep. 2010.
277.Yuichi Fujinaka, 倉橋 清衛, Sumiko Yoshida, Mizuho Kinouchi, Nanako Kataoka, Itsuro Endo, Ken-ichi Aihara, Toshio Matsumoto, Minako Saito, Daisuke Fukumoto and 大島 康志 :
インスリングルリジンの少量投与が有効であった即時型インスリンアレルギーの一例,
第10回日本内分泌学会四国支部学術集会, Sep. 2010.
278.Masahiro Hiasa, Masahiro Abe, 中野 綾子, 小田 明日香, 天羽 宏枝, Kyoko Takeuchi, Kumiko Kagawa, Shingen Nakamura, 三木 浩和, Ken-ichiro Yata, Keiichiro Watanabe, Shuji Ozaki, Kenzo Asaoka, Eiji Tanaka and Toshio Matsumoto :
骨髄間質細胞は,単球のTACE活性を抑制し樹状細胞分化を抑制し破骨細胞文化を誘導する,
第28回日本骨代謝学会, Jul. 2010.
279.Keiichiro Watanabe, Masahiro Abe, Kawatani Makoto, Masahiro Hiasa, Shingen Nakamura, Eiji Tanaka, 長田 裕之 and Toshio Matsumoto :
リベロマイシンAは骨髄腫骨破壊病変の形成と腫瘍進展を抑制する,
第28回日本骨代謝学会, Jul. 2010.
280.Shingen Nakamura, Masahiro Abe, Cui Qu, Keiichiro Watanabe, Akishige Ikegame, Masahiro Hiasa, 三木 浩和, 中野 綾子, 小田 明日香, 天羽 宏枝, 神野 雅, 原田 武志, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
ボルテゾミブによる骨芽細胞分化の促進は過剰な小胞体ストレスによって抑制される,
第28回日本骨代謝学会, Jul. 2010.
281.Sumiko Yoshida, Ken-ichi Aihara, Takayuki Ise, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
A role of androgen receptor in ischemia-induced tissue damage and angiogenesis in male,
第42回日本動脈硬化学会総会・学術集会 長良川国際会議場, Jul. 2010.
282.Y. Sumiko, Ken-ichi Aihara, T. Ise, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
A role of androgen receptor in iscchemia-induced tissue damage and angiogenesis in male.,
第42回日本動脈硬化学会総会・学術集会, Jul. 2010.
283.Sumiko Yoshida, Ken-ichi Aihara, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
アンドロゲンーアンドロゲン受容体系は下肢虚血における組織傷害防御と血管新生に必須である,
2010 年度(第 52 回)日本老年医学会学術集会 神戸国際会議場・神戸商工会議所・神戸ポートピアホテル, Jun. 2010.
284.Sumiko Yoshida, 倉橋 清衛, Mizuho Kinouchi, Nanako Kataoka, Itsuro Endo, Yuichi Fujinaka, Ken-ichi Aihara and Toshio Matsumoto :
ピオグリタゾンが著効したWerner症候群の1例,
第102回日本内科学会四国地方会, May 2010.
285.Ken-ichi Aihara, Yuichi Fujinaka, Sumiko Yoshida, Itsuro Endo and Toshio Matsumoto :
血管内皮機能と頸動脈硬化症の連関に関する検討,
第102回日本内科学会四国地方会, May 2010.
286.中川 航司, Shinsuke Kido, 遠藤 逸郎, 坂田 雅映, 橋本 由衣, 佐々木 祥平, Sawako Tatsumi, Toshio Matsumoto and Ken-ichi Miyamoto :
糖尿病性骨症の発症機序の解明:終末糖化産物(AGEs)によるCanonical Wnt経路抑制機序の解析,
第64回日本栄養・食糧学会大会, May 2010.
287.倉橋 清衛, Mizuho Kinouchi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Yuichi Fujinaka and Toshio Matsumoto :
抗副腎薬投与により内因性コルチゾールの低下とともにACTHの劇的な低下が得られた異所性ACTH症候群の一例,
第83回日本内分泌学会学術総会, Vol.86, No.1, 144, Mar. 2010.
288.Ken-ichi Aihara, Sumiko Yoshida, 倉橋 清衛, Mizuho Kinouchi, Itsuro Endo, Yuichi Fujinaka, Toshio Matsumoto, Takashi Iwase, Masashi Akaike and Masataka Sata :
ロスバスタチンによる心筋リモデリング抑制効果の検討,
第83回日本内分泌学会学術総会, Mar. 2010.
289.Sumiko Yoshida, Ken-ichi Aihara, Takayuki Ise, Yuka Ueda, Yasumasa Ikeda, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Accelerated cellular apoptosis and impaired angiogenesis after hindlimb ischemia in male mice lacking androgen receptor,
第74回 日本循環器学会総会・学術集会 国立京都国際会館, Mar. 2010.
290.Hirotsugu Kurobe, 浦田 将久, Yayoi Fukuhara, Tamotsu Kanbara, Ken-ichi Aihara, Masashi Akaike, Yousuke Takahama, Toshiaki Tamaki, Toshio Matsumoto, Shuhei Tomita and Tetsuya Kitagawa :
血管リモデリング時の転写因子HIF-1αの役割 (第110回日本外科学会定期学術集会),
Journal of Japan Surgical Society, Vol.111, No.2, 701, Mar. 2010.
(CiNii: 110007718434)
291.倉橋 清衛, Ken-ichi Aihara, Sumiko Yoshida, Itsuro Endo and Toshio Matsumoto :
強化インスリン療法による2型糖尿病患者の左室リモデリングおよび拡張能改善効果に関する検討,
第240回徳島医学会学術集会, Feb. 2010.
292.阿部 容子, Itsuro Endo, Ken-ichi Aihara and Toshio Matsumoto :
重症低血糖昏睡および肺炎をきたした神経性食思不振症の救命症例,
第240回徳島医学会学術集会, Feb. 2010.
293.Itsuro Endo and Toshio Matsumoto :
FGF23関連低リン血症性くる病・骨軟化症の第一次全国調査,
厚生労働科学研究費補助金ホルモン受容機構異常に関する調査研究, Jan. 2010.
294.木戸 里佳, Yuichi Fujinaka, 寺澤 敏秀, Mizuho Kinouchi, Sumiko Yoshida, Tomoyuki Yuasa, 瀬尾 浩二, 笠松 哲司, Toshio Matsumoto and 鶴尾 美穂 :
インスリン治療中に副腎不全および粘液水腫を合併し,意識障害を伴う低血糖を繰り返した一例,
第101回日本内科学会四国地方会, Nov. 2009.
295.Ken-ichi Aihara, Sumiko Yoshida, 倉橋 清衛, Mizuho Kinouchi, Itsuro Endo, Yuichi Fujinaka and Toshio Matsumoto :
強化インスリン療法による血糖コントロールの改善により左室拡張能の改善がみられた3例,
第101回日本内科学会四国地方会, Nov. 2009.
296.Sumiko Yoshida, 倉橋 清衛, Mizuho Kinouchi, Itsuro Endo, Ken-ichi Aihara, Yuichi Fujinaka and Toshio Matsumoto :
家族内集積が疑われた緩徐進行1型糖尿病の一例,
第47回に本糖尿病学会中国四国地方会, Nov. 2009.
297.Sumiko Yoshida, Yuichi Fujinaka, 倉橋 清衛, Mizuho Kinouchi, Itsuro Endo, Ken-ichi Aihara and Toshio Matsumoto :
SPIDDMが疑われる1型糖尿病の家族内集積例,
第47回日本糖尿病学会中国四国地方会, Nov. 2009.
298.Yuichi Fujinaka, Ken-ichi Aihara, 鈴木 麗子, Mizuho Kinouchi, Sumiko Yoshida, 倉橋 清衛, Itsuro Endo and Toshio Matsumoto :
メタボリックシンドローム検診における糖代謝異常の検討,
第47回日本糖尿病学会中国四国地方会, Nov. 2009.
299.Daisuke Tsuji, Shuji Ozaki, Akishige Ikegame, 伊藤 良和, 徳田 美幸, 岡野 和真, Masahiro Abe, Toshio Matsumoto and Kouji Itou :
ヒト多発性骨髄腫由来ガン幹細胞の単離及び性質決定,
第82回日本生化学会大会, Oct. 2009.
300.Sumiko Yoshida, Ken-ichi Aihara, Takayuki Ise, 住友 由佳, Toshio Matsumoto, Shusuke Yagi, Takashi Iwase, Masashi Akaike, Hirotsugu Yamada, Masataka Sata and 西尾 進 :
副腎アンドロゲンDHEASの抗動脈硬化作用における性差の検討,
第32回日本高血圧学会学術集会, Oct. 2009.
301.Ken-ichi Aihara, Yuichi Fujinaka, Mizuho Kinouchi, Sumiko Yoshida, 鈴木 麗子, 倉橋 清衛, Itsuro Endo, Shusuke Yagi, Takashi Iwase, 平田 陽一郎, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
内臓脂肪蓄積制御に関わる因子の臨床的検討,
第32回日本高血圧学会総会, 196, Oct. 2009.
302.Sumiko Yoshida, Ken-ichi Aihara, 伊勢 孝之, 上田 由佳, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
副腎アンドロゲンDHEASの抗動脈硬化作用における性差の検討,
第32回日本高血圧学会総会, Oct. 2009.
303.Masashi Akaike, Ken-ichi Aihara, Yasumasa Ikeda, 石川 カズ江, Sumiko Yoshida, Yuka Ueda, Shusuke Yagi, Takashi Iwase, Toshio Matsumoto and Masataka Sata :
ミネラルコルチコイド受容体を介したグルココルチコイド過剰による血管内皮細胞障害作用,
第32回日本高血圧学会総会, 244, Oct. 2009.
304.倉橋 清衛, Itsuro Endo, Ken-ichi Aihara, Yuichi Fujinaka, Toshio Matsumoto, Shinya Watanabe and Tetsuro Ohmori :
脳波の徐波化を伴う重症低血糖昏睡を来たした神経性食思不振症の一例,
第9回 日本内分泌学会 四国支部学術集会, Sep. 2009.
305.Yuichi Fujinaka, Ken-ichi Aihara, 鈴木 麗子, Mizuho Kinouchi, Sumiko Yoshida, 倉橋 清衛, Itsuro Endo and Toshio Matsumoto :
当院メタボリックシンドローム検診における糖代謝異常の検討.,
第239回徳島医学会学術総会, Aug. 2009.
306.Ken-ichi Aihara, Yuichi Fujinaka, Mizuho Kinouchi, Sumiko Yoshida, 倉橋 清衛, Itsuro Endo, Yuka Ueda, 平田 陽一郎, Shusuke Yagi, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Influence of lipid profile on endothelial function in subjects with cardiovascular risk factors,
第41回日本動脈硬化学会総会・学術集会, Jul. 2009.
307.Sumiko Yoshida, Ken-ichi Aihara, Yuka Ueda, 倉橋 清衛, Mizuho Kinouchi, Itsuro Endo, Yuichi Fujinaka, Shusuke Yagi, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
Regular use of rosuvastatin attenuates carotid atherosclerosis regardless of LDL cholesterol lowering effect,
第41回日本動脈硬化学会総会・学術集会, Jul. 2009.
308.Itsuro Endo, 大西 幸代, 木戸 里佳, 倉橋 清衛, Sumiko Yoshida, Yuichi Fujinaka, Ken-ichi Aihara, Masahiro Abe, 福本 誠二 and Toshio Matsumoto :
新規calcilytics,JTT305は常染色体優性低Ca血症におけるCa感知受容体活性型変異シグナルを抑制する,
第27回日本骨代謝学会学術集会, 195, Jul. 2009.
309.倉橋 清衛, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Yuichi Fujinaka, Shusuke Yagi, Takashi Iwase, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
一酸化炭素中毒にて急性心筋梗塞を発症した2型糖尿病の1例,
第100回日本内科学会四国地方会, May 2009.
310.Itsuro Endo, 藤村 光則, Sumiko Yoshida, 栗若 里佳, Shinsuke Kido, Takashi Iwase, Daisuke Inoue, Ken-ichi Aihara, Yuichi Fujinaka, Masashi Akaike and Toshio Matsumoto :
冠動脈不安定プラーク予測因子としてのICTP,
第82回日本内分泌学会学術総会, Vol.85, No.1, 283, Apr. 2009.
311.Masashi Akaike, Ken-ichi Aihara, Yasumasa Ikeda, 石川 カズ江, 住友 由佳, Sumiko Yoshida, Shusuke Yagi, Takashi Iwase, Toshio Matsumoto and Masataka Sata :
グルココルチコイド誘発性血管内皮細胞障害におけるミネラルコルチコイド受容体の関与,
第82回日本内分泌学会学術総会, Vol.85, No.1, 373, Apr. 2009.
312.Sumiko Yoshida, Ken-ichi Aihara, 西尾 進, 倉橋 清衛, Itsuro Endo, Yuichi Fujinaka, Takayuki Ise, 住友 由佳, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Masashi Akaike, Masataka Sata and Toshio Matsumoto :
副腎アンドロゲンDHEASは血管内皮機能非依存的に頸動脈硬化を抑制する,
第82回日本内分泌学会学術総会, Vol.85, No.1, 366, Apr. 2009.
313.Ken-ichi Aihara, Yuichi Fujinaka, Sumiko Yoshida, 鈴木 麗子, 倉橋 清衛, Itsuro Endo and Toshio Matsumoto :
尿中アルブミンは内臓脂肪蓄積の強力な増悪因子である,
第82回日本内分泌学会学術総会, Vol.85, No.1, 337, Apr. 2009.
314.Ken-ichi Aihara, Yuichi Fujinaka, Sumiko Yoshida, 鈴木 麗子, 倉橋 清衛, Itsuro Endo and Toshio Matsumoto :
内臓脂肪増大因子に関する臨床的検討,
第106回日本内科学会総会・講演会, Vol.98, No.Suppl., 233, Apr. 2009.
315.Sumiko Yoshida, Ken-ichi Aihara, 倉橋 清衛, Itsuro Endo, Yuichi Fujinaka, 住友 由佳, Toshio Matsumoto, Shusuke Yagi, Takashi Iwase and Masashi Akaike :
DHEASは血管内皮機能に依存せず動脈硬化を抑制する(頸動脈エコーを用いた臨床的検討),
第106回日本内科学会総会・講演会, Vol.98, No.Suppl., 139, Ap